
<html lang="en"     class="pb-page"  data-request-id="6424d658-20b9-4a74-8146-eb4de50b64c0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm3017078;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2013.56.issue-6;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of Novel Potent trans-3,4-Disubstituted Pyrrolidine Inhibitors of the Human Aspartic Protease Renin from in Silico Three-Dimensional (3D) Pharmacophore Searches" /></meta><meta name="dc.Creator" content="Edwige  Lorthiois" /></meta><meta name="dc.Creator" content="Werner  Breitenstein" /></meta><meta name="dc.Creator" content="Frederic  Cumin" /></meta><meta name="dc.Creator" content="Claus  Ehrhardt" /></meta><meta name="dc.Creator" content="Eric  Francotte" /></meta><meta name="dc.Creator" content="Edgar  Jacoby" /></meta><meta name="dc.Creator" content="Nils  Ostermann" /></meta><meta name="dc.Creator" content="Holger  Sellner" /></meta><meta name="dc.Creator" content="Takatoshi  Kosaka" /></meta><meta name="dc.Creator" content="Randy L.  Webb" /></meta><meta name="dc.Creator" content="Dean F.  Rigel" /></meta><meta name="dc.Creator" content="Ulrich  Hassiepen" /></meta><meta name="dc.Creator" content="Paul  Richert" /></meta><meta name="dc.Creator" content="Trixie  Wagner" /></meta><meta name="dc.Creator" content="Jürgen  Maibaum" /></meta><meta name="dc.Description" content="The small-molecule trans-3,4-disubstituted pyrrolidine 6 was identified from in silico three-dimensional (3D) pharmacophore searches based on known X-ray structures of renin–inhibitor complexes and..." /></meta><meta name="Description" content="The small-molecule trans-3,4-disubstituted pyrrolidine 6 was identified from in silico three-dimensional (3D) pharmacophore searches based on known X-ray structures of renin–inhibitor complexes and..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 15, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3017078" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3017078" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3017078" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3017078" /></link>
        
    
    

<title>The Discovery of Novel Potent trans-3,4-Disubstituted Pyrrolidine Inhibitors of the Human Aspartic Protease Renin from in Silico Three-Dimensional (3D) Pharmacophore Searches | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3017078" /></meta><meta property="og:title" content="The Discovery of Novel Potent trans-3,4-Disubstituted Pyrrolidine Inhibitors of the Human Aspartic Protease Renin from in Silico Three-Dimensional (3D) Pharmacophore Searches" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0009.jpeg" /></meta><meta property="og:description" content="The small-molecule trans-3,4-disubstituted pyrrolidine 6 was identified from in silico three-dimensional (3D) pharmacophore searches based on known X-ray structures of renin–inhibitor complexes and demonstrated to be a weakly active inhibitor of the human enzyme. The unexpected binding mode of the more potent enantiomer (3S,4S)-6a in an extended conformation spanning the nonprime and S1′ pockets of the recombinant human (rh)-renin active site was elucidated by X-ray crystallography. Initial structure–activity relationship work focused on modifications of the hydrophobic diphenylamine portion positioned in S1 and extending toward the S2 pocket. Replacement with an optimized P3–P1 pharmacophore interacting to the nonsubstrate S3sp cavity eventually resulted in significantly improved in vitro potency and selectivity. The prototype analogue (3S,4S)-12a of this new class of direct renin inhibitors exerted blood pressure lowering effects in a hypertensive double-transgenic rat model after oral administration." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3017078"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3017078">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3017078&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3017078&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3017078&amp;href=/doi/10.1021/jm3017078" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2207-2217</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301706j" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3007933" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of Novel Potent <i>trans</i>-3,4-Disubstituted Pyrrolidine Inhibitors of the Human Aspartic Protease Renin from in Silico Three-Dimensional (3D) Pharmacophore Searches</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edwige++Lorthiois">Edwige Lorthiois</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Werner++Breitenstein">Werner Breitenstein</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederic++Cumin">Frederic Cumin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Claus++Ehrhardt">Claus Ehrhardt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Francotte">Eric Francotte</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edgar++Jacoby">Edgar Jacoby</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nils++Ostermann">Nils Ostermann</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Holger++Sellner">Holger Sellner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Takatoshi++Kosaka">Takatoshi Kosaka</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Randy+L.++Webb">Randy L. Webb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dean+F.++Rigel">Dean F. Rigel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ulrich++Hassiepen">Ulrich Hassiepen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Richert">Paul Richert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Trixie++Wagner">Trixie Wagner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=J%C3%BCrgen++Maibaum">Jürgen Maibaum</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Novartis Pharma AG, Institutes for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Novartis Institutes for BioMedical Research, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Novartis Pharmaceuticals Corp., Institutes for BioMedical Research, East Hanover, New Jersey, United States</span></div><div class="corresp-info"><strong>*</strong>For E.L.: phone, +41-61-6961955; fax, +41-61-6967155; E-mail, <a href="/cdn-cgi/l/email-protection#0b6e6f7c626c6e256764797f63626462784b65647d6a797f627825686466"><span class="__cf_email__" data-cfemail="97f2f3e0fef0f2b9fbf8e5e3fffef8fee4d7f9f8e1f6e5e3fee4b9f4f8fa">[email protected]</span></a>. For J.M.: phone, +41-61-6965560; fax, +41-61-6967155; E-mail, <a href="/cdn-cgi/l/email-protection#8be1feeef9eceee5d4e0e7eafef8a5e6eae2e9eafee6cbe5e4fdeaf9ffe2f8a5e8e4e6"><span class="__cf_email__" data-cfemail="e38996869184868dbc888f829690cd8e828a8182968ea38d8c958291978a90cd808c8e">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3017078&amp;href=/doi/10.1021%2Fjm3017078" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2207–2217</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 20, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>20 November 2012</li><li><span class="item_label"><b>Published</b> online</span>15 March 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 28 March 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3017078" title="DOI URL">https://doi.org/10.1021/jm3017078</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2207%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEdwige%2BLorthiois%252C%2BWerner%2BBreitenstein%252C%2BFrederic%2BCumin%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D6%26contentID%3Djm3017078%26title%3DThe%2BDiscovery%2Bof%2BNovel%2BPotent%2Btrans-3%252C4-Disubstituted%2BPyrrolidine%2BInhibitors%2Bof%2Bthe%2BHuman%2BAspartic%2BProtease%2BRenin%2Bfrom%2Bin%2BSilico%2BThree-Dimensional%2B%25283D%2529%2BPharmacophore%2BSearches%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2217%26publicationDate%3DMarch%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3017078"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1489</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3017078" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of Novel Potent trans-3,4-Disubstituted Pyrrolidine Inhibitors of the Human Aspartic Protease Renin from in Silico Three-Dimensional (3D) Pharmacophore Searches&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Edwige&quot;,&quot;last_name&quot;:&quot;Lorthiois&quot;},{&quot;first_name&quot;:&quot;Werner&quot;,&quot;last_name&quot;:&quot;Breitenstein&quot;},{&quot;first_name&quot;:&quot;Frederic&quot;,&quot;last_name&quot;:&quot;Cumin&quot;},{&quot;first_name&quot;:&quot;Claus&quot;,&quot;last_name&quot;:&quot;Ehrhardt&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Francotte&quot;},{&quot;first_name&quot;:&quot;Edgar&quot;,&quot;last_name&quot;:&quot;Jacoby&quot;},{&quot;first_name&quot;:&quot;Nils&quot;,&quot;last_name&quot;:&quot;Ostermann&quot;},{&quot;first_name&quot;:&quot;Holger&quot;,&quot;last_name&quot;:&quot;Sellner&quot;},{&quot;first_name&quot;:&quot;Takatoshi&quot;,&quot;last_name&quot;:&quot;Kosaka&quot;},{&quot;first_name&quot;:&quot;Randy&quot;,&quot;last_name&quot;:&quot;L. Webb&quot;},{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;F. Rigel&quot;},{&quot;first_name&quot;:&quot;Ulrich&quot;,&quot;last_name&quot;:&quot;Hassiepen&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Richert&quot;},{&quot;first_name&quot;:&quot;Trixie&quot;,&quot;last_name&quot;:&quot;Wagner&quot;},{&quot;first_name&quot;:&quot;Jürgen&quot;,&quot;last_name&quot;:&quot;Maibaum&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;2207-2217&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3017078&quot;},&quot;abstract&quot;:&quot;The small-molecule trans-3,4-disubstituted pyrrolidine 6 was identified from in silico three-dimensional (3D) pharmacophore searches based on known X-ray structures of renin–inhibitor complexes and demonstrated to be a weakly active inhibitor of the human enzyme. The unexpected binding mode of the more potent enantiomer (3S,4S)-6a in an extended conformation spanning the nonprime and S1′ pockets of the recombinant human (rh)-renin active site was elucidated by X-ray crystallography. Initial structure–activity relationship work focused on modifications of the hydrophobic diphenylamine portion positioned in S1 and extending toward the S2 pocket. Replacement with an optimized P3–P1 pharmacophore interacting to the nonsubstrate S3sp cavity eventually resulted in significantly improved in vitro potency and selectivity. The prototype analogue (3S,4S)-12a of this new class of direct renin inhibitors exerted blood pressure lowering effects in a hypertensive double-transgenic rat model after oral administration.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3017078&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3017078" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3017078&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3017078" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3017078&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3017078" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3017078&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3017078&amp;href=/doi/10.1021/jm3017078" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3017078" /></input><a href="/doi/pdf/10.1021/jm3017078" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3017078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3017078%26sid%3Dliteratum%253Aachs%26pmid%3D23425156%26genre%3Darticle%26aulast%3DLorthiois%26date%3D2013%26atitle%3DThe%2BDiscovery%2Bof%2BNovel%2BPotent%2Btrans-3%252C4-Disubstituted%2BPyrrolidine%2BInhibitors%2Bof%2Bthe%2BHuman%2BAspartic%2BProtease%2BRenin%2Bfrom%2Bin%2BSilico%2BThree-Dimensional%2B%25283D%2529%2BPharmacophore%2BSearches%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D6%26spage%3D2207%26epage%3D2217%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292164" title="Pyrrolidines">Pyrrolidines</a>,</li><li><a href="/action/doSearch?ConceptID=290663" title="Pharmacophores">Pharmacophores</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291026" title="Conformation">Conformation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jmcmar.2013.56.issue-6/production/jmcmar.2013.56.issue-6.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The small-molecule <i>trans</i>-3,4-disubstituted pyrrolidine <b>6</b> was identified from in silico three-dimensional (3D) pharmacophore searches based on known X-ray structures of renin–inhibitor complexes and demonstrated to be a weakly active inhibitor of the human enzyme. The unexpected binding mode of the more potent enantiomer (3<i>S</i>,4<i>S</i>)-<b>6a</b> in an extended conformation spanning the nonprime and S1′ pockets of the recombinant human (rh)-renin active site was elucidated by X-ray crystallography. Initial structure–activity relationship work focused on modifications of the hydrophobic diphenylamine portion positioned in S1 and extending toward the S2 pocket. Replacement with an optimized P3–P1 pharmacophore interacting to the nonsubstrate S3<sup>sp</sup> cavity eventually resulted in significantly improved in vitro potency and selectivity. The prototype analogue (3<i>S</i>,4<i>S</i>)-<b>12a</b> of this new class of direct renin inhibitors exerted blood pressure lowering effects in a hypertensive double-transgenic rat model after oral administration.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28650" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28650" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chronic elevation of systemic blood pressure, known as hypertension, is an important risk factor for cardiovascular disease such as congestive heart failure, stroke, and myocardial infarction and is the leading cause of death in the western world.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The renin–angiotensin–aldosterone system (RAAS)<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> plays a fundamental role in normal blood pressure control and body fluid volume homeostasis, while excessive stimulation of the RAAS contributes directly to cardiorenal diseases.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The highly substrate-specific aspartic protease renin found in the circulation following synthesis and release from juxtaglomerular cells of the kidney<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> catalyzes the first and rate limiting cleavage step of the RAAS, generating the biologically inactive decapeptide angiotensin I (AngI) from the α2-globulin angiotensinogen substrate.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> AngI is further processed by the angiotensin-converting enzyme (ACE) to generate the octapeptide AngII. The interaction of AngII with the AT1 receptor triggers various hemodynamic effects, such as sodium and water retention, stimulation of aldosterone release, and potent vasoconstriction.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Furthermore, AngII exerts direct growth factor-like effects via several pathways mainly downstream of AT1 inducing cell proliferation or fibrosis.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Direct renin inhibitors (DRIs) may provide unique therapeutic benefits<a onclick="showRef(event, 'ref5 ref8 ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref5 ref8 ref9 ref10 ref11">(5, 8-11)</a> as a result of more complete blockade of the RAAS at source by preventing the formation of AngI and AngII at compensatory elevated circulating renin levels and hence the formation of AngI derived products<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> without affecting kinin metabolism.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Moreover, clinical studies have demonstrated the potential of direct renin inhibition for end organ protection beyond blood pressure lowering effects.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Our current perspective on designing orally active DRIs has experienced a remarkable transformation during more than three decades starting from peptide-like transition-state inhibitors and subsequently progressing toward various distinct classes of nonpeptide inhibitors (<b>1</b>–<b>4</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Inhibitor <b>1</b> (aliskiren, Tekturna, Rasilez) has received recently marketing approval as the first DRI for the treatment of hypertension. The compound has emerged from a S<sub>3</sub>–S<sub>1</sub> topological design concept, which notably exploited in addition tight binding interactions to the nonsubstrate S<sub>3</sub> subpocket (S<sub>3</sub><sup>sp</sup>) of human renin.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> The early class of 3,4-piperidine-based “group replacement assisted binding (GRAB) peptidomimetics”,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> first reported by Hoffmann-La Roche,<a onclick="showRef(event, 'ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref20 ref21">(20, 21)</a> has further advanced to 3,9-diazabicyclo[3.3.1]nones, such as <b>2</b> (ACT-077825) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which has undergone phase II clinical trials.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The basic amine mono- or bicyclic center scaffolds of such GRAB peptidomimetic inhibitors form favorable charge-enforced H-bond interactions to the catalytic Asp<sub>32</sub> and Asp<sub>215</sub>. More intriguingly, these DRIs bind to a fundamentally different enzyme active site topography characterized by an open conformation of the flap β-hairpin and formation of a large hydrophobic pocket (Tyr<sub>75</sub> flap pocket) that is unrecognized by the renin substrate. A series of potent 2,4-diaminopyrimidines, such as <b>3</b>, bearing a P<sub>3</sub>–P<sub>1</sub> benzoxazinone pharmacophore and interacting with the basic heterocyclic headgroup to the catalytic dyad, have been reviewed elsewhere.<a onclick="showRef(event, 'ref16 ref23'); return false;" href="javascript:void(0);" class="ref ref16 ref23">(16, 23)</a> Most recently, the alkylamine class of DRIs has attracted much interest with compound <b>4</b> (VTP-27999) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) having been reported to be under clinical investigation.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Diverse classes of nonpeptide direct inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">We have embarked on a broad integrated screening program encompassing multiple approaches in parallel in the quest for identifying attractive novel-class druglike scaffolds, potentially leading to orally efficacious DRIs with improved oral bioavailability and reduced cost of goods. These efforts included two large-scale HTS campaigns using both an enzymatic and a competitive ligand binding assay format, a combined NMR/X-ray fragment-based screen of an aspartic protease-family directed library, as well as virtual searches utilizing the renin–inhibitor X-ray structure knowledge. The various screening approaches that were utilized proved to be remarkably complementary in identifying attractive hits of high structural diversity from different sources.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> We report herein the discovery of the novel 3,4-disubstituted pyrrolidine <b>6</b> from a computational pharmacophore search and our initial SAR work guided by X-ray crystallography, leading to the orally active (3<i>S</i>,4<i>S</i>)-<b>12a</b> with significantly improved potency and selectivity.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08750" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08750" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A virtual screening approach was developed based on three-dimensional (3D) pharmacophore models constructed from the X-ray crystal structures of renin–inhibitor complexes representing a diversity of active site binding topographies, followed by Unity 3D flexible pharmacophore searching within the Novartis compound database.<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> The selected X-ray complexes included that of the low-affinity <i>trans</i>-3,4-piperidine <b>5</b><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> (34% inhibition of rh-renin at 10 μM concentration in the FRET enzymatic assay;<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), which was resolved in our group at 2.4 Å resolution.<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> In brief, the key elements of the three-point pharmacophore derived from (3<i>R</i>,4<i>R</i>)-<b>5</b> were defined by the basic piperidine nitrogen atom interacting to the catalytic Asp<sub>32</sub> and Asp<sub>215</sub>, the geometric center of the S<sub>3</sub>–S<sub>1</sub> binding naphthyl, and of the C4 phenyl residue positioned in the Tyr<sub>75</sub> flap pocket. Both hydrophobic centers were defined with a positional constraint of 1.5 Å.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>trans</i>-3,4-Piperidine (3<i>R</i>,4<i>R</i>)-<b>5</b> used for 3D pharmacophore search and pharmacophore hit <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of the <i>trans</i>-3,4-pyrrolidine <b>6a</b> (shown as stick model in green color) bound to the active site of glycosylated rh-renin (refined at 2.6 Å resolution) and superimposed with inhibitor <b>1</b> (left-hand side picture; orange color; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v0z">2V0Z</a>)<a onclick="showRef(event, 'cit17b ref28'); return false;" href="javascript:void(0);" class="ref cit17b ref28">(17b, 28)</a> and inhibitor <b>5</b> (right-hand side picture; magenta color) in complex with rh-renin. Shown is the solvent accessible surface of renin. Residues of the flap β-hairpin (residues Tyr<sub>75</sub>, Ser<sub>76</sub>, Thr<sub>77</sub>, and Gly<sub>78</sub>) are depicted as thin lines in green, orange, and magenta for the rh-renin/<b>6a</b>, rh-renin/<b>1</b>, and rh-renin/<b>5</b> complexes, respectively, and have been omitted from the protein surface calculation. The oxygen and nitrogen atoms of the ligands are colored in red and blue, respectively. The absolute (3<i>S</i>,4<i>S</i>)-configuration of <b>6a</b> was tentatively assigned based on the observed difference electron density and was subsequently confirmed by synthesis and chemical correlation with an authentic sample (see text for discussion).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The primary in silico hit list comprising a total of 3717 compounds was further refined by adding Unity volume constraints for the van der Waals surfaces of the protein atoms calculated with MOLCAD.<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> The surface constraints were generated and applied independently by using both the X-ray crystal complex structure of <b>5</b> and that of a related analogue bearing an extended <i>ortho</i>-chlorobenzyloxymethyl moiety at the C4′ phenyl position (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PR8">1PR8</a>).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Triaging by visual inspection of the combined remaining hits removed compounds with an apparent structural alert, and physical availability in the corporate database was then checked. A total of 328 compounds were finally tested for renin inhibition using a fluorescence resonance energy transfer (FRET) biochemical assay identifying four weakly active nonpeptide hits. (<i>Rac</i>)-<b>6</b> was the most potent, with an IC<sub>50</sub> of 14 μM (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), representing the first attractive analogue of a new chemotype DRI. Racemic resolution of <b>6</b> by chiral HPLC (Chiracel OD) afforded the single enantiomer <b>6a</b> (enantiomeric excess <i>ee</i> >99.9%), with an IC<sub>50</sub> of 7.6 μM toward rh-renin and being slightly more potent compared to its antipode <b>6b</b> (IC<sub>50</sub> = 18 μM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Also, compound <b>6a</b> only weakly inhibited other human aspartic proteases with IC<sub>50</sub> = 11 μM for both rh-cathepsin D and E and IC<sub>50</sub> = 4.5 and 29 μM for rh-pepsin A and C, respectively. The absolute configuration of (3<i>S</i>,4<i>S</i>)-<b>6a</b> was subsequently confirmed by synthesis and chemical correlation with an authentic sample (vide infra).<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Inhibition of rh-Renin<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0008.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Half–maximal inhibition of rh-renin determined in a FRET-based enzymatic assay using (RE(EDANS)IHPFHLVIHTK(Dabcyl)R as the substrate in 100 mM Tris–HCl buffer pH 7.4.<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> Data represent mean values from duplicates.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">All compounds prepared as HCl salts.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Racemic mixture.</p></div></div><div></div></div><div class="NLM_p">We were very gratified that the X-ray crystal structure of the weakly active <b>6a</b> in its complex with rh-renin could be rapidly resolved by the soaking method,<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> revealing an unexpected ligand binding orientation along the axis of the enzyme substrate cleft (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). In its complex, <b>6a</b> adopted an extended conformation spanning both the prime and nonprime recognition sites. Most notably, <b>6a</b> lacked any binding interaction to the open flap Tyr<sub>75</sub> pocket similar to the C4 phenyl of piperidine <b>5</b>, as was anticipated from the 3D pharmacophore search and suggested by additional modeling work. The basic pyrrolidine nitrogen atom of <b>6a</b> occupied the pivotal position almost symmetrical between the catalytic Asp<sub>32</sub> and Asp<sub>215</sub> of renin, as was predicted by modeling, most likely forming electrostatically enforced H-bond interactions to both carboxylates. The very close superposition of the five-membered ring transition-state surrogate of <b>6a</b> with the center piperidine scaffold of renin-bound <b>5</b> was quite noteworthy.</div><div class="NLM_p">The difference electron density map observed for <b>6a</b> was only compatible with absolute (3<i>S</i>,4<i>S</i>)-configuration. The ligand was bound in an energetically less favored trans-pseudoaxial conformation which allowed the hydrophobic 3(<i>S</i>)-benzyl residue to be positioned in the S<sub>1</sub>′ pocket in an unusual orientation almost perpendicular to the axis of this binding site (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Interestingly, a significant conformational movement of Pro<sub>292</sub> toward the phenyl C4 of <b>6a</b> was noted. On the other hand, the lipophilic <i>N</i>,<i>N</i>-diphenylamino moiety was bound to the nonprime site with the unsubstituted <i>N</i>-phenyl interacting with S<sub>1</sub> pocket. The <i>N</i>-4-chlorophenyl was located at the entrance of the S<sub>2</sub> pocket of rh-renin and in close distance to Ser<sub>219</sub>, with the chlorine atom pointing toward the aryl side chain of Tyr<sub>220</sub> within 3.4 Å binding distance. The 4-chlorophenyl portion nicely overlapped with the P<sub>3</sub>/P<sub>2</sub> carboxamide group of peptide-like peptidomimetic DRIs<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> in a perpendicular relative conformation. Notably, the closed flap β-hairpin adopted a significantly different conformation as was observed for the S<sub>3</sub>–S<sub>1</sub> topological inhibitor <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). This was attributed to the fact that a second molecule of <b>6a</b> was observed in the crystal structure, binding to the S<sub>3</sub> and S<sub>4</sub> nonprime sites with the chlorophenyl residue being in close contact with the flap region and forming a direct H-bond interaction to the side chain of Tyr<sub>220</sub> via its pyrrolidine nitrogen. Two entities of renin were present in the asymmetric unit of the crystal, each complexed with two molecules of inhibitor <b>6a</b>. The unsubstituted phenyl ring of each “second site” inhibitor molecules was engaged in intermolecular contacts with the Phe<sub>242</sub> side chains of both renin entities in the crystal packing.<a onclick="showRef(event, 'cit26c'); return false;" href="javascript:void(0);" class="ref cit26c">(26c)</a> Interestingly, the electron density was well-defined and the inhibitor occupancy was identical for both ligands binding to the active site of renin in the S<sub>1</sub>′ and S<sub>2</sub> or the S<sub>3</sub> and S<sub>4</sub> nonprime sites, respectively. On the basis of these observations, a significant contribution of the second ligand to the binding affinity of <b>6a</b> to the S<sub>1</sub>′/S<sub>2</sub> active site cannot be ruled out. Quantification of the energetic contributions of the “second ligand” would require additional experiments.</div><div class="NLM_p">Retrospectively, the 3D pharmacophore-assisted discovery of <b>6a</b> as a weakly active inhibitor of human renin is quite remarkable in view of its unexpected binding pose unveiled by X-ray crystallography. The two hydrophobic constraints in combination with the basic amine constraint of our pharmacophore model derived from the GRAB peptidomimetic <b>5</b> were fully matched by the two aromatic substituents of the <i>N</i>,<i>N</i>-diphenylamino moiety and the pyrrolidine template of <b>6a</b>, respectively. In this model, the unsubstituted <i>N</i>-phenyl moiety of <b>6a</b> matched with the C4 phenyl group of <b>5</b> binding to the open-flap conformation, and the <i>N</i>-<i>para</i>-Cl-phenyl corresponded to the S<sub>1</sub>–S<sub>3</sub> naphthalene scaffold of <b>5</b>. Notably, the exclusion volume derived from the published X-ray structure (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PR8">1PR8</a>) of a GRAB peptidomimetic binding deeply into the open flap pocket accommodated <b>6</b> in its pharmacophore-derived orientation and conformation. On the other hand, there was not sufficient space within the exclusion volume derived from the human renin/<b>5</b> crystal complex structure because the open-conformation flap pocket in this case was too narrow in order to identify <b>6</b> as a potential ligand of the enzyme.</div><div class="NLM_p">The insight gained by X-ray crystallography into the binding interactions of (3<i>S</i>,4<i>S</i>)-<b>6a</b> was crucial for developing an efficient hit-to-lead optimization strategy. Initially, we focused our attention on exploring the potential offered by the unprecedented <i>N</i>,<i>N</i>-diphenylamine nonprime site binding motif to improve the binding affinity to rh-renin. Specifically, major efforts addressed modifications of the “upper” <i>N</i>-4-chlorophenyl portion with the aim to induce a H-bond to the Ser<sub>219</sub> at the entrance of the nonsubstrate S<sub>3</sub><sup>sp</sup> cavity and/or to tether this aryl portion by a short linker and to further expand into the unoccupied S<sub>2</sub> pocket. Combined attempts were also made to fill the large hydrophobic S<sub>3</sub>–S<sub>1</sub> pocket by appropriately substituting the S<sub>1</sub> binding <i>N</i>-phenyl residue. However, while more than 150 analogues of <b>6</b> with such modifications of both <i>N</i>-aryl groups were synthesized, no significant improvement in potency was accomplished (data not shown).</div><div class="NLM_p">The superimposed X-ray crystal structures of (3<i>S</i>,4<i>S</i>)-<b>6a</b> and <b>1</b><a onclick="showRef(event, 'ref17 ref28'); return false;" href="javascript:void(0);" class="ref ref17 ref28">(17, 28)</a> revealed the <i>N</i>,<i>N</i>-diphenylamine nitrogen atom of <b>6a</b> to be positioned very closely to the chirality center bearing the S<sub>1</sub> isopropyl group of <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). This prompted us to merge the unique key structural elements of both inhibitor chemotypes by combining the optimized topological P<sub>3</sub>/P<sub>3</sub><sup>sp</sup>–P<sub>1</sub> pharmacophore of <b>1</b> with the 3,4-pyrrolidine center transition-state surrogate of <b>6a</b>. Analogues of <b>1</b> bearing either a basic <i>N</i>-isopropyl tertiary amine or the related neutral <i>N</i>-isopropyl benzamide P<sub>3</sub>–P<sub>1</sub> motif had been previously discovered to display high in vitro potency toward human renin.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Compounds (<i>rac</i>)-<b>7</b> and (<i>rac</i>)-<b>8</b> in which the <i>N</i>-phenyl of <b>6</b> is replaced by an unsubstituted benzyl and a P<sub>3</sub><sup>sp</sup>-tethered dialkoxybenzyl group, respectively, were found to be equipotent to (3<i>S</i>,4<i>S</i>)-<b>6a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Furthermore, the <i>N</i>-isopropyl analogue (<i>rac</i>)-<b>9</b> surprisingly did not show improved inhibitory affinity in the FRET biochemical assay.</div><div class="NLM_p">Next, we investigated the introduction of a carbonyl linker in order to avoid a basic amine functional group at P<sub>1</sub> and to constrain the ligand conformational flexibility. In addition, computational docking predicted a H-bond interaction between the spacer carbonyl and Thr<sub>77</sub> of the flap β-hairpin,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> anticipating a closed binding conformation similar to that of the renin–inhibitor <b>1</b> complex. A ∼5-fold improvement in potency was observed for the <i>N</i>-chlorophenyl-<i>N</i>-benzamide (<i>rac</i>)-<b>10</b> (IC<sub>50</sub> = 1.7 μM) and its <i>des</i>-chloro analogue (<i>rac</i>)-<b>11</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Most notably, a further significant increase in inhibitory affinity was accomplished with the <i>N</i>-isopropyl analogue (<i>rac</i>)-<b>12</b> (IC<sub>50</sub> = 0.45 μM). This result was considered to be in line with previous findings<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> indicating that the <i>N</i>-phenyl residue would be suboptimal for this inhibitor series to be smoothly accommodated by the S<sub>1</sub> pocket. The pure enantiomer (3<i>S</i>,4<i>S</i>)-<b>12a</b> showed an IC<sub>50</sub> of 170 nM and was 15 times more active compared to the distomer (3<i>R</i>,4<i>R</i>)-<b>12b</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Importantly, the potency of (3<i>S</i>,4<i>S</i>)-<b>12a</b> toward renin was retained when measured in the presence of human plasma (IC<sub>50</sub> = 300 nM). Furthermore, (3<i>S</i>,4<i>S</i>)-<b>12a</b> was highly selective against human pepsins A, C, human cathepsins D, E, as well as human BACE-1 and BACE-2 (all IC<sub>50</sub> >30 μM).</div><div class="NLM_p">The X-ray crystal structure of (3<i>S</i>,4<i>S</i>)<b>-12a</b> in complex with rh-renin (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) revealed a strikingly close overlay of the 3,4-dialkoxy phenyl portion accommodated by the S<sub>3</sub>–S<sub>3</sub><sup>sp</sup> cavity and of the S<sub>1</sub><i>N</i>-isopropyl group with the respective pharmacophore residues of inhibitor <b>1</b>. The methoxypropyloxy side chain of <b>12a</b> was bound in an extended conformation into the nonsubstrate S<sub>3</sub><sup>sp</sup> channel of rh-renin, forming an H-bond between the distal ether oxygen and the NH of the Tyr<sub>14</sub> backbone, while the <i>para</i>-methoxy group fills the S<sub>3</sub> pocket. The <i>N</i>-isopropyl of <b>12a</b> was penetrating more deeply into S<sub>1</sub> compared to the <i>N</i>-phenyl of (3<i>S</i>,4<i>S</i>)-<b>6a</b>,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> thereby forming closer van der Waals contacts to the hydrophobic surface of this pocket. The benzamide moiety of <b>12a</b> was bridging the contiguous S<sub>3</sub>–S<sub>1</sub> “superpocket” by adopting a distorted conformation in which the carbonyl group is rotated by a 90° angle relative to the plane of the phenyl portion. In addition, the carbonyl of the P<sub>3</sub>–P<sub>1</sub> carboxamide spacer was in H-bond distance (2.8 Å) to the hydroxyl of the flap Thr<sub>77</sub> residue.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The flap β-hairpin loop was in a closed conformation with the backbone and side chains of Tyr<sub>75</sub>–Ser<sub>76</sub>–Thr<sub>77</sub>–Gly<sub>78</sub>, being in a very similar orientation as observed for inhibitor <b>1</b>. The only major difference was found for the hydroxyl group of Ser<sub>76</sub>, which was flipped toward solvent space in the case of rh-renin bound <b>6a</b>. On the other hand, the center pyrrolidine scaffold as well as the hydrophobic 3(<i>S</i>)-benzyl group binding to the S<sub>1</sub>′ site of both <b>12a</b> and the initial hit <b>6a</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>) were in a virtually identical position within the rh-renin active cleft. Interestingly, the basic pyrrolidine nitrogen atom of <b>12a</b> was located almost symmetrically between the primary amine NH<sub>2</sub> and the hydroxyl group of the aminohydroxyethylene dipeptide isostere of <b>1</b>, forming a H-bond network to the catalytic dyad which is partially distinct from that of classical hydroxyethylene (HE) isosteres of peptide-derived peptidomimetics.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of (3<i>S</i>,4<i>S</i>)-<b>12a</b> (shown as stick model in green color) bound in the rh-renin active site (2.8 Å resolution), see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Shown is the solvent accessible surface of the active site of rh-renin. Residues of the flap β-hairpin are depicted in yellow as thin lines and have been omitted for protein surface calculation. The catalytic aspartates are shown as stick models. Oxygen and nitrogen atoms are shown in red and blue color, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">With the discovery of the 3,4-piperidine based GRAB peptidomimetic renin inhibitors, basic cyclic secondary amine skeletons have been recognized as privileged core structural entities interacting with the enzyme family specific catalytic dyad for the conceptual design of novel aspartic protease inhibitors.<a onclick="showRef(event, 'ref20 ref31 ref32 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref20 ref31 ref32 ref33 ref34">(20, 31-34)</a> The five-membered 3,4-di(aminomethyl)-pyrrolidine template has been utilized for the design of potent HIV-1 protease inhibitors as well as for cathepsin D and was predicted by modeling to bind into the S<sub>2</sub>–S<sub>2</sub>′ specificity pockets.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> X-ray crystallography confirmed the basic pyrrolidine nitrogen atom to be positioned in close binding distance to both catalytic aspartates of the HIV protease and, most notably, unveiled an unexpected inhibitor pose characterized by an altered occupation of the recognition pockets and a major conformational distortion of the flap region.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> 3,4-Trisubstituted pyrrolidine-based BACE-1 inhibitors have been reported recently and were demonstrated by X-ray crystallography to form a bidentate interaction between the pyrrolidine nitrogen and the two aspartate residues from the catalytic dyad.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Notably, the spiro-tetrahydronaphthalene moiety in position 4 binding in the S<sub>1</sub> pocket and the 2,4-diphenyl substituted piperidine moiety attached to the C3 occupied a newly formed pocket under the flap with one phenyl group pointing toward the S<sub>2</sub>′ pocket.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> The <i>trans</i>-3,4-pyrrolidine <b>12a</b> reported herein represents the first prototype of a new class of DRIs that interacts to the extended β-strand substrate binding topography with the flap β-hairpin in a closed conformation and by spanning the S<sub>3</sub>–S<sub>1</sub>′ specificity pockets in a topological fashion.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><div class="NLM_p">An efficient synthesis of the key <i>trans</i>-pyrrolidine-3-carbaldehyde intermediate (<i>rac</i>)-<b>16</b> was established as outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, providing flexible access to various nonprime side chain modifications. Ethyl <i>trans</i>-4-phenyl-2-butenoate <b>13</b> readily obtained from phenylacetaldehyde by Wittig–Horner olefination was converted via a 1,3-dipolar cycloaddition reaction to afford the <i>trans</i>-configured pyrrolidine (<i>rac</i>)-<b>14</b>.<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a> Reductive debenzylation and in situ <i>N</i>-Boc protection followed by LiBH<sub>4</sub> reduction of the ester furnished the alcohol derivative (<i>rac</i>)-<b>15</b>. Dess–Martin oxidation to the aldehyde (<i>rac</i>)-<b>16</b> was followed by reductive amination to afford the secondary amine derivatives (<i>rac</i>)<b>-17</b> to (<i>rac</i>)-<b>19</b>, respectively. Inhibitors (<i>rac</i>)-<b>7</b> to (<i>rac</i>)-<b>9</b> were prepared from (<i>rac</i>)-<b>17</b> or (<i>rac</i>)-<b>19</b> by <i>N</i>-alkylation with the respective benzylbromides in the presence of K<sub>2</sub>CO<sub>3</sub> or by reductive amination using 4-methoxy-3-(3-methoxypropoxy)-benzaldehyde/NaBH(OAc)<sub>3</sub>, followed by removal of the <i>N</i>-Boc protecting group (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). <i>N</i>-Acylation of amines (<i>rac</i>)-<b>17</b> to (<i>rac</i>)-<b>19</b> with 4-methoxy-3-(3-methoxypropoxy)-benzoylchloride and final deprotection afforded inhibitors (<i>rac</i>)-<b>10</b>, (<i>rac</i>)-<b>11</b>, and (<i>rac</i>)-<b>12</b>, respectively (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>).</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0006.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Benzyl-<i>N</i>-(methoxymethyl)trimethylsilyl methylamine, TFA, toluene, 0°C, 88%; (b) H<sub>2</sub>, Pd(OH)<sub>2</sub>, (Boc)<sub>2</sub>O, EtOH, RT, 95%; (c) LiBH<sub>4</sub>, THF, reflux, 60%; (d) Dess–Martin periodinane, wet CH<sub>2</sub>Cl<sub>2</sub>, 89%; (e) R<sup>1</sup>–NH<sub>2</sub>, NaBH(OAc)<sub>3</sub>, 1,2-dichloroethane, RT.</p></p></figure><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0007.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R–CH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 80°C <i>or</i> 4-methoxy-3-(3-methoxypropoxy)-benzaldehyde, NaBH(OAc)<sub>3</sub>, 1,2-dichloroethane, RT; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> and formation of HCl salt,<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a><i>or</i> 4 M HCl–dioxane; (c) 4-methoxy-3-(3-methoxypropoxy)-benzoylchloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, RT; (d) HCl–<sup><i>i</i></sup>PrOH, RT; (e) [Pd(μ-Br)(<i>t</i>-Bu<sub>3</sub>P)]<sub>2</sub>, tBuOK, PhBr, toluene 110 °C.</p></p></figure><div class="NLM_p">Resolution of the alcohol intermediate (<i>rac</i>)-<b>15</b> was accomplished by preparative chiral HPLC (Chiracel OJ) to afford the single enantiomers (3<i>S</i>,4<i>S</i>)-<b>15a</b> and (3<i>R</i>,4<i>R</i>)-<b>15b</b> with high enantiomeric excess of <i>ee</i> ≥ 99.8%. The absolute configuration of both (3<i>S</i>,4<i>S</i>)-<b>15a</b> and (3<i>R</i>,4<i>R</i>)-<b>15b</b> was unambiguously assigned by their transformation to the crystalline aniline derivatives (3<i>S</i>,4<i>R</i>)-<b>17a</b> and (3<i>R</i>,4<i>S</i>)-<b>17b</b> according to Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> and subsequent X-ray diffraction analysis.<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> Intermediate (3<i>S</i>,4<i>R</i>)-<b>17a</b> served as starting material for the preparation of the pure enantiomer (3<i>S</i>,4<i>S</i>)-<b>6a</b> according to Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, thereby confirming the initially tentative assignment of the absolute configuration of rh-renin bound <b>6a</b> as determined by X-ray crystallography (vide supra). Furthermore, both enantiomeric inhibitors (3<i>S</i>,4<i>S</i>)-<b>12a</b> and (3<i>R</i>,4<i>R</i>)-<b>12b</b> were prepared from (3<i>S</i>,4<i>S</i>)-<b>15a</b> and (3<i>R</i>,4<i>R</i>)-<b>15b</b>, respectively, according to Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><div class="NLM_p last">To further assess the lead potential of the prototype inhibitor (3<i>S</i>,4<i>S</i>)-<b>12a</b>, the in vitro selectivity against a broad safety pharmacology panel of receptors and ion channels, the pharmacokinetic profile in rat and the in vivo efficacy in hypertensive double-transgenic rats (dTGRs) overexpressing both human renin and human angiotensinogen<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> were evaluated. (3<i>S</i>,4<i>S</i>)-<b>12a</b> was found to be inactive against 52 receptors (all IC<sub>50</sub> >10 μM) and only weakly active against 5-HT1A, 2A, 2B, and the α1-adrenoceptor (IC<sub>50</sub>s ranging between 1 and 10 μM), respectively. The compound had modest affinity to the hERG channel with IC<sub>50</sub> = 14.5 μM (mean value from two independent measurements using an in vitro dofetilide binding assay). Absolute oral bioavailability was 53% in cannulated fed Sprague–Dawley rats when dosed at 2 mg/kg intravenously and 6 mg/kg orally (estimated <i>t</i><sub>1/2</sub> = 2 h; Cl<sub>P</sub> = 1.5 L/h/kg; <i>V</i><sub>dss</sub> = 2.8 L/kg; oral <i>C</i><sub>max</sub> = 1310 nM; oral AUC<sub>(0–24 h)</sub> = 4810 nM·h). Single oral dosing of (3<i>S</i>,4<i>S</i>)-<b>12a</b> to telemetered dTGRs at 6 and 30 mg/kg resulted in a dose-dependent moderate reduction in mean arterial blood pressure (MAP) with peak changes in MAP of 15 and 35 mmHg, respectively. Blood pressure returned to baseline pretreatment levels after 12 h, demonstrating a sustained pharmacological effect of the compound in this model.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88220" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88220" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary, a small-molecule <i>trans</i>-3,4-disubstituted pyrrolidine derivative was discovered from an in silico 3D pharmacophore approach as a weakly active screening hit toward rh-renin. Utilizing X-ray crystal structure information, the combination of the center basic amine transition-state surrogate with an optimized P<sub>3</sub>/P<sub>3</sub><sup>sp</sup>–P<sub>1</sub> scaffold derived from <b>1</b> resulted in (3<i>S</i>,4<i>S</i>)-<b>12a</b> with submicromolar in vitro potency. The druglike lead compound of a novel class of DRIs demonstrated promising pharmacokinetic and pharmacodynamic properties in rat. Results from continued work focusing on prime site modifications and leading to highly potent clinical candidates will be presented in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60355" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60355" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Chemistry General Procedures</h3><div class="NLM_p last">Unless otherwise specified, all solvents and reagents were obtained from commercial suppliers and used without further drying or purification. Normal-phase flash chromatography was performed using Merk silica gel 60 (230–400 mesh). <i>R</i><sub>f</sub> values for TLC are measured on 5 cm × 10 cm TLC plates, silica gel F<sub>254</sub>, Merck, Darmstadt, Germany. Purity was determined by analytical HPLC from the integration of the area under the UV absorption curve at λ = 254 or 214 nm signals. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker DPX400 BBO spectrometer and a Bruker Avance 600 spectrometer using a <sup>13</sup>C–<sup>1</sup>H dual cryoprobe. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded at 394 K on a Bruker DPX400 TXI spectrometer. Chemical shift (δ) values were referenced to tetramethylsilane as internal standard and are reported in parts per million (ppm). Mass spectral HRMS were obtained using electrospray ionization in positive ion modus. The elemental composition was derived from the averaged mass spectra acquired at the high resolution of about 30000 on an 9.4T APEX-III FT-MS (Bruker Daltonics). The high mass accuracy below 1 ppm was obtained using an internal calibration.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Preparation of Intermediates <b>13</b>, <b>14</b>, <b>15</b>(<b>a</b>,<b>b</b>), <b>16</b>, <b>17</b>(<b>a</b>,<b>b</b>), <b>19</b>(<b>a</b>,<b>b</b>)</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8"> (<i>E</i>)-4-Phenyl-but-2-enoic Acid Ethyl Ester (<b>13</b>)</h4><div class="NLM_p last">To a solution of triethylphosphonoacetate (9.00 mL, 45.4 mmol) in THF (90 mL) was added sodium hydride (60% dispersion in oil, 1.81 g, 45.4 mmol) at RT under an N<sub>2</sub> atmosphere. The reaction mixture was stirred at 25 °C for 45 min, and phenylacetaldehyde (4.87 mL, 41.0 mmol) was added. After 30 min at RT, the reaction was partitioned between Et<sub>2</sub>O and water. The aqueous layer was extracted three times with Et<sub>2</sub>O, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography on silica gel (eluent: <i>c</i>-hexane–EtOAc 90:10) to give <b>13</b> (7.0 g, 81%) as a colorless oil. TLC, <i>R</i><sub>f</sub> (<i>c</i>-hexane–EtOAc 90:10) = 0.55. MS (LC-MS): 191.0 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 5–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 3.6 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 1.17 (t, <i>J</i> = 7.1 Hz, 3H), 3.53 (dd, <i>J</i> = 7.0, 1.3 Hz, 2H), 4.08 (q, <i>J</i> = 7.1 Hz, 2H), 5.83 (dt, <i>J</i> = 15.6, 1.3 Hz, 1H), 6.97 (dt, <i>J</i> = 15.6, 7.0 Hz, 1H), 7.20–7.24 (m, 3H), 7.30–7.33 (m, 2H).</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i9" class="anchor-spacer"></div><h4 class="article-section__title" id="_i9"> (3<i>S</i>*,4<i>S</i>*)-1,4-Dibenzyl-pyrrolidine-3-carboxylic Acid Ethyl Ester ((<i>rac</i>)-<b>14</b>)</h4><div class="NLM_p last">To a stirred solution of <b>13</b> (4.70 g, 24.7 mmol) in toluene (60 mL) was added <i>N</i>-benzyl-<i>N</i>-(methoxymethyl)trimethylsilylamine (6.54 mL, 25.6 mmol) at 0 °C under an N<sub>2</sub> atmosphere. Trifluoroacetic acid (0.19 mL, 2.47 mmol) was added at 0 °C, and the mixture was stirred for 30 min at RT overnight.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The reaction was quenched by addition of a saturated aqueous solution of NaHCO<sub>3</sub> and was the extracted three times with EtOAc. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude material was purified by flash chromatography on silica gel (eluent: hexane–EtOAc 90:10) to give (<i>rac</i>)-<b>14</b> (7.0 g, 88%) as a colorless oil. TLC, <i>R</i><sub>f</sub> (<i>c</i>-hexane–EtOAc 90:10) = 0.25. MS (LC–MS): 324.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 2.7 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 1.08 (t, <i>J</i> = 7.1 Hz, 3H), 2.22 (dd, <i>J</i> = 8.85, 5.8 Hz, 1H), 2.55 (m, 1H), 2.66–2.70 (m, 5H), 2.76 (m, 1H), 3.47 (d, <i>J</i> = 13.1 Hz, 1H), 3.56 (d, <i>J</i> = 13.1 Hz, 1H), 3.95 (q, <i>J</i> = 7.1 Hz, 2H), 7.12–7.30 (m, 10H).</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> (3<i>S</i>*,4<i>S</i>*)-4-Benzylpyrrolidine-1,3-dicarboxylic Acid 1-<i>tert</i>-Butyl Ester 3-Ethyl Ester</h4><div class="NLM_p last">A mixture of (<i>rac</i>)-<b>14</b> (6.57 g, 20.3 mmol), di-<i>tert</i>-butylcarbonate (4.43 g, 20.3 mmol) and Pd(OH)<sub>2</sub> (0.6 g, 50% wet) in EtOH (300 mL) was stirred under an hydrogen atmosphere for 20 h. After filtration through a pad of Celite, the filtrate was dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. Purification of the residue by chromatography on silica gel (eluent: <i>c</i>-hexane–EtOAc 90:10) afforded (3<i>S</i>*,4<i>S</i>*)-4-benzylpyrrolidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester (6.42 g, 95%). TLC, <i>R</i><sub>f</sub> (<i>c</i>-hexane–EtOAc 80:20) = 0.35. MS (LC–MS): 356.1 [M + Na]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 4.1 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 1.14 (t, <i>J</i> = 7.1 Hz, 3H), 1.36 (s, 9H), 2.62 (m, 2H), 2.81 (m, 2H), 2.95 (m, 1H), 3.29–3.36 (m, 2H), 3.57 (m, 1H), 3.98 (q, <i>J</i> = 7.1 Hz, 2H), 7.19 (m, 3H), 7.27 (m, 2H).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> (3<i>S</i>*,4<i>S</i>*)-3-Benzyl-4-hydroxymethyl-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester ((<i>rac</i>)-<b>15</b>)</h4><div class="NLM_p last">To a solution of (3<i>S</i>*,4<i>S</i>*)-4-benzylpyrrolidine-1,3-dicarboxylic acid 1-<i>tert</i>-butyl ester 3-ethyl ester (0.15 g, 0.45 mmol) in THF (4 mL) was slowly added a solution of LiBH<sub>4</sub> (2N in THF, 0.225 mL, 0.450 mmol) at 0 °C under an N<sub>2</sub> atmosphere. The reaction mixture was stirred overnight at RT, then refluxed for 2 h and subsequently carefully poured into an aqueous saturated NaHCO<sub>3</sub> solution. EtOAc was added, the layers were separated, and the aqueous phase was back-extracted twice with EtOAc. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography on silica gel (eluent: <i>c</i>-hexane–EtOAc 100:0 to 80:20) to give (<i>rac</i>)-<b>15</b> (0.79 g, 60%) as a colorless oil. TLC, <i>R</i><sub>f</sub> (<i>c</i>-hexane–EtOAc 80:20) = 0.20. MS (LC–MS): 236.1 [M-tBu + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 3.4 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 1.35 (s, 9H), 1.96 (m, 1H), 2.14–2.24 (m, 1H), 2.46 (m, 1H), 2.81 (m, 1H), 2.90 (m, 1H), 3.05 (m, 1H), 3.20 (m, 1H), 3.30 (m, 1H), 3.37–3.45 (m, 2H), 4.65 (t, <i>J</i> = 5.3 Hz, 1H, OH), 7.18 (m, 3H), 7.27 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz, 2 rotamers): δ 28.14, 37.73, 37.85, 40.35, 41.09, 44.76, 45.68, 48.33, 48.78, 50.61, 50.64, 61.29, 61.40, 78.08, 125.97, 128.28, 128.60, 140.24, 153.47, 153.50.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> (3<i>S</i>,4<i>S</i>)-3-Benzyl-4-hydroxymethyl-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>15a</b>) and (3<i>R</i>,4<i>R</i>)-3-Benzyl-4-hydroxymethyl-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester (<b>15b</b>)</h4><div class="NLM_p last">(<i>Rac</i>)-<b>15</b> (1.2 g) was separated into its enantiomers by preparative chiral HPLC column: Chiracel OJ, Diacel Chemical Industries Ltd., 10 cm × 50 cm, 20 μm; eluent, hexane–EtOH 85:15; flow rate, 120 mL/min; detection, UV at 210 nm. (<b>3</b><i><b>S</b></i>,4<i><b>S</b></i>)-<b>15a</b>: <i>t</i><sub>R</sub> 40.9 min (preparative chiral HPLC), <i>t</i><sub>R</sub> (HPLC, Chiracel OJ (1099), 0.46 cm × 25 cm, hexane/EtOH 90–10; flow, 1 mL/min): 7.1 min; enantiomeric excess <i>ee</i> = 99.8%, [α]<sub>D</sub><sup>20</sup> −48.4 (<i>c</i> = 0.99, MeOH). The absolute configuration of the 2 stereogenic centers was determined based on X-ray structure crystallography of the corresponding (3<i>S</i>,4<i>R</i>)-3-benzyl-4-[(4-chloro-phenylamino)-methyl]-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester <b>17a</b><a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> prepared in 2 steps as described below. (3<i>R</i>,4<i>R</i>)-<b>15b</b>: <i>t</i><sub>R</sub> 32.5 min (preparative chiral HPLC), <i>t</i><sub>R</sub> (HPLC, Chiracel OJ (1099), 0.46 cm × 25 cm, hexane–EtOH 90–10; flow, 1 mL/min): 5.2 min; enantiomeric excess <i>ee</i> = 100%. [α]<sub>D</sub><sup>20</sup> +46 (<i>c</i> = 1.02, MeOH). The absolute configuration of the 2 stereogenic centers was determined based on X-ray structure crystallography of the corresponding (3<i>R</i>,4<i>S</i>)-3-benzyl-4-[(4-chloro-phenylamino)-methyl]-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester <b>17b</b><a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a> prepared in two steps as described below.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> (3<i>S</i>*,4<i>S</i>*)-3-Benzyl-4-formyl-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester ((<i>rac</i>)-<b>16</b>)</h4><div class="NLM_p last">To a well stirred mixture of (<i>rac</i>)-<b>15</b> (10.0 g, 34.3 mol) and Dess–Martin periodinane (14.6 g, 34.3 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) was slowly added wet CH<sub>2</sub>Cl<sub>2</sub> (0.68 mL of water in 50 mL of CH<sub>2</sub>Cl<sub>2</sub>, 37.7 mmol). The clear solution turned cloudy toward the end of wet CH<sub>2</sub>Cl<sub>2</sub> addition. The mixture was diluted with Et<sub>2</sub>O and then concentrated by rotary evaporation to a small volume. The residue was taken up in Et<sub>2</sub>O, washed with a 1:1 mixture of a 10% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution and a saturated aqueous NaHCO<sub>3</sub> solution, followed by washing with H<sub>2</sub>O and brine. The combined aqueous phases were back-extracted with Et<sub>2</sub>O. The combined organics were washed with H<sub>2</sub>O and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by flash chromatography on silica gel (eluent: <i>c</i>-hexane–EtOAc 2:1) to give (<i>rac</i>)-<b>16</b> as a slightly yellow oil (8.8 g, 89%). TLC, <i>R</i><sub>f</sub> (<i>c</i>-hexane–EtOAc 2:1) = 0.50. MS (LC–MS): 234.1 [M-tBu + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 3.55 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 1.36 (s, 9H), 2.65–2.78 (m, 3H), 2.83 (m, 1H), 3.05 (m, 1H), 3.20 (m, 1H), 3.42 (m, 1H), 3.50 (m, 1H), 7.21 (m, 3H), 7.29 (m, 2H), 9.45 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz, 2 rotamers): δ 28.1, 37.54, 39.99, 40.54, 44.43, 44.60, 49.91, 49.95, 53.64, 54.46, 78.55, 126.31, 128.82, 139.49, 153.35, 201.81, 201.87.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> (3<i>S</i>*,4<i>R</i>*)-3-Benzyl-4-[(4-chlorophenylamino)-methyl]-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester ((<i>rac</i>)-<b>17</b>)</h4><div class="NLM_p">A mixture of (<i>rac</i>)-<b>16</b> (0.50 g, 1.72 mmol) and 4-chloroaniline (0.220 g, 1.69 mmol) in 1,2-dichloroethane (7 mL) was treated with sodium triacetoxyborohydride<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (0.510 g, 2.42 mmol) with stirring at RT under a N<sub>2</sub> atmosphere overnight. The reaction was quenched by addition of aqueous saturated NaHCO<sub>3</sub> solution (10 mL), followed by extraction with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residual brown oil was purified by flash chromatography on silica gel (eluent: <i>c</i>-hexane–EtOAc 90:10) to give (<i>rac</i>)-<b>17</b> (0.66 g, 95%). TLC, <i>R</i><sub>f</sub> (<i>c</i>-hexane–EtOAc 90:10) = 0.20. MS (LC–MS): 445.1 [M + HCOOH]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 4.38 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 1.35 (s, 9H), 2.10–2.15 (m, 1H), 2.20–2.28 (m, 1H), 2.52 (m, 1H), 2.84–2.97 (m, 3H), 3.02 (dd, <i>J</i> = 10.8, 7.6 Hz, 1H), 3.08 (m, 1H), 3.24 (m, 1H), 3.50 (m, 1H), 5.89 (m, 1H, NH), 6.51 (m, 2H), 7.05 (m, 2H), 7.19 (m, 3H), 7.28 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz, 2 rotamers): δ 28.1, 37.69, 37.76, 41.67, 41.85, 42.59, 44.77, 44.84, 49.49, 49.94, 50.48, 50.56, 78.23, 113.18, 118.70, 126.03, 128.31, 128.52, 128.65, 140.13, 147.68, 153.45.</div><div class="NLM_p last">Crystallographic data (excluding structure factors) for (3<i>S</i>,4<i>R</i>)-<b>17a</b> and (3<i>R</i>,4<i>S</i>)-<b>17b</b> have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 904172 (<b>17a</b>) and CCDC 904173 (<b>17b</b>). Copies of the data can be obtained, free of charge, on application to CCDC, 12 Union Road, Cambridge CB2 1 EZ, UK [fax: +44-(0)1223–336033 or email: <a href="/cdn-cgi/l/email-protection#adc9c8ddc2dec4d9edcecec9ce83ceccc083ccce83d8c6"><span class="__cf_email__" data-cfemail="acc8c9dcc3dfc5d8eccfcfc8cf82cfcdc182cdcf82d9c7">[email protected]</span></a>].</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> (3<i>S</i>,4<i>R</i>)-3-Benzyl-4-[(4-chlorophenylamino)methyl]-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester ((3<i>S</i>,4<i>R</i>)-<b>17a</b>)</h4><div class="NLM_p last">The title compound was prepared as described for (<i>rac</i>)-<b>17</b> from (3<i>S</i>,4<i>S</i>)-<b>15a</b>. [α]<sub>D</sub><sup>20</sup> – 33.1 (<i>c</i> = 1.17, MeOH). Absolute configuration determined by X-ray crystallography.<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a></div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> (3<i>R</i>,4<i>S</i>)-3-Benzyl-4-[(4-chlorophenylamino)methyl]-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester ((3<i>R</i>,4<i>S</i>)-<b>17b</b>)</h4><div class="NLM_p last">The title compound was prepared as described for (<i>rac</i>)-<b>17</b> from (3<i>R</i>,4<i>R</i>)-<b>15b</b>. [α]<sub>D</sub><sup>20</sup> + 33 (<i>c</i> = 0.96, MeOH). Absolute configuration determined by X-ray crystallography.<a onclick="showRef(event, 'cit26a'); return false;" href="javascript:void(0);" class="ref cit26a">(26a)</a></div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (3<i>S</i>*,4<i>R</i>*)-3-Benzyl-4-(isopropylamino-methyl)-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester ((<i>rac</i>)-<b>19</b>)</h4><div class="NLM_p last">A mixture of (<i>rac</i>)-<b>16</b> (2.64 g, 9.12 mmol), isopropylamine (2.35 mL, 27.4 mmol), and 1,2-dichloroethane (150 mL) was stirred at RT for 10 min. Sodium triacetoxyborohydride<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (4.83 g, 22.8 mmol) was added, and the mixture was stirred for 20 h at RT. The reaction was quenched by addition of a saturated aqueous NaHCO<sub>3</sub> solution. After separation of the organic layer, the aqueous phase was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, and volatiles were removed in vacuo to afford (<i>rac</i>)-<b>19</b> as a colorless oil (3.1 g, quantitative yield). <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 2.82 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 0.94 (m, 6H), 1.35 (m, 9H), 1.94 (m, 1H), 2.11–2.19 (m, 1H), 2.39 (m, 1H), 2.45 (m, 1H), 2.64 (m, 2H), 2.82 (m, 1H), 2.89 (m, 1H), 2.98 (dd, <i>J</i> = 10.5, 7.9 Hz, 1H), 3.20 (m, 1H), 3.40 (m, 1H), 7.19 (m, 3H), 7.27 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz, 2 rotamers): δ 21.28, 22.26, 22.50, 22.57, 28.16, 37.77, 37.84, 39.99, 42.00, 42.65, 42.73, 43.69, 48.37, 48.52, 49.99, 50.40, 50.58, 50.63, 78.12, 125.98, 128.28, 128.30, 128.64, 140.24, 153.44, 153.47, 172.17.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> (3<i>S</i>,4<i>R</i>)-3-Benzyl-4-(isopropylamino-methyl)-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester ((3<i>S</i>,4<i>R</i>)-<b>19a</b>)</h4><div class="NLM_p last">The title compound was prepared as described for (<i>rac</i>)-<b>19</b> in two steps from (3<i>S</i>,4<i>S</i>)-<b>15a</b>. [α]<sub>D</sub><sup>20</sup> – 44.9 (<i>c</i> = 1.18, MeOH).</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> (3<i>R</i>,4<i>S</i>)-3-Benzyl-4-(isopropylamino-methyl)-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester ((3<i>R</i>,4<i>S</i>)-<b>19b</b>)</h4><div class="NLM_p last">The title compound was prepared as described for (<i>rac</i>)-<b>19</b> in two steps from (3<i>R</i>,4<i>R</i>)-<b>15b</b>. [α]<sub>D</sub><sup>20</sup> + 40.9 (<i>c</i> = 1.16, MeOH).</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Preparation of Compounds <b>6</b>(<b>a</b>,<b>b</b>), (<i>rac</i>) <b>7</b>–<b>11</b>, <b>12</b>(<b>a</b>,<b>b</b>)</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> ((3<i>S</i>,4<i>S</i>)-4-Benzylpyrrolidin-3-ylmethyl)-(4-chlorophenyl)-phenylamine Hydrochloride Salt (<b>6a</b>) and ((3<i>R</i>,4<i>R</i>)-4-Benzylpyrrolidin-3-ylmethyl)-(4-chlorophenyl)-phenylamine Hydrochloride Salt (<b>6b</b>)</h4><div class="NLM_p">((3<i>S</i>*,4<i>S</i>*)-4-Benzyl-pyrrolidin-3-ylmethyl)-(4-chlorophenyl)phenylamine, (<i>rac</i>)-<b>6</b>,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (215 mg) was separated into its enantiomers by preparative chiral HPLC column: Chiracel OD prep, Diacel Chemical Industries Ltd., 50 mm × 500 mm (20 μm); eluent, hexane–EtOH 95:5 + 0.1% TFA; flow rate, 80 mL/min; detection, UV at 210 nm. (3<i>S</i>,4<i>S</i>)-<b>6a</b>: The product (contaminated with residual trifluoroacetic acid) was isolated as peak 1 with <i>t</i><sub>R</sub> 52.7 min (preparative chiral HPLC). This material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and subsequently washed with a saturated aqueous solution of NaHCO<sub>3</sub>. The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was dissolved in dioxane (1 mL), followed by addition of 4 M HCl in dioxane (1 equiv) and lyophilization to afford (3<i>S</i>,4<i>S</i>)-<b>6a</b>, HCl salt, (67 mg). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 2.25 (m, 1H), 2.31 (m, 1H), 2.65 (dd, <i>J</i> = 13.5, 8.3 Hz, 1H), 2.75 (dd, <i>J</i> = 13.5, 6.6 Hz, 1H), 2.83 (m, 1H), 2.91 (m, 1H), 3.18 (m, 1H), 3.26 (m, 1H), 3.64 (dd, <i>J</i> = 14.8, 5.6 Hz, 1H), 3.72 (dd, <i>J</i> = 14.8, 9.2 Hz, 1H), 6.79 (d, <i>J</i> = 8.9 Hz, 2H), 6.95 (d, <i>J</i> = 7.9 Hz, 2H), 7.04 (t, <i>J</i> = 7.6 Hz, 1H), 7.14 (d, <i>J</i> = 7.25 Hz, 2H), 7.23 (m, 3H), 7.30 (m, 4H), 9.03 (m, 1H), 9.1 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 37.43, 41.12, 42.22, 48.14, 49.16, 53.37, 120.95, 122.66, 122.96, 124.31, 126.40, 128.51, 128.78, 129.02, 129.64, 139.33, 146.81, 146.99. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 3.46 min, purity 99.3%. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 50 mm, 10–98% CH<sub>3</sub>CN–H<sub>2</sub>O/8.6 min, 98% CH<sub>3</sub>CN/1.4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min, temperature 40 °C): 4.69 min, purity 99%. <i>t</i><sub>R</sub> (HPLC, Daicel OD-H, 250 mm × 4.6 mm (5 μm), hexane–EtOH 95:5 + 0.1% TFA, flow 1 mL/min, UV 210 nm, injection volume 10 μL of a 0.1% solution in EtOH): 14.5 min; enantiomeric excess <i>ee</i> > 99.9%. HRMS calcd for C<sub>24</sub>H<sub>25</sub>ClN<sub>2</sub> [M + H]<sup>+</sup>, 377.1779; found, 377.1778. (3<i>R</i>,4<i>R</i>)-<b>6b</b>: The product (contaminated with residual trifluoroacetic acid) was isolated as peak 2 with <i>t</i><sub>R</sub> 76.4 min (preparative chiral HPLC). This material was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and subsequently washed with a saturated aqueous solution of NaHCO<sub>3</sub>. The organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was dissolved in dioxane (1 mL), followed by addition of 4 M HCl in dioxane (1 equiv) and lyophilization to afford (3<i>R</i>,4<i>R</i>)-<b>6b</b>, HCl salt, (80 mg). <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 3.44 min, purity 100%. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 50 mm, 10–98% CH<sub>3</sub>CN-H<sub>2</sub>O/8.6 min, 98% CH<sub>3</sub>CN/1.4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min, temperature 40 °C): 4.70 min, purity 99%. <i>t</i><sub>R</sub> (HPLC, Daicel OD-H, 250 mm × 4.6 mm (5 μm), hexane–EtOH 95:5 + 0.1% TFA, flow 1 mL/min, UV 210 nm, injection volume 10 μL of a 0.1% solution in EtOH): 18.7 min; enantiomeric excess <i>ee</i> > 99.9%. HRMS calcd for C<sub>24</sub>H<sub>25</sub>ClN<sub>2</sub> [M + H]<sup>+</sup>, 377.1779; found, 377.1779.</div><div class="NLM_p last">The synthesis of (3<i>S</i>,4<i>S</i>)-<b>6a</b>, HCl salt, was also accomplished in two steps starting from enantiomerically pure (3<i>S</i>,4<i>R</i>)-<b>17a</b> of known absolute configuration (vide infra) according to the following procedure:</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (3<i>S</i>,4<i>R</i>)-3-Benzyl-4-{[(4-chlorophenyl)-phenylamino]-methyl}-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A dry three-necked flask equipped with a magnetic stirring bar, septum, and condenser with an argon inlet–outlet was charged with [Pd(μ-Br)(<i>t</i>-Bu<sub>3</sub>P)]<sub>2</sub><a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> (9.70 mg, 0.0125 mmol), sodium <i>tert</i>-butoxide (35.5 mg, 0.37 mmol), bromobenzene (59 mg, 0.37 mmol), and dry toluene (0.5 mL). A solution of (3<i>S</i>,4<i>R</i>)-<b>17a</b> (100 mg, 0.25 mmol) in dry degassed toluene (1 mL) was added, and the mixture was stirred at RT for 15 min, followed by heating to 110 °C (gentle reflux) overnight. After cooling to RT, the mixture was poured into water and the water phase was extracted twice with EtOAc. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by flash chromatography on silica gel (eluent: <i>c</i>-hexane–EtOAc 90:10) to afford the title compound (91 mg, 76%). TLC, <i>R</i><sub>f</sub> (<i>c</i>-hexane–EtOAc 80:20) = 0.50. MS (LC–MS): 421 [M-tBu + H]<sup>+</sup>, 477 [M + H]<sup>+</sup>, 499 [M + Na]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 5.16 min. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 1.43 (s, 9H), 2.25 (m, 1H), 2.33 (m, 1H), 2.60 (m, 1H), 2.78 (m, 1H), 3.04–3.21 (m, 2H), 3.43 (m, 1H), 3.53 (dd, <i>J</i> = 14.6, 8.85 Hz, 1H), 3.59 (m, 1H), 3.73 (m, 1H), 6.76 (d, <i>J</i> = 8.4 Hz, 2H), 6.91 (d, <i>J</i> = 7.8 Hz, 2H), 7.0 (t, <i>J</i> = 7.3 Hz, 1H), 7.09 (m, 2H), 7.16 (m, 2H), 7.24–7.28 (m, 5H).</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> ((3<i>S</i>,4<i>S</i>)-4-Benzyl-pyrrolidin-3-ylmethyl)-(4-chlorophenyl)-phenylamine, (3<i>S</i>,4<i>S</i>)-<b>6a</b>, Hydrochloride Salt</h4><div class="NLM_p last">To a solution of (3<i>S</i>,4<i>R</i>)-3-benzyl-4-{[(4-chlorophenyl)-phenylamino]-methyl}-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (91 mg, 0.19 mmol) in dioxane (2 mL) was added 1 M HCl in dioxane (2 mL), and the reaction mixture was stirred at RT for 4 h followed by lyophilization to afford (3<i>S</i>,4<i>S</i>)-<b>6a</b>, HCl salt (78 mg, quantitative yield). The product thus obtained showed the same retention time as the corresponding enantiomer (peak 1, vide supra) by analytical chiral HPLC. <i>t</i><sub>R</sub> (HPLC, Daicel OD-H, 250 mm × 4.6 mm (5 μm), hexane–EtOH 95:5 + 0.1% TFA, flow 1 mL/min, UV 210 nm, injection volume 10 μL of a 0.1% solution in EtOH): 14.5 min.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Preparation of (<i>rac</i>)-<b>7</b>, HCl Salt</h3><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (3<i>S</i>*,4<i>R</i>*)-3-Benzyl-4-{[benzyl-(4-chlorophenyl)-amino]-methyl}-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">To a solution of (<i>rac</i>)-<b>17</b> (80 mg, 0.20 mmol) in DMF (1 mL) were added K<sub>2</sub>CO<sub>3</sub> (0.062 g, 0.44 mmol) and benzylbromide (0.052 mL, 0.44 mmol). Stirring was continued at 80 °C for 5 h before the reaction mixture was quenched with a saturated aqueous NaHCO<sub>3</sub> solution. The water phase was extracted with EtOAc, and the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude residue was purified by flash chromatography (eluent: <i>c</i>-hexane–EtOAc 95:5 to 90:10) to give the title compound (64 mg, 65%). TLC, <i>R</i><sub>f</sub> (<i>c</i>-hexane–EtOAc 80:20) = 0.55. <sup>1</sup>H NMR (CD<sub>3</sub>OD, 400 MHz): δ 1.39 (s, 9H), 2.18 (m, 1H), 2.32 (m, 1H), 2.50 (m, 1H), 2.73 (dd, <i>J</i> = 17.9, 8.9 Hz, 1H), 3.0 (dd, <i>J</i> = 14.8, 8.6 Hz, 1H), 3.23–3.06 (m, 2H), 3.34–3.49 (m, 3H), 4.42 (m, 2H), 6.55 (d, <i>J</i> = 12.1 Hz, 2H), 6.99–7.31 (m, 12H).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Benzyl-((3<i>S</i>*,4<i>S</i>*)-4-benzylpyrrolidin-3-ylmethyl)-(4-chlorophenyl)-amine (<i>rac</i>)-<b>7</b>, Hydrochloride Salt</h4><div class="NLM_p last">To a solution of (3<i>S</i>*,4<i>R</i>*)-3-benzyl-4-{[benzyl-(4-chlorophenyl)-amino]-methyl}-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (64 mg, 0.13 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added trifluoroacetic acid (0.05 mL), and the mixture was stirred at RT overnight. Volatile were removed under reduced pressure. The mixture was then poured into a saturated aqueous solution of NaHCO<sub>3</sub>, the water phase was extracted with EtOAc, and the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude residue was purified by Isolute Flash NH<sub>2</sub> ion exchange chromatography (eluent: CH<sub>2</sub>Cl<sub>2</sub>–MeOH 97:3 to 90:10 + 1% of NH<sub>4</sub>OH) to give (<i>rac</i>)-<b>7</b> as the free base (44.2 mg, 87%). This material was dissolved in dioxane (2 mL), followed by addition of 4 M HCl in dioxane (28 μL, 0.113 mmol) and lyophilization to afford (<i>rac</i>)-<b>7</b>, HCl salt (94% purity by HPLC using two analytical methods). MS (LC-MS): 391, 393 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 30 mm, 10–98% CH<sub>3</sub>CN/H<sub>2</sub>O/3 min, 98% CH<sub>3</sub>CN/0.5 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min; temperature 40 °C): 2.34 min, purity 99%. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 50 mm, 10–98% CH<sub>3</sub>CN–H<sub>2</sub>O/8.6 min, 98% CH<sub>3</sub>CN/1.4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min; temperature 40 °C): 4.73 min, purity 99%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 2.31 (m, 1H), 2.41 (m, 1H), 2.68 (m, 1H), 2.78 (m, 1H), 2.86 (m, 1H), 3.02 (m, 1H), 3.23 (m, 1H), 3.30 (m, 1H), 3.42–3.49 (m, 2H), 4.55 (bs, 2H), 6.50 (d, <i>J</i> = 8.95 Hz, 2H), 7.05 (d, <i>J</i> = 8.95 Hz, 2H), 7.08 (d, <i>J</i> = 7.3 Hz, 2H), 7.18–7.24 (m, 4H), 7.28–7.32 (m, 4H), 9.05 (m,1H), 9.12 (m,1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 37.78, 40.71, 42.17, 47.86, 49.21, 53.09, 54.15, 114.01, 119.77, 126.38, 126.69, 128.48, 128.52, 128.59, 128.80, 138.23, 139.49, 146.37. HRMS calcd for C<sub>25</sub>H<sub>28</sub>ClN<sub>2</sub> [M + H]<sup>+</sup>, 391.1936; found, 391.1933.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Preparation of (<i>rac</i>)-<b>8</b>, HCl Salt</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (3<i>S</i>*,4<i>R</i>*)-3-Benzyl-4-({(4-chlorophenyl)-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-amino}-methyl)-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">The title compound was prepared using the same procedure as described for (<i>rac</i>)-<b>7</b> using 4-bromomethyl-1-methoxy-2-(3-methoxypropoxy)-benzene<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> for the alkylation reaction. The crude product obtained after aqueous workup was purified by preparative HPLC (Waters Sunfire C18-OBD, 5 μm, 19 mm × 50 mm; eluent, 20% CH<sub>3</sub>CN/1 min, 20–100% CH<sub>3</sub>CN–H<sub>2</sub>O/16 min, 100% CH<sub>3</sub>CN/4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% HCOOH; flow, 20 mL/min). The HPLC fractions were collected, concentrated, diluted with EtOAc, and washed with a saturated aqueous solution of NaHCO<sub>3</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the title compound (73 mg, 48%). TLC, <i>R</i><sub>f</sub> (CH<sub>2</sub>Cl<sub>2</sub>–MeOH 95:5) = 0.45. MS (LC–MS): 609.2 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 5–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 4.7 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 1.33 (s, 9H), 1.87 (p, <i>J</i> = 6.4 Hz, 2H), 2.20–2.31 (m, 2H), 2.45–2.53 (m, 1H), 2.80 (dd, <i>J</i> = 13.6, 5.3 Hz, 1H), 2.94 (m, 1H), 3.05 (m, 1H), 3.20 (s, 3H), 3.25 (m, 1H), 3.30–3.35 (m, 1H), 3.41 (t, <i>J</i> = 6.4 Hz, 2H), 3.41–3.46 (m, 1H), 3.48 (m, 1H), 3.68 (s, 3H), 3.89 (t, <i>J</i> = 6.4 Hz, 2H), 4.44 (m, 2H), 6.60 (m, 1H), 6.63 (d, <i>J</i> = 8.8 Hz, 2H), 6.73 (m, 1H), 6.84 (d, <i>J</i> = 8.1 Hz, 1H), 7.08 (d, <i>J</i> = 8.8 Hz, 2H), 7.16 (m, 3H), 7.26 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz, 2 rotamers): δ 28.09, 28.94, 37.82, 37.94, 40.96, 41.61, 41.98, 42.72, 49.26, 50.30, 50.40, 53.04, 53.24, 54.00, 54.06, 55.51, 57.91, 65.22, 68.47, 69.76, 78.19, 78.25, 111.80, 112.04, 114.25, 114.31, 118.59, 118.64, 119.61, 126.04, 128.31, 128.50, 128.60, 128.63, 130.52, 140.10, 146.96, 147.03, 147.81, 147.98, 153.40.</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>N</i>-((3<i>S</i>*,4<i>S</i>*)-4-Benzylpyrrolidin-3-yl-methyl)-(4-chlorophenyl)-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-amine (<i>rac</i>)-<b>8</b>, Hydrochloride Salt</h4><div class="NLM_p last">To a solution of (3<i>S</i>*,4<i>R</i>*)-3-benzyl-4-({(4-chlorophenyl)-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-amino}-methyl)-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (52 mg, 0.085 mmol) in dioxane (2 mL) was added 4 M HCl in dioxane (1 mL) followed by stirring for 2 h at RT. Lyophilization afforded (<i>rac</i>)-<b>8</b>, HCl salt, as a solid (50 mg, 100%). MS (LC–MS): 509.1 [MH]<sup>+</sup>. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 30 mm, 10–98% CH<sub>3</sub>CN/H<sub>2</sub>O/3 min, 98% CH<sub>3</sub>CN/0.5 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min; temperature 40 °C): 2.18 min, purity 99%. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 50 mm, 10–98% CH<sub>3</sub>CN–H<sub>2</sub>O/8.6 min, 98% CH<sub>3</sub>CN/1.4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min, temperature 40 °C): 4.58 min, purity 99%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 1.87 (p, <i>J</i> = 6.3 Hz, 2H), 2.31 (m, 1H), 2.38 (m, 1H), 2.66 (dd, <i>J</i> = 13.5, 8.2 Hz, 1H), 2.76 (dd, <i>J</i> = 13.5, 7.0 Hz, 1H), 2.86 (m, 1H), 3.0 (m, 1H), 3.21 (s, 3H), 3.22 (m, 1H), 3.28 (m, 1H), 3.38 (m, 2H), 3.41 (t, <i>J</i> = 6.3 Hz, 2H), 3.68 (s, 3H), 3.89 (m, 2H), 4.44 (d, <i>J</i> = 16.8 Hz, 1H), 4.48 (d, <i>J</i> = 16.8 Hz, 1H), 6.53 (d, <i>J</i> = 8.9 Hz, 2H), 6.55 (m, 1H), 6.71 (m, 1H), 6.82 (d, <i>J</i> = 8.2 Hz, 1H), 7.06 (d, <i>J</i> = 8.9 Hz, 2H), 7.19–7.23 (m, 3H), 7.31 (m, 2H), 8.98 (m, 1H), 9.05 (m, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 28.95, 37.74, 40.70, 42.20, 47.96, 49.23, 52.98, 54.05, 55.52, 57.93, 65.25, 68.46, 111.77, 112.05, 114.29, 118.51, 119.84, 126.38, 128.51, 128.54, 128.78, 130.39, 139.49, 146.53, 147.84, 147.99. HRMS calcd for C<sub>30</sub>H<sub>38</sub>ClN<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 509.2566; found, 509.2563. HRMS calcd for C<sub>30</sub>H<sub>37</sub>ClN<sub>2</sub>O<sub>3</sub>Na [M + Na]<sup>+</sup>, 531.2385; found, 531.2385.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Preparation of (<i>rac</i>)-<b>9</b>, HCl Salt</h3><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (3<i>S</i>*,4<i>R</i>*)-3-Benzyl-4-({isopropyl-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-amino}-methyl)-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A mixture of (<i>rac</i>)-<b>19</b> (300 mg, 0.9 mmol) and 4-methoxy-3-(3-methoxypropoxy)-benzaldehyde<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (202 mg, 0.90 mmol) in 1,2-dichloroethane (5 mL) was treated with sodium triacetoxyborohydride<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> (765 mg, 3.61 mmol) with stirring at RT under a N<sub>2</sub> atmosphere overnight and was then poured into an aqueous saturated solution of NaHCO<sub>3</sub>. The layers were separated, and the water phase was extracted twice with CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by preparative HPLC (YMC-Pack C18-ODS-AQ 5 μm, 20 mm × 50 mm; eluent, 5% CH<sub>3</sub>CN/2.5 min, 5–100% CH<sub>3</sub>CN–H<sub>2</sub>O/10.5 min, 100% CH<sub>3</sub>CN/5 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% HCOOH; flow, 20 mL/min). The compound containing HPLC fractions were collected, diluted with EtOAc, and washed with a saturated aqueous solution of NaHCO<sub>3</sub>. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the title compound (72 mg, 15%). MS (LC–MS): 541 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 0.90 (m, 6H), 1.32 (m, 9H), 1.89 (m, 2H), 1.99 (m, 1H), 2.08–2.22 (m, 2H), 2.31 (m, 1H), 2.44 (m, 1H), 2.75 (m, 2H), 2.85–2.94 (m, 2H), 3.08 (m, 1H), 3.20 (s, 3H), 3.35 (m, 2H), 3.39 (m, 1H), 3.42 (t, <i>J</i> = 6.1 Hz, 2H), 3.70 (s, 3H), 3.93 (m, 2H), 6.75 (m, 1H), 6.85 (m, 2H), 7.15 (m, 3H), 7.26 (m, 2H).</div></div><div id="sec4_6_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> ((3<i>S</i>*4<i>S</i>*)-4-Benzylpyrrolidin-3-ylmethyl)-isopropyl-[4-methoxy-3-(3-methoxypropoxy)benzyl]-amine, (<i>rac</i>)-<b>9</b>, Hydrochloride Salt</h4><div class="NLM_p last">To a solution of (3<i>S</i>*,4<i>R</i>*)-3-benzyl-4-({isopropyl-[4-methoxy-3-(3-methoxypropoxy)-benzyl]-amino}-methyl)-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (72.0 mg, 0.133 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was added trifluoroacetic acid (0.1 mL), and the mixture was stirred at RT for 1 h. The mixture was then poured into a saturated aqueous solution of NaHCO<sub>3</sub>, extracted with EtOAc, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude residue was purified by Isolute Flash NH<sub>2</sub> ion exchange chromatography (eluent: CH<sub>2</sub>Cl<sub>2</sub>–MeOH 100:0 to 90:10 + 5% of NH<sub>4</sub>OH) to give (<i>rac</i>)-<b>9</b> as the free base (47.7 mg). This material was dissolved in dioxane (2 mL), followed by addition of 4 M HCl in dioxane (27 μL, 0.11 mmol) and lyophilization to afford (<i>rac</i>)-<b>9</b>, HCl salt (48 mg, 86%). MS (LC–MS): 441 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 2.18 min; purity 100%. <i>t</i><sub>R</sub> (HPLC, MN Nucleosil C18HD, 3 μm, 70 mm × 4 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 3.57 min; purity 100%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 394 K): δ 1.12 (m, 6H), 1.94 (m, 2H), 2.25 (m, 2H), 2.52 (m, 1H), 2.80–2.90 (m, 2H), 3.12 (dd, <i>J</i> = 17.0, 10.6 Hz, 1H), 3.25 (s, 3H), 3.25 (m, 1H), 3.46 (m, 1H), 3.48 (t, <i>J</i> = 9.5 Hz, 2H), 3.51 (m, 1H), 3.77 (s, 3H), 3.78 (m, 2H), 4.04 (m, 2H), 6.90 (m, 1H), 6.94–7.10 (m, 2H), 7.19 (m, 3H), 7.27 (m, 2H), 9.19 (m, 2H). HRMS calcd for C<sub>27</sub>H<sub>41</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup>, 441.3112; found, 441.3110.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Preparation of (<i>rac</i>)-<b>10</b>, HCl Salt</h3><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> <i>N</i>-((3<i>S</i>*,4<i>S</i>*)-4-Benzylpyrrolidin-3-ylmethyl)-<i>N</i>-(4-chlorophenyl)-4-methoxy-3-(3-methoxypropoxy)benzamide, (<i>rac</i>)-<b>10</b></h4><div class="NLM_p last">The title compound was prepared as described for (<i>rac</i>)-<b>12</b> in two steps from (<i>rac</i>)-<b>17</b>. MS (LC–MS): 523.4 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN/H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 3.01 min; purity 97%. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 50 mm, 10–98% CH<sub>3</sub>CN–H<sub>2</sub>O/8.6 min, 98% CH<sub>3</sub>CN/1.4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min, temperature 40 °C): 3.96 min, purity 96%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 1.78 (m, 2H), 2.09 (m, 1H), 2.32 (m, 1H), 2.59 (dd, <i>J</i> = 13.3, 7.9 Hz, 1H), 2.69 (dd, <i>J</i> = 13.3, 6.6 Hz, 1H), 2.85 (m, 1H), 3.0 (m, 1H), 3.22 (m, 1H), 3.23 (s, 3H), 3.30–3.39 (m, 3H), 3.69 (s, 3H), 3.73 (m, 2H), 3.90 (bd, <i>J</i> = 7.0 Hz, 2H), 6.72 (m, 1H), 6.80 (m, 2H), 7.0 (d, <i>J</i> = 8.4 Hz, 2H), 7.10 (d, <i>J</i> = 7.3 Hz, 2H), 7.21 (m, 1H), 7.25 (m, 2H), 7.30 (d, <i>J</i> = 8.4 Hz, 2H), 8.91 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 28.68, 36.73, 39.98, 41.03, 42.11, 48.05, 48.87, 50.26, 55.41, 57.95, 65.23, 68.34, 110.71, 113.57, 122.22, 126.38, 127.33, 128.47, 128.86, 129.16, 129.36, 130.94, 139.11, 141.80, 146.60, 150.12, 169.30. HRMS calcd for C<sub>30</sub>H<sub>36</sub>ClN<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 523.2358; found, 523.2358.</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Preparation of (<i>rac</i>)-<b>11</b>, HCl Salt</h3><div id="sec4_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> <i>N</i>-((3<i>S</i>*,4<i>S</i>*)-4-Benzylpyrrolidin-3-ylmethyl)-<i>N</i>-phenyl-4-methoxy-3-(3-methoxypropoxy)-benzamide, (<i>rac</i>)-<b>11</b>, Hydrochloride Salt</h4><div class="NLM_p last">The title compound was prepared as described for (<i>rac</i>)-<b>12</b> in two steps from (<i>rac</i>)-<b>18</b> (prepared as described for (<i>rac</i>)-<b>17</b> using aniline instead of 4-chloroaniline). MS (LC–MS): 489 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 30 mm, 10–98% CH<sub>3</sub>CN/H<sub>2</sub>O/3 min, 98% CH<sub>3</sub>CN/0.5 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min, temperature 40 °C): 1.81 min, purity 100%. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 50 mm, 10–98% CH<sub>3</sub>CN–H<sub>2</sub>O/8.6 min, 98% CH<sub>3</sub>CN/1.4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min; temperature 40 °C): 3.57 min, purity 100%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 1.77 (m, 2H), 2.12 (m, 1H), 2.34 (m, 1H), 2.60 (dd, <i>J</i> = 13.55, 8.1 Hz, 1H), 2.70 (dd, <i>J</i> = 13.55, 6.6 Hz, 1H), 2.84 (dd, <i>J</i> = 11.5, 7.6 Hz, 1H), 3.0 (dd, <i>J</i> = 11.9, 7.6 Hz, 1H), 3.21 (dd, <i>J</i> = 11.5, 7.4 Hz, 1H), 3.23 (s, 3H), 3.37 (t, <i>J</i> = 6.2 Hz, 3H), 3.68 (m, 5H), 3.90 (dd, <i>J</i> = 14.0, 8.2 Hz, 1H), 3.96 (dd, <i>J</i> = 14.0, 6.1 Hz, 1H), 6.69 (d, <i>J</i> = 2.0 Hz, 1H), 6.76 (d, <i>J</i> = 8.4 Hz, 1H), 6.82 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 6.99 (d, <i>J</i> = 7.4 Hz, 2H), 7.11 (m, 2H), 7.17–7.22 (m, 2H), 7.25 (m, 4H), 8.94 (m, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 150 MHz): δ 28.7, 36.77, 41.20, 42.19, 48.07, 48.82, 50.40, 55.38, 57.39, 65.16, 68.35, 110.62, 113.53, 122.19, 126.34, 126.62, 127.61, 128.47, 128.86, 128.94, 129.24, 139.14, 142.91, 146.49, 149.96, 169.31. HRMS: 489.27470 [M + H]<sup>+</sup> (calcd 489.27478 for C<sub>30</sub>H<sub>36</sub>N<sub>2</sub>O<sub>4</sub>).</div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Preparation of (<i>rac</i>)-<b>12</b>, (3<i>S</i>,4<i>S</i>)-<b>12a</b>, (3<i>R</i>,4<i>R</i>)-<b>12b</b>, HCl Salt</h3><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (3<i>S</i>*,4<i>R</i>*)-3-Benzyl-3-({isopropyl-[4-methoxy-3-(3-methoxypropoxy)-benzoyl]-amino}-methyl)-pyrrolidine-1-carboxylic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A mixture of (<i>rac</i>)-<b>19</b> (600 mg, 1.80 mmol), 4-methoxy-3-(3-methoxypropoxy)-benzoyl chloride<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (512 mg, 1.98 mmol), and triethylamine (326 μL, 2.34 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (6 mL) was stirred at RT overnight and then quenched by the addition of an aqueous NaHCO<sub>3</sub> solution. The organic layer was separated, and the aqueous phase was extracted three times with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), and volatiles were removed in vacuo. The crude product was purified by flash chromatography (eluent: <i>c</i>-hexane–EtOAc 2:1) to afford the title compound (791 mg, 79%). MS (LC-MS): 455 [M-Boc + H]<sup>+</sup>. <sup>1</sup>H NMR (MeOD, 400 MHz): δ 1.12 (m, 6H), 1.45 (s, 9H), 2.03 (m, 2H), 2.32–2.43 (m, 2H), 2.62 (m, 1H), 2.84 (m, 1H), 3.09 (m, 1H), 3.23 (m, 2H), 3.25 (s, 3H), 3.46–3.56 (m, 3H), 3.57 (m, 2H), 3.86 (s, 3H), 4.07 (m, 3H), 6.90 (m, 2H), 7.19 (m, 4H), 7.27 (m, 2H).</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> <i>N</i>-((3<i>S</i>*,4<i>S</i>*)-4-Benzylpyrrolidin-3-ylmethyl)-<i>N</i>-isopropyl-4-methoxy-3-(3-methoxypropoxy)benzamide, (<i>rac</i>)-<b>12</b>, Hydrochloride Salt</h4><div class="NLM_p">To a solution of (3<i>S</i>*,4<i>R</i>*)-3-benzyl-4-({isopropyl-[4-methoxy-3-(3-methoxypropoxy)-benzoyl]-amino}-methyl)-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (343.4 mg, 0.619 mmol) in 2-propanol (2 mL) was added 6 M HCl in 2-propanol (1 mL), and stirring was continued for 2 h at RT. The reaction mixture was concentrated, diluted with CH<sub>2</sub>Cl<sub>2</sub>, and neutralized by the addition of 1 N NaOH. The aqueous phase was extracted three times with CH<sub>2</sub>Cl<sub>2</sub> , and the combined organics were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude residue was purified by preparative HPLC (Macheney-Nagel C18 Nucleosil-100 10 μm, 40 mm × 250 mm; eluent, 20–100% CH<sub>3</sub>CN/10 min, 100% CH<sub>3</sub>CN/10 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 40 mL/min). The compound containing fractions were combined and concentrated in vacuo. The residue was diluted with CH<sub>2</sub>Cl<sub>2</sub>, neutralized by addition of a saturated aqueous solution of NaHCO<sub>3</sub>, and extracted three times with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to afford (<i>rac</i>)-<b>12</b> as the free base (214 mg, 76%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz, 394 K): δ 1.07 (d, <i>J</i> = 6.7 Hz, 3H), 1.11 (d, <i>J</i> = 6.7 Hz, 3H), 1.93 (p, <i>J</i> = 6.3 Hz, 2H), 2.10–2.22 (m, 2H), 2.59 (m, 2H), 2.78 (m, 1H), 2.97 (dd, <i>J</i> = 8.0, 7.5 Hz, 1H), 3.09 (dd, <i>J</i> = 11.2, 7.5 Hz, 1H), 3.25 (s, 3H), 3.26 (m, 2H), 3.48 (t, <i>J</i> = 6.3 Hz, 2H), 3.80 (s, 3H), 3.96 (m, 1H), 4.02 (t, <i>J</i> = 6.3 Hz, 2H), 6.86 (m, 2H), 6.96 (m, 1H), 7.18 (m, 3H), 7.27 (m, 2H).</div><div class="NLM_p last">To a solution of (<i>rac</i>)-<b>12</b>, free base, in dioxane was added 4N HCl in dioxane (117 μL, 0.470 mmol) followed by lyophilization to afford the (<i>rac</i>)-<b>12</b>, HCl salt. MS (LC–MS): 455 [M + H]<sup>+</sup>. <i>t</i><sub>R</sub> (HPLC, Waters Symmetry C18, 3.5 μm, 2.1 mm × 50 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 2.75 min, purity 96%. t<sub>R</sub> (HPLC, MN Nucleosil C18HD, 3 μm, 70 mm × 4 mm, 20–95% CH<sub>3</sub>CN–H<sub>2</sub>O/3.5 min, 95% CH<sub>3</sub>CN/2 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 0.6 mL/min): 4.15 min, purity 96.5%. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 600 MHz): δ 0.96 (m, 3H), 1.04 (m, 3H), 1.92 (m, 2H), 2.34 (m, 2H), 2.64 (m, 1H), 2.88 (m, 2H), 3.04 (m, 1H), 3.16 (m, 1H), 3.22 (s, 3H), 3.32 (m, 2H), 3.37 (m, 1H), 3.44 (m, 2H), 3.77 (s, 3H), 3.90 (m, 1H), 3.98 (m, 2H), 6.86 (m, 2H), 6.98 (m, 1H), 7.22 (m, 1H), 7.25 (m, 2H), 7.31 (m, 2H), 8.95 (m, 2H). HRMS calcd for C<sub>27</sub>H<sub>39</sub>N<sub>2</sub>O<sub>4</sub>, 455.2904 [M + H]<sup>+</sup>; found, 455.2904.</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-((3<i>S</i>,4<i>S</i>)-4-Benzylpyrrolidin-3-ylmethyl)-<i>N</i>-isopropyl-4-methoxy-3-(3-methoxypropoxy)benzamide, (3<i>S</i>,4<i>S</i>)-<b>12a</b></h4><div class="NLM_p last">The title compound was prepared in two steps as described for (<i>rac</i>)-<b>12</b> from (3<i>S</i>,4<i>R</i>)-<b>19a</b>. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 30 mm, 10–98% CH<sub>3</sub>CN/H<sub>2</sub>O/3 min, 98% CH<sub>3</sub>CN/0.5 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min; temperature 40 °C): 1.78 min, purity 99%. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 50 mm, 10–98% CH<sub>3</sub>CN–H<sub>2</sub>O/8.6 min, 98% CH<sub>3</sub>CN/1.4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min; temperature 40 °C): 3.50 min, purity 99%. [α]<sub>D</sub><sup>20</sup> −11.1 (<i>c</i> = 1.15, MeOH). HRMS calcd for C<sub>27</sub>H<sub>39</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 455.2904; found, 455.2905.</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-((3<i>R</i>,4<i>R</i>)-4-Benzylpyrrolidin-3-ylmethyl)-<i>N</i>-isopropyl-4-methoxy-3-(3-methoxypropoxy)benzamide, (3<i>R</i>,4<i>R</i>)-<b>12b</b></h4><div class="NLM_p last">The title compound was prepared in two steps as described for (<i>rac</i>)-<b>12</b> from (3<i>R</i>,4<i>S</i>)-<b>19b</b>. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 30 mm, 10–98% CH<sub>3</sub>CN/H<sub>2</sub>O/3 min, 98% CH<sub>3</sub>CN/0.5 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min; temperature 40 °C): 1.78 min, purity 99%. <i>t</i><sub>R</sub> (Waters XBridge C18, 2.5 μm, 3 mm × 50 mm, 10–98% CH<sub>3</sub>CN–H<sub>2</sub>O/8.6 min, 98% CH<sub>3</sub>CN/1.4 min, CH<sub>3</sub>CN and H<sub>2</sub>O containing 0.1% TFA; flow, 1.4 mL/min; temperature 40 °C): 3.50 min, purity 100%. [α]<sub>D</sub><sup>20</sup> +10.6 (<i>c</i> = 0.95, MeOH). HRMS calcd for C<sub>27</sub>H<sub>39</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup>, 455.2904; found, 455.2904.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42"><a href="/doi/suppl/10.1021/jm3017078">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77217" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77217" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Description of the 3D pharmacophore searching protocol, experimental procedures for biological assays, in vivo pharmacokinetics, in vivo pharmacology, X-ray crystallographic information for the rh-renin–inhibitor complexes with <b>5</b>, <b>6a</b>, and <b>12a</b>, X-ray crystal structure of two ligands <i>trans</i>-3,4-pyrrolidine <b>6a</b> bound to the active site of glycosylated rh-renin. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3017078/suppl_file/jm3017078_si_001.pdf">jm3017078_si_001.pdf (652.61 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The crystal structures of rh-renin in complex with <b>5</b>, <b>6a</b>, and <b>12a</b> have been deposited at the Protein Data Bank RSCB PDB with the PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ5">4GJ5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ6">4GJ6</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ7">4GJ7</a>, respectively.</p><div class="testing" data-doi="10.1021/jm3017078" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48582" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48582" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edwige Lorthiois</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6c09081b050b094200031e18040503051f2c02031a0d1e18051f420f03014c0619091e0b09023307000d191f42010d050e0d19012c02031a0d1e18051f420f0301"><span class="__cf_email__" data-cfemail="1a7f7e6d737d7f347675686e72737573695a74756c7b686e736934797577">[email protected]</span> <span class="__cf_email__" data-cfemail="8be1feeef9eceee5d4e0e7eafef8a5e6eae2e9eafee6cbe5e4fdeaf9ffe2f8a5e8e4e6">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jürgen Maibaum</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#147170637d73713a787b66607c7d7b7d67547a7b627566607d673a777b79347e61716673717a4b7f787561673a79757d76756179547a7b627566607d673a777b79"><span class="__cf_email__" data-cfemail="87e2e3f0eee0e2a9ebe8f5f3efeee8eef4c7e9e8f1e6f5f3eef4a9e4e8ea">[email protected]</span> <span class="__cf_email__" data-cfemail="412b34243326242f1e2a2d2034326f2c20282320342c012f2e3720333528326f222e2c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Werner Breitenstein</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederic Cumin</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claus Ehrhardt</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Francotte</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edgar Jacoby</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nils Ostermann</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Holger Sellner</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Takatoshi Kosaka</span> - <span class="hlFld-Affiliation affiliation">Novartis Institutes for BioMedical
Research, Ohkubo 8, Tsukuba, Ibaraki 300-2611, Japan</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Randy L. Webb</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharmaceuticals Corp.,
Institutes for BioMedical Research, East Hanover, New Jersey, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean F. Rigel</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharmaceuticals Corp.,
Institutes for BioMedical Research, East Hanover, New Jersey, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrich Hassiepen</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Richert</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Trixie Wagner</span> - <span class="hlFld-Affiliation affiliation">Novartis Pharma AG, Institutes
for BioMedical Research, Novartis Campus, CH-4056 Basel, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5116-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Anne Rogemont, Jean-Francois Bulber, and Florence Zink for excellent technical assistance and Hans-Peter Baum and Markus Sanner for IC<sub>50</sub> determinations. We are grateful to Gabrielle Lecis and Claude Hager for chiral separations and to Markus Krömer for X-ray data depositions.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i46" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i46"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i47" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i47"> Abbreviations Used</h2><tr><td class="NLM_term">AngI</td><td class="NLM_def"><p class="first last">angiotensin I</p></td></tr><tr><td class="NLM_term">AngII</td><td class="NLM_def"><p class="first last">angiotensin II</p></td></tr><tr><td class="NLM_term">AT1 receptor</td><td class="NLM_def"><p class="first last">angiotensin I receptor</p></td></tr><tr><td class="NLM_term">DRI</td><td class="NLM_def"><p class="first last">direct renin inhibitor</p></td></tr><tr><td class="NLM_term">FRET</td><td class="NLM_def"><p class="first last">fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">GRAB</td><td class="NLM_def"><p class="first last">group replacement assisted binding</p></td></tr><tr><td class="NLM_term">HE</td><td class="NLM_def"><p class="first last">hydroxyethylene</p></td></tr><tr><td class="NLM_term">RAAS</td><td class="NLM_def"><p class="first last">renin–angiotensin–aldosterone system</p></td></tr><tr><td class="NLM_term">rh-renin</td><td class="NLM_def"><p class="first last">recombinant human renin</p></td></tr><tr><td class="NLM_term">S3<sup>sp</sup></td><td class="NLM_def"><p class="first last">S3 subpocket</p></td></tr><tr><td class="NLM_term">dTGR</td><td class="NLM_def"><p class="first last">double transgenic rats</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Ezzati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander-Hoorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. J. L.</span><span> </span><span class="NLM_article-title">Selected major risk factors and global and regional burden of disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x"> (</span><span class="NLM_issue">9343</span><span class="NLM_x">) </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2002&pages=1347-1360&issue=9343&author=M.+Ezzatiauthor=A.+D.+Lopezauthor=A.+Rodgersauthor=S.+Vander-Hoornauthor=C.+J.+L.+Murray&title=Selected+major+risk+factors+and+global+and+regional+burden+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEzzati%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DA.%2BD.%26aulast%3DRodgers%26aufirst%3DA.%26aulast%3DVander-Hoorn%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DC.%2BJ.%2BL.%26atitle%3DSelected%2520major%2520risk%2520factors%2520and%2520global%2520and%2520regional%2520burden%2520of%2520disease%26jtitle%3DLancet%26date%3D2002%26volume%3D360%26issue%3D9343%26spage%3D1347%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R. R.</span><span> </span><span class="NLM_article-title">Development of inhibitors of the aspartyl protease renin for the treatment of hypertension</span> <span class="citation_source-journal">Curr. Protein Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.2174%2F138920306777452330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=16787263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1emtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=241-254&author=B.+B.+Scottauthor=G.+M.+McGeehanauthor=R.+R.+Harrison&title=Development+of+inhibitors+of+the+aspartyl+protease+renin+for+the+treatment+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Development of inhibitors of the aspartyl protease renin for the treatment of hypertension</span></div><div class="casAuthors">Scott, Boyd B.; McGeehan, Gerard M.; Harrison, Richard K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-254</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Renin is the rate-limiting enzyme in the renin-angiotensin-aldosterone system (RAS) which controls blood pressure and vol.  The biol. function of renin is to cleave the N-terminus of angiotensinogen releasing the decapeptide, angiotensin I (ANGI).  Subsequently, angiotensin I is further processed by the angiotensin converting enzyme (ACE) to produce angiotensin II (ANGII).  The RAS cascade is a major target for the clin. management of hypertension.  Current clin. treatments include angiotensin converting enzyme inhibitors (ACEi) and ANGII receptor blockers (ARBs).  As the rate-limiting enzyme in ANGII prodn., renin inhibitors have been pursued as an addnl. class of antihypertensives.  Clin. studies conducted with renin inhibitors have shown them to be as effective as ACE inhibitors in lowering blood pressure.  Most importantly, inhibitors of renin may have a no. of potential advantages over ACEi and ARBs.  Renin is specific for angiotensinogen and will not carry the ancillary pharmacol. assocd. with ACEi or ARBs.  To date, no renin inhibitors have made it to market.  The development of these inhibitors has been hindered by poor bioavailability and complex synthesis.  However, despite the pharmacokinetic challenges of designing renin inhibitors, the enzyme remains a promising target for the development of novel treatments for hypertension.  This review consists of an overview of renin biol., the pharmacol. of renin and RAS and focus in on renin as a target for blood pressure regulation.  The authors also cover the evaluation of renin inhibitors in animal models and clin. studies.  Presently a no. of new generation inhibitors of renin are in development with at least one in the clinic and these are discussed.  Finally the authors discuss what might distinguish renin inhibitors from current therapeutic options and discuss other therapeutic indications renin inhibitors might have.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLk69AZtJAJbVg90H21EOLACvtfcHk0ljcYMeUp75SDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1emtb8%253D&md5=8810483befefacec51f88378dfba763a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F138920306777452330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920306777452330%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DHarrison%26aufirst%3DR.%2BR.%26atitle%3DDevelopment%2520of%2520inhibitors%2520of%2520the%2520aspartyl%2520protease%2520renin%2520for%2520the%2520treatment%2520of%2520hypertension%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2006%26volume%3D7%26spage%3D241%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Nicholls, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagami, T.</span><span> </span><span class="NLM_article-title">The renin–angiotensin system in the twenty-first century</span> <span class="citation_source-journal">Blood Pressure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=327-343&author=M.+G.+Nichollsauthor=J.+I.+S.+Robertsonauthor=T.+Inagami&title=The+renin%E2%80%93angiotensin+system+in+the+twenty-first+century"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicholls%26aufirst%3DM.%2BG.%26aulast%3DRobertson%26aufirst%3DJ.%2BI.%2BS.%26aulast%3DInagami%26aufirst%3DT.%26atitle%3DThe%2520renin%25E2%2580%2593angiotensin%2520system%2520in%2520the%2520twenty-first%2520century%26jtitle%3DBlood%2520Pressure%26date%3D2001%26volume%3D10%26spage%3D327%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Castrop, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höcherl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todorov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C.</span><span> </span><span class="NLM_article-title">Physiology of kidney renin</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=607-673&author=H.+Castropauthor=K.+H%C3%B6cherlauthor=A.+Kurtzauthor=F.+Schwedaauthor=V.+Todorovauthor=C.+Wagner&title=Physiology+of+kidney+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastrop%26aufirst%3DH.%26aulast%3DH%25C3%25B6cherl%26aufirst%3DK.%26aulast%3DKurtz%26aufirst%3DA.%26aulast%3DSchweda%26aufirst%3DF.%26aulast%3DTodorov%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DC.%26atitle%3DPhysiology%2520of%2520kidney%2520renin%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D607%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Skeggs, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumway, N. P.</span><span> </span><span class="NLM_article-title">Preparation, purification and amino acid sequence of a polypeptide renin substrate</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1957&pages=439-453&author=L.+Skeggsauthor=J.+R.+Kahnauthor=K.+E.+Lentzauthor=N.+P.+Shumway&title=Preparation%2C+purification+and+amino+acid+sequence+of+a+polypeptide+renin+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkeggs%26aufirst%3DL.%26aulast%3DKahn%26aufirst%3DJ.%2BR.%26aulast%3DLentz%26aufirst%3DK.%2BE.%26aulast%3DShumway%26aufirst%3DN.%2BP.%26atitle%3DPreparation%252C%2520purification%2520and%2520amino%2520acid%2520sequence%2520of%2520a%2520polypeptide%2520renin%2520substrate%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1957%26volume%3D106%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Jackson, E. K.</span><span> </span><span class="NLM_article-title">Renin and Angiotensin</span>. In  <span class="citation_source-book">Goodman and Gilman’s: The Pharmacological Basis of Therapeutics</span>, <span class="NLM_edition">11th</span> ed.; <span class="NLM_contrib-group">Brunton, L.; Lazo, J.; Parker, K.; Buxton, I.; Blumenthal, D.</span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=789-821&author=E.+K.+Jacksonauthor=L.+Brunton&author=J.+Lazo&author=K.+Parker&author=I.+Buxton&author=D.+Blumenthal&title=Goodman+and+Gilman%E2%80%99s%3A+The+Pharmacological+Basis+of+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DE.%2BK.%26atitle%3DRenin%2520and%2520Angiotensin%26btitle%3DGoodman%2520and%2520Gilman%25E2%2580%2599s%253A%2520The%2520Pharmacological%2520Basis%2520of%2520Therapeutics%26aulast%3DBrunton%26aufirst%3DL.%26pub%3DMcGraw-Hill%26date%3D2006%26spage%3D789%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Mehta, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griendling, K. K.</span><span> </span><span class="NLM_article-title">Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system</span> <span class="citation_source-journal">Am. J. Physiol. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">C82</span><span class="NLM_x">–</span> <span class="NLM_lpage">C97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=C82-C97&author=P.+K.+Mehtaauthor=K.+K.+Griendling&title=Angiotensin+II+cell+signaling%3A+physiological+and+pathological+effects+in+the+cardiovascular+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DP.%2BK.%26aulast%3DGriendling%26aufirst%3DK.%2BK.%26atitle%3DAngiotensin%2520II%2520cell%2520signaling%253A%2520physiological%2520and%2520pathological%2520effects%2520in%2520the%2520cardiovascular%2520system%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DC82%26epage%3DC97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofbauer, K. G.</span><span> </span><span class="NLM_article-title">Inhibitors of renin as potential therapeutic agents</span> <span class="citation_source-journal">J. Enzyme Inhib.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.3109%2F14756368709020115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=3334243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADyaL2sXhs1yht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1987&pages=169-185&author=J.+M.+Woodauthor=J.+L.+Stantonauthor=K.+G.+Hofbauer&title=Inhibitors+of+renin+as+potential+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of renin as potential therapeutic agents</span></div><div class="casAuthors">Wood, Jeanette M.; Stanton, James L.; Hofbauer, Karl G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-85</span>CODEN:
                <span class="NLM_cas:coden">ENINEG</span>;
        ISSN:<span class="NLM_cas:issn">8755-5093</span>.
    </div><div class="casAbstract">A review, with 98 refs., of the biochem. of human renin  [9015-94-5]; the structures and biol. activity of various renin inhibitors; and the therapeutic potential of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAfx87wdULsbVg90H21EOLACvtfcHk0liFK_5-HLpUEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhs1yht70%253D&md5=0ffad109e3123855070aeef23fb27035</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3109%2F14756368709020115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756368709020115%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DHofbauer%26aufirst%3DK.%2BG.%26atitle%3DInhibitors%2520of%2520renin%2520as%2520potential%2520therapeutic%2520agents%26jtitle%3DJ.%2520Enzyme%2520Inhib.%26date%3D1987%26volume%3D1%26spage%3D169%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Fisher, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Is there a future for renin inhibitors?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=417-426&author=N.+D.+Fisherauthor=N.+K.+Hollenberg&title=Is+there+a+future+for+renin+inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DIs%2520there%2520a%2520future%2520for%2520renin%2520inhibitors%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2001%26volume%3D10%26spage%3D417%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Ferro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krum, H.</span><span> </span><span class="NLM_article-title">Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1111%2Fj.1368-5031.2006.00920.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=16700858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlGntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2006&pages=577-581&author=A.+Ferroauthor=R.+Gilbertauthor=H.+Krum&title=Importance+of+renin+in+blood+pressure+regulation+and+therapeutic+potential+of+renin+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition</span></div><div class="casAuthors">Ferro, A.; Gilbert, R.; Krum, H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">577-581</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite improvements in its detection and treatment, hypertension remains a significant public health problem worldwide.  In recent years, many international hypertension societies and organizations have set increasingly rigorous blood pressure (BP) targets, with the aim of reducing cardiovascular complications, and this has in turn necessitated the use of more antihypertensive medications to reach these targets in individual patients.  There is therefore an ongoing need to develop antihypertensive drugs with new mechanisms of action.  Renin inhibitors represent a novel class of compds. which offer considerable promise as BP-lowering agents.  Here, we review the rationale for renin inhibition as a therapeutic target and examine the preclin. and clin. evidence for the antihypertensive effectiveness of the renin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-BT84LqqRZrVg90H21EOLACvtfcHk0liFK_5-HLpUEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlGntrY%253D&md5=006b2b8d40a0dcc5ed3b33b6f8f4cc38</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1368-5031.2006.00920.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1368-5031.2006.00920.x%26sid%3Dliteratum%253Aachs%26aulast%3DFerro%26aufirst%3DA.%26aulast%3DGilbert%26aufirst%3DR.%26aulast%3DKrum%26aufirst%3DH.%26atitle%3DImportance%2520of%2520renin%2520in%2520blood%2520pressure%2520regulation%2520and%2520therapeutic%2520potential%2520of%2520renin%2520inhibition%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D60%26spage%3D577%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. C.</span><span> </span><span class="NLM_article-title">Potential side effects of renin inhibitors—mechanisms based on comparison with other renin–angiotensin blockers</span> <span class="citation_source-journal">Expert Opin. Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1517%2F14740338.5.5.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=16907653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=631-641&author=H.+Chengauthor=R.+C.+Harris&title=Potential+side+effects+of+renin+inhibitors%E2%80%94mechanisms+based+on+comparison+with+other+renin%E2%80%93angiotensin+blockers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Potential side effects of renin inhibitors - mechanisms based on comparison with other renin-angiotensin blockers</span></div><div class="casAuthors">Cheng, Huifang; Harris, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">631-641</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Angiotensin (Ang) II plays important roles in the development of hypertension and cardiovascular and renal injury.  Pharmaceutical approaches to block its activity led to the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.  Numerous trials have documented their efficacy in controlling blood pressure, minimizing left ventricular remodelling, preventing progression to heart failure, ameliorating proteinuria and retarding renal disease progression.  Although they are considered safe in general, there remain concerns about the potential for adverse events in certain target populations.  Recently, several novel, low mol. wt. renin inhibitors without the extended peptide-like backbone of previous renin inhibitors were developed with favorable pharmacokinetic properties.  They have been shown to successfully reduce Ang II levels in normal volunteers and to lower blood pressure in patients with mild-to-moderate hypertension.  In this review, the authors summarize current knowledge about these renin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmu6jtwrNjn7Vg90H21EOLACvtfcHk0liFK_5-HLpUEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKhtL0%253D&md5=dfdbd57c1e456dfbaace6fb9ad5bb52a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F14740338.5.5.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.5.5.631%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DR.%2BC.%26atitle%3DPotential%2520side%2520effects%2520of%2520renin%2520inhibitors%25E2%2580%2594mechanisms%2520based%2520on%2520comparison%2520with%2520other%2520renin%25E2%2580%2593angiotensin%2520blockers%26jtitle%3DExpert%2520Opin.%2520Drug%2520Safety%26date%3D2006%26volume%3D5%26spage%3D631%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Azizi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span> </span><span class="NLM_article-title">Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">2492</span><span class="NLM_x">–</span> <span class="NLM_lpage">2499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=2492-2499&author=M.+Aziziauthor=J.+Menard&title=Combined+blockade+of+the+renin-angiotensin+system+with+angiotensin-converting+enzyme+inhibitors+and+angiotensin+II+type+1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DM.%26aulast%3DMenard%26aufirst%3DJ.%26atitle%3DCombined%2520blockade%2520of%2520the%2520renin-angiotensin%2520system%2520with%2520angiotensin-converting%2520enzyme%2520inhibitors%2520and%2520angiotensin%2520II%2520type%25201%2520receptor%2520antagonists%26jtitle%3DCirculation%26date%3D2004%26volume%3D109%26spage%3D2492%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karlberg, B. E.</span><span> </span><span class="NLM_article-title">Cough and inhibition of the renin–angiotensin system</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">S49</span><span class="NLM_x">–</span> <span class="NLM_lpage">S52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1993&pages=S49-S52&issue=Suppl&author=B.+E.+Karlberg&title=Cough+and+inhibition+of+the+renin%E2%80%93angiotensin+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarlberg%26aufirst%3DB.%2BE.%26atitle%3DCough%2520and%2520inhibition%2520of%2520the%2520renin%25E2%2580%2593angiotensin%2520system%26jtitle%3DJ.%2520Hypertens.%26date%3D1993%26volume%3D11%26issue%3DSuppl%26spage%3DS49%26epage%3DS52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cugno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostoni, A.</span><span> </span><span class="NLM_article-title">Bradykinin and the pathophysiology of angioedema</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS1567-5769%2802%2900162-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=12639808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFGktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=311-317&author=M.+Cugnoauthor=J.+Nussbergerauthor=M.+Cicardiauthor=A.+Agostoni&title=Bradykinin+and+the+pathophysiology+of+angioedema"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin and the pathophysiology of angioedema</span></div><div class="casAuthors">Cugno, Massimo; Nussberger, Jurg; Cicardi, Marco; Agostoni, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">311-317</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Angioedema has different causes and different clin. presentations.  Some types of angioedema may be mediated by bradykinin.  We measured plasma levels of bradykinin-(1-9) nonapeptide by RIA after high-performance liq. chromatog. in patients with different types of angioedema during acute attacks and/or in remission, i.e. hereditary C1-inhibitor deficiency, angiotensin converting enzyme (ACE) inhibitor treatment, idiopathic non histaminergic and responders to antihistamines.  Eleven patients with the deficiency of C1-inhibitor had very high levels of bradykinin during acute attacks of angioedema (18.0-90.0 pM) (normal range 0.2-7.1 pM).  In three patients with history of ACE inhibitor-related angioedema, plasma bradykinin was high during ACE inhibitor treatment (62.0, 8.9 and 27.0 pM) and in a fourth patient was 47.0 pM during an acute attack and decreased by 93% to 3.2 pM after withdrawal of the ACE inhibitor.  The patient with idiopathic angioedema, during an acute attack involving the right arm, had high levels of bradykinin in the venous blood refluent from the angioedematous arm (20.0 pM) while in the contralateral arm bradykinin levels were normal (6.6 pM), similarly to what we previously obsd. in cases of brachial angioedema due to C1-inhibitor deficiency.  The four patients with angioedema responsive to antihistamines had normal levels of bradykinin even during acute attacks (5.7, 3.4, 4.7 and 1.2 pM).  In one of these patients who had a brachial angioedema, bradykinin levels were normal in the venous blood refluent from both arms.  Bradykinin is involved in hereditary C1-inhibitor deficiency angioedema, in ACE inhibitor-related angioedema, and in idiopathic non-histaminergic angioedema, while bradykinin is not related to allergen-dependent or idiopathic angioedema that are responsive to antihistamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMq4a94xBobLVg90H21EOLACvtfcHk0ljOFBJDLkas4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFGktLY%253D&md5=8a549aaf69ac0108ad33be591729f615</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2FS1567-5769%2802%2900162-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1567-5769%252802%252900162-5%26sid%3Dliteratum%253Aachs%26aulast%3DCugno%26aufirst%3DM.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DCicardi%26aufirst%3DM.%26aulast%3DAgostoni%26aufirst%3DA.%26atitle%3DBradykinin%2520and%2520the%2520pathophysiology%2520of%2520angioedema%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2003%26volume%3D3%26spage%3D311%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Parving, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Aliskiren combined with losartan in type 2 diabetes and nephropathy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1056%2FNEJMoa0708379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=18525041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFKmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2008&pages=2433-2445&author=H.+H.+Parvingauthor=F.+Perssonauthor=J.+B.+Lewisauthor=E.+J.+Lewisauthor=N.+K.+Hollenberg&title=Aliskiren+combined+with+losartan+in+type+2+diabetes+and+nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren combined with losartan in type 2 diabetes and nephropathy</span></div><div class="casAuthors">Parving, Hans-Henrik; Persson, Frederik; Lewis, Julia B.; Lewis, Edmund J.; Hollenberg, Norman K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2433-2446</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries.  We evaluated the renoprotective effects of dual blockade of the renin-angiotensin-aldosterone system by adding treatment with aliskiren, an oral direct renin inhibitor, to treatment with the maximal recommended dose of losartan (100 mg daily) and optimal antihypertensive therapy in patients who had hypertension and type 2 diabetes with nephropathy.  We enrolled 599 patients in this multinational, randomized, double-blind study.  After a 3-mo, open-label, run-in period during which patients received 100 mg of losartan daily, patients were randomly assigned to receive 6 mo of treatment with aliskiren (150 mg daily for 3 mo, followed by an increase in dosage to 300 mg daily for another 3 mo) or placebo, in addn. to losartan.  The primary outcome was a redn. in the ratio of albumin to creatinine, as measured in an early-morning urine sample, at 6 mo.  The baseline characteristics of the two groups were similar.  Treatment with 300 mg of aliskiren daily, as compared with placebo, reduced the mean urinary albumin-to-creatinine ratio by 20% (95% confidence interval, 9 to 30; P<0.001), with a redn. of 50% or more in 24.7% of the patients who received aliskiren as compared with 12.5% of those who received placebo (P<0.001).  A small difference in blood pressure was seen between the treatment groups by the end of the study period (systolic, 2 mm Hg lower [P = 0.07] and diastolic, 1 mm Hg lower [P = 0.08] in the aliskiren group).  The total nos. of adverse and serious adverse events were similar in the groups.  Aliskiren may have renoprotective effects that are independent of its blood pressure-lowering effect in patients with hypertension, type 2 diabetes, and nephropathy who are receiving the recommended renoprotective treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrVSPga0hzXrVg90H21EOLACvtfcHk0ljOFBJDLkas4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFKmtLY%253D&md5=e53fcda0023dbc3c567f412179cd3328</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0708379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0708379%26sid%3Dliteratum%253Aachs%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DLewis%26aufirst%3DJ.%2BB.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DAliskiren%2520combined%2520with%2520losartan%2520in%2520type%25202%2520diabetes%2520and%2520nephropathy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D358%26spage%3D2433%26epage%3D2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiering, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedrani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Direct Renin Inhibitors as A New Therapy for Hypertension</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7490</span><span class="NLM_x">–</span> <span class="NLM_lpage">7520</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901885s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7490-7520&author=R.+L.+Webbauthor=N.+Schieringauthor=R.+Sedraniauthor=J.+Maibaum&title=Direct+Renin+Inhibitors+as+A+New+Therapy+for+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm901885s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901885s%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DSchiering%26aufirst%3DN.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDirect%2520Renin%2520Inhibitors%2520as%2520A%2520New%2520Therapy%2520for%2520Hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7490%26epage%3D7520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16a"><span><span class="NLM_contrib-group">Tice, C. M.; Singh, S. B.</span><span> </span><span class="NLM_article-title">Evolution of Diverse Classes of Renin Inhibitors through the Years</span>. In  <span class="citation_source-journal">Aspartic Acid Proteases as Therapeutic Targets</span>, <span class="NLM_contrib-group">Ghosh, A. K.</span>, Ed.; <span class="NLM_series">Methods and Principles in Medicinal Chemistry</span>, <span class="NLM_contrib-group">Mannhold, R.; Kubinyi, H.; Folkers, G.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span>Vol.  <span class="NLM_volume">45</span>, pp  <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=297-324&author=C.+M.+Tice&author=S.+B.+Singhauthor=A.+K.+Ghoshauthor=R.+Mannhold&author=H.+Kubinyi&author=G.+Folkers&title=Evolution+of+Diverse+Classes+of+Renin+Inhibitors+through+the+Years"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTice%26aufirst%3DC.%2BM.%26atitle%3DEvolution%2520of%2520Diverse%2520Classes%2520of%2520Renin%2520Inhibitors%2520through%2520the%2520Years%26jtitle%3DAspartic%2520Acid%2520Proteases%2520as%2520Therapeutic%2520Targets%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DMannhold%26aufirst%3DR.%26pub%3DWiley-VCH%26date%3D2010%26volume%3D45%26spage%3D297%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedigian, M. P.</span><span> </span><span class="NLM_article-title">Structure-based design of aliskiren, a novel orally effective renin inhibitor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS0006-291X%2803%2901451-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=12927775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2003&pages=698-705&author=J.+M.+Woodauthor=J.+Maibaumauthor=J.+Rahuelauthor=M.+G.+Gr%C3%BCtterauthor=N.-C.+Cohenauthor=V.+Rasettiauthor=H.+R%C3%BCegerauthor=R.+G%C3%B6schkeauthor=S.+Stutzauthor=W.+Fuhrerauthor=W.+Schillingauthor=P.+Rigollierauthor=Y.+Yamaguchiauthor=F.+Cuminauthor=H.-P.+Baumauthor=C.+R.+Schnellauthor=P.+Heroldauthor=R.+Mahauthor=C.+Jensenauthor=E.+O%E2%80%99Brienauthor=A.+Stantonauthor=M.+P.+Bedigian&title=Structure-based+design+of+aliskiren%2C+a+novel+orally+effective+renin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of aliskiren, a novel orally effective renin inhibitor</span></div><div class="casAuthors">Wood, Jeanette M.; Maibaum, Juergen; Rahuel, Joseph; Gruetter, Markus G.; Cohen, Nissim-Claude; Rasetti, Vittorio; Rueger, Heinrich; Goeschke, Richard; Stutz, Stefan; Fuhrer, Walter; Schilling, Walter; Rigollier, Pascal; Yamaguchi, Yasuchika; Cumin, Frederic; Baum, Hans-Peter; Schnell, Christian R.; Herold, Peter; Mah, Robert; Jensen, Chris; O'Brien, Eoin; Stanton, Alice; Bedigian, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">698-705</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Hypertension is a major risk factor for cardiovascular diseases such as stroke, myocardial infarction, and heart failure, the leading causes of death in the Western world.  Inhibitors of the renin-angiotensin system (RAS) have proven to be successful treatments for hypertension.  As renin specifically catalyzes the rate-limiting step of the RAS, it represents the optimal target for RAS inhibition.  Several peptide-like renin inhibitors have been synthesized previously, but poor pharmacokinetic properties meant that these compds. were not clin. useful.  We employed a combination of mol. modeling and crystallog. structure anal. to design renin inhibitors lacking the extended peptide-like backbone of earlier inhibitors, for improved pharmacokinetic properties.  This led to the discovery of aliskiren, a highly potent and selective inhibitor of human renin in vitro, and in vivo; once-daily oral doses of aliskiren inhibit renin and lower blood pressure in sodium-depleted marmosets and hypertensive human patients.  Aliskiren represents the first in a novel class of renin inhibitors with the potential for treatment of hypertension and related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5YmV3cdr0LVg90H21EOLACvtfcHk0lh_nd56QFJ8fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGkt7k%253D&md5=20b71ca3ccfe2324752cb2bb541d9ba2</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901451-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901451-7%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DR%25C3%25BCeger%26aufirst%3DH.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DBaum%26aufirst%3DH.-P.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DHerold%26aufirst%3DP.%26aulast%3DMah%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DStanton%26aufirst%3DA.%26aulast%3DBedigian%26aufirst%3DM.%2BP.%26atitle%3DStructure-based%2520design%2520of%2520aliskiren%252C%2520a%2520novel%2520orally%2520effective%2520renin%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D308%26spage%3D698%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4832</span><span class="NLM_x">–</span> <span class="NLM_lpage">4844</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070316i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maibaum%2C+J.%3B+Stutz%2C+S.%3B+G%C3%B6schke%2C+R.%3B+Rigollier%2C+P.%3B+Yamaguchi%2C+Y.%3B+Cumin%2C+F.%3B+Rahuel%2C+J.%3B+Baum%2C+H.-P.%3B+Cohen%2C+N.-C.%3B+Schnell%2C+C.+R.%3B+Fuhrer%2C+W.%3B+Gr%C3%BCtter%2C+M.+G.%3B+Schilling%2C+W.%3B+Wood%2C+J.+M.J.+Med.+Chem.+2007%2C+50%2C+4832%E2%80%934844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modification of the P2' Position of 2,7-Dialkyl-Substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: The Discovery of Aliskiren, a Potent Nonpeptide Human Renin Inhibitor Active after Once Daily Dosing in Marmosets</span></div><div class="casAuthors">Maibaum, Juergen; Stutz, Stefan; Goeschke, Richard; Rigollier, Pascal; Yamaguchi, Yasuchika; Cumin, Frederic; Rahuel, Joseph; Baum, Hans-Peter; Cohen, Nissim-Claude; Schnell, Christian R.; Fuhrer, Walter; Gruetter, Markus G.; Schilling, Walter; Wood, Jeanette M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4832-4844</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Due to its function in the rate limiting initial step of the renin-angiotensin system, renin is a particularly promising target for drugs designed to control hypertension, a growing risk to health worldwide.  Despite vast efforts over more than two decades, no orally efficacious renin inhibitor had reached the market.  As a result of a structure-based topol. design approach, we have identified a novel class of small-mol. inhibitors with good oral blood-pressure lowering effects in primates.  Further lead optimization aimed for improvement of in vivo potency and duration of action, mainly by P2' modifications at the hydroxyethylene transition-state isostere.  These efforts resulted in the discovery of aliskiren (46, CGP060536B, SPP100), a highly potent, selective inhibitor of renin, demonstrating excellent efficacy in sodium-depleted marmosets after oral administration, with sustained duration of action in reducing dose-dependently mean arterial blood pressure.  Aliskiren has recently received regulatory approval by the U.S. Food and Drug Administration for the treatment of hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfKfNx9HchP7Vg90H21EOLACvtfcHk0lh_nd56QFJ8fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgs7zJ&md5=bce469eed92c55b133b4be98ffdc2794</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm070316i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070316i%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DBaum%26aufirst%3DH.-P.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4832%26epage%3D4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span> </span><span class="NLM_article-title">Case history on Tekturna/Rasilez (aliskiren), a highly efficacious direct oral renin inhibitor as a new therapy for hypertension</span> <span class="citation_source-journal">Annu. Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS0065-7743%2809%2904405-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=105-127&author=J.+Maibaumauthor=D.+L.+Feldman&title=Case+history+on+Tekturna%2FRasilez+%28aliskiren%29%2C+a+highly+efficacious+direct+oral+renin+inhibitor+as+a+new+therapy+for+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Case history on Tekturna Rasilez (Aliskiren), a highly efficacious direct oral renin inhibitor as a new therapy for hypertension</span></div><div class="casAuthors">Maibaum, Jurgen; Feldman, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-127</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The rationale for the use of direct renin inhibitors, pre-clin. models to study direct renin inhibitors, and the early renin inhibitor program at Ciba-Geigy are shown.  The first convergent and scalable synthesis development, pre-clin. properties of aliskiren, effects of aliskiren in disease models, and clin. studies with aliskiren are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOCbXc9SNs7LVg90H21EOLACvtfcHk0lh_nd56QFJ8fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsrnM&md5=7fb4459d367392233e0569a8809a3f41</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2809%2904405-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252809%252904405-4%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26atitle%3DCase%2520history%2520on%2520Tekturna%252FRasilez%2520%2528aliskiren%2529%252C%2520a%2520highly%2520efficacious%2520direct%2520oral%2520renin%2520inhibitor%2520as%2520a%2520new%2520therapy%2520for%2520hypertension%26jtitle%3DAnnu.%2520Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D105%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010425b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVantw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=541-558&author=M.+G.+Bursavichauthor=D.+H.+Rich&title=Designing+non-peptide+peptidomimetics+in+the+21st+century%3A+inhibitors+targeting+conformational+ensembles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Designing Non-Peptide Peptidomimetics in the 21st Century: Inhibitors Targeting Conformational Ensembles</span></div><div class="casAuthors">Bursavich, Matthew G.; Rich, Daniel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The goal of this Perspective is to outline for medicinal chemists the potential impact of receptor conformational mobility on rational drug design.  While others have postulated receptor-based conformational selection of ligands and successfully designed inhibitors to emulate the -strand binding motif of native ligands , we show that novel protein conformations (not obsd. in either native or enzyme-inhibitor complexes) can be exploited to create nonpeptide enzyme inhibitors.  We begin with a review of the development of peptidomimetic aspartic peptidase inhibitors and conclude with a new proposal for discovering fundamentally novel nonpeptide peptidomimetics by targeting conformational ensembles.  Although we focus on the aspartic peptidases, the lessons derived therein are applicable to other peptidase and receptor-ligand systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1URmBiLvD97Vg90H21EOLACvtfcHk0lgb_cT3bfmUSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVantw%253D%253D&md5=8f00dc08b4d51c3021dd22a247bd56c0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm010425b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010425b%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DDesigning%2520non-peptide%2520peptidomimetics%2520in%2520the%252021st%2520century%253A%2520inhibitors%2520targeting%2520conformational%2520ensembles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D541%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><div class="note"><p class="first last">The X-ray structure for the disclosed GRAB peptidomimetic inhibitor 2-chloro-benzoic acid 4-[(3<i>S</i>,4<i>R</i>,5<i>R</i>)-3-methoxymethyl-5-(naphthalen-2-ylmethoxy)-piperidin-4-yl]-benzyl ester in complex with recombinant human renin (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PR8">1PR8</a>) had been made publicly available by the Protein Data Bank during a restricted time period. This data has been retracted in the meantime for unknown reasons</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS1074-5521%2899%2989004-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=10074464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1yqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Oefner%2C+C.%3B+Binggeli%2C+A.%3B+Breu%2C+V.%3B+Bur%2C+D.%3B+Clozel%2C+J.-P.%3B+D%E2%80%99Arcy%2C+A.%3B+Dorn%2C+A.%3B+Fischli%2C+W.%3B+Gr%C3%BCninger%2C+F.%3B+G%C3%BCller%2C+R.%3B+M%C3%A4rki%2C+H.+P.%3B+Mathews%2C+S.%3B+M%C3%BCller%2C+M.%3B+Ridley%2C+R.+G.%3B+Stadler%2C+H.%3B+Vieira%2C+E.%3B+Wilhelm%2C+M.%3B+Winkler%2C+F.+K.%3B+Wostl%2C+W.Chem.+Biol.+1999%2C+6%2C+127%E2%80%93131The+X-ray+structure+for+the+disclosed+GRAB+peptidomimetic+inhibitor+2-chloro-benzoic+acid+4-%5B%283S%2C4R%2C5R%29-3-methoxymethyl-5-%28naphthalen-2-ylmethoxy%29-piperidin-4-yl%5D-benzyl+ester+in+complex+with+recombinant+human+renin+%28PDB+code+1PR8%29+had+been+made+publicly+available+by+the+Protein+Data+Bank+during+a+restricted+time+period.+This+data+has+been+retracted+in+the+meantime+for+unknown+reasons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?</span></div><div class="casAuthors">Oefner, C.; Binggeli, A.; Breu, V.; Bur, D.; Clozel, J.-P.; D'Arcy, A.; Dorn, A.; Fischli, W.; Gruninger, F.; Guller, R.; Hirth, G.; Marki, H. P.; Mathews, S.; Muller, M.; Ridley, R. G.; Stadler, H.; Vieira, E.; Wilhelm, M.; Winkler, F. K.; Wostl, W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">127-131</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">The aspartic proteinase renin catalyzes the first and rate-limiting step in the conversion of angiotensinogen to the hormone angiotensin II, and therefore plays an important physiol. role in the regulation of blood pressure.  Numerous potent peptidomimetic inhibitors of this important drug target have been developed, but none of these compds. have progressed past clin. phase II trials.  Limited oral bioavailability or excessive prodn. costs have prevented these inhibitors from becoming new antihypertensive drugs.  We were interested in developing new nonpeptidomimetic renin inhibitors.  High-throughput screening of the Roche compd. library identified a simple 3,4-disubstituted piperidine lead compd.  We detd. the crystal structures of recombinant human renin complexed with two representatives of this new class.  Binding of these substituted piperidine derivs. is accompanied by major induced-fit adaptations around the enzyme's active site.  The efficient optimization of the piperidine inhibitors was facilitated by structural anal. of the renin active site in two renin-inhibitor complexes (some of the piperidine derivs. have picomolar affinities for renin).  These structural changes provide the basis for a novel paradigm for inhibition of monomeric aspartic proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvIEMz9YB6oLVg90H21EOLACvtfcHk0lgb_cT3bfmUSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1yqsrY%253D&md5=071dd0984f8880eb09ee26c878d47e61</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2989004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252989004-8%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DClozel%26aufirst%3DJ.-P.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DMathews%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DRidley%26aufirst%3DR.%2BG.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DF.%2BK.%26aulast%3DWostl%26aufirst%3DW.%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohner-Lang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, Ph.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebeli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foricher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenny, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervaala, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montavon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oefner, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanwald-Ducray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleimer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdenaire, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand-Chou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, R.</span><span> </span><span class="NLM_article-title">Piperidine renin inhibitors: from leads to drug candidates</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS0014-827X%2801%2901004-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=11347960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFKqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=21-27&author=H.+P.+M%C3%A4rkiauthor=A.+Binggeliauthor=B.+Bittnerauthor=V.+Bohner-Langauthor=V.+Breuauthor=D.+Burauthor=Ph.+Coassoloauthor=J.+P.+Clozelauthor=A.+D%E2%80%99Arcyauthor=H.+Doebeliauthor=W.+Fischliauthor=Ch.+Funkauthor=J.+Foricherauthor=T.+Gillerauthor=F.+Gr%C3%BCningerauthor=A.+Guenziauthor=R.+G%C3%BCllerauthor=T.+Hartungauthor=G.+Hirthauthor=Ch.+Jennyauthor=M.+Kansyauthor=U.+Klinkhammerauthor=T.+Laveauthor=B.+Lohriauthor=F.+C.+Luftauthor=E.+M.+Mervaalaauthor=D.+N.+M%C3%BCllerauthor=M.+M%C3%BCllerauthor=F.+Montavonauthor=Ch.+Oefnerauthor=C.+Qiuauthor=A.+Reichelauthor=P.+Sanwald-Ducrayauthor=M.+Scaloneauthor=M.+Schleimerauthor=R.+Schmidauthor=H.+Stadlerauthor=A.+Treiberauthor=O.+Valdenaireauthor=E.+Vieiraauthor=P.+Waldmeierauthor=R.+Wiegand-Chouauthor=M.+Wilhelmauthor=W.+Wostlauthor=M.+Zellauthor=R.+Zell&title=Piperidine+renin+inhibitors%3A+from+leads+to+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidine renin inhibitors: from leads to drug candidates</span></div><div class="casAuthors">Marki, H. P.; Binggeli, A.; Bittner, B.; Bohner-Lang, V.; Breu, V.; Bur, D.; Coassolo, Ph.; Clozel, J. P.; D'Arcy, A.; Doebeli, H.; Fischli, W.; Funk, Ch.; Foricher, J.; Giller, T.; Gruninger, F.; Guenzi, A.; Guller, R.; Hartung, T.; Hirth, G.; Jenny, Ch.; Kansy, M.; Klinkhammer, U.; Lave, T.; Lohri, B.; Luft, F. C.; Mervaala, E. M.; Muller, D. N.; Muller, M.; Montavon, F.; Oefner, Ch.; Qiu, C.; Reichel, A.; Sanwald-Ducray, P.; Scalone, M.; Schleimer, M.; Schmid, R.; Stadler, H.; Treiber, A.; Valdenaire, O.; Vieira, E.; Waldmeier, P.; Wiegand-Chou, R.; Wilhelm, M.; Wostl, W.; Zell, M.; Zell, R.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">21-27</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">Non-peptidomimetic renin inhibitors of the piperidine type represent a novel structural class of compds. potentially free of the drawbacks seen with peptidomimetic compds. so far.  Synthetic optimization in two structural series focusing on improvement of potency, as well as on physicochem. properties and metabolic stability, has led to the identification of two candidate compds.  Both display potent and long-lasting blood pressure lowering effects in conscious sodium-depleted marmoset monkeys and double transgenic rats harboring both the human angiotensinogen and the human renin genes.  In addn., one of compds. normalizes albuminuria and kidney tissue damage in these rats when given over a period of 4 wk.  These data suggest that treatment of chronic renal failure patients with a renin inhibitor might result in a significant improvement of the disease status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBZ7-kozTn8LVg90H21EOLACvtfcHk0lgb_cT3bfmUSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFKqsLg%253D&md5=e1d96ac5db152e148a3deca5289a3b11</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2801%2901004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252801%252901004-7%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DB.%26aulast%3DBohner-Lang%26aufirst%3DV.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DCoassolo%26aufirst%3DPh.%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DDoebeli%26aufirst%3DH.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DFunk%26aufirst%3DCh.%26aulast%3DForicher%26aufirst%3DJ.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26aulast%3DGuenzi%26aufirst%3DA.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DJenny%26aufirst%3DCh.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKlinkhammer%26aufirst%3DU.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DLohri%26aufirst%3DB.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DMervaala%26aufirst%3DE.%2BM.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DMontavon%26aufirst%3DF.%26aulast%3DOefner%26aufirst%3DCh.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DReichel%26aufirst%3DA.%26aulast%3DSanwald-Ducray%26aufirst%3DP.%26aulast%3DScalone%26aufirst%3DM.%26aulast%3DSchleimer%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DR.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DValdenaire%26aufirst%3DO.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWaldmeier%26aufirst%3DP.%26aulast%3DWiegand-Chou%26aufirst%3DR.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DZell%26aufirst%3DM.%26aulast%3DZell%26aufirst%3DR.%26atitle%3DPiperidine%2520renin%2520inhibitors%253A%2520from%2520leads%2520to%2520drug%2520candidates%26jtitle%3DFarmaco%26date%3D2001%26volume%3D56%26spage%3D21%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bezencon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Bildstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remeň, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corminboeuf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisostomi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span> </span><span class="NLM_article-title">Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3702</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900022f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3689-3702&author=O.+Bezenconauthor=D.+Burauthor=T.+Wellerauthor=S.+Richard-Bildsteinauthor=L.+Reme%C5%88author=T.+Sifferlenauthor=O.+Corminboeufauthor=C.+Grisostomiauthor=C.+Bossauthor=L.+Pradeauthor=S.+Delahyeauthor=A.+Treiberauthor=P.+Stricknerauthor=C.+Binkertauthor=P.+Hessauthor=B.+Steinerauthor=W.+Fischli&title=Design+and+preparation+of+potent%2C+nonpeptidic%2C+bioavailable+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm900022f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900022f%26sid%3Dliteratum%253Aachs%26aulast%3DBezencon%26aufirst%3DO.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DRichard-Bildstein%26aufirst%3DS.%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DDelahye%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DStrickner%26aufirst%3DP.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DFischli%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520potent%252C%2520nonpeptidic%252C%2520bioavailable%2520renin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3689%26epage%3D3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For the discovery of ACT-178882/MK-1597, see also</p></div><span class="NLM_contrib-group">Corminboeuf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezençon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remeň, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisostomi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Bildstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span> </span><span class="NLM_article-title">Piperidine-based renin inhibitors: upper chain optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6291</span><span class="NLM_x">–</span> <span class="NLM_lpage">6296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6291-6296&author=O.+Corminboeufauthor=O.+Bezen%C3%A7onauthor=L.+Reme%C5%88author=C.+Grisostomiauthor=S.+Richard-Bildsteinauthor=D.+Burauthor=L.+Pradeauthor=P.+Stricknerauthor=P.+Hessauthor=W.+Fischliauthor=B.+Steinerauthor=A.+Treiber&title=Piperidine-based+renin+inhibitors%3A+upper+chain+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DBezen%25C3%25A7on%26aufirst%3DO.%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DRichard-Bildstein%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DStrickner%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DTreiber%26aufirst%3DA.%26atitle%3DPiperidine-based%2520renin%2520inhibitors%253A%2520upper%2520chain%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6291%26epage%3D6296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kasai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span> </span><span class="NLM_article-title">Cardiovascular agents: renin inhibitors and factor Xa inhibitors</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=47-85&author=A.+Kasaiauthor=R.+Subediauthor=M.+Stierauthor=D.+D.+Holsworth&title=Cardiovascular+agents%3A+renin+inhibitors+and+factor+Xa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DA.%26aulast%3DSubedi%26aufirst%3DR.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26atitle%3DCardiovascular%2520agents%253A%2520renin%2520inhibitors%2520and%2520factor%2520Xa%2520inhibitors%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D73%26spage%3D47%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacatian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishchenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhtiyarov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span> </span><span class="NLM_article-title">Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200137x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=747-751&author=L.+Jiaauthor=R.+D.+Simpsonauthor=J.+Yuanauthor=Z.+Xuauthor=W.+Zhaoauthor=S.+Cacatianauthor=C.+M.+Ticeauthor=J.+Guoauthor=A.+Ishchenkoauthor=S.+B.+Singhauthor=Z.+Wuauthor=B.+M.+McKeeverauthor=Y.+Bukhtiyarovauthor=+Johnsonauthor=A.+Judithauthor=C.+P.+Doeauthor=R.+K.+Harrisonauthor=G.+M.+McGeehanauthor=L.+W.+Dillardauthor=J.+J.+Baldwinauthor=D.+A.+Claremon&title=Discovery+of+VTP-27999%2C+an+Alkyl+Amine+Renin+Inhibitor+with+Potential+for+Clinical+Utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml200137x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200137x%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DSimpson%26aufirst%3DR.%2BD.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DCacatian%26aufirst%3DS.%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DJohnson%26aulast%3DJudith%26aufirst%3DA.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DHarrison%26aufirst%3DR.%2BK.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DDiscovery%2520of%2520VTP-27999%252C%2520an%2520Alkyl%2520Amine%2520Renin%2520Inhibitor%2520with%2520Potential%2520for%2520Clinical%2520Utility%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D747%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ostermann, N.; Ruedisser, S.; Ehrhardt, C.; Breitenstein, W.; Marzinzik, A.; Jacoby, E.; Vangrevelinghe, E.; Ottl, J.; Klumpp, M.; Hartwieg, J. C. D.; Cumin, F.; Hassiepen, U.; Trappe, J.; Sedrani, R.; Geisse, S.; Gerhartz, B.; Richert, P.; Francotte, E.; Wagner, T.; Krömer, M.; Kosaka, T.; Webb, R. L.; Rigel, D. F.; Maibaum, J.; Baeschlin, D. K.</span><span> </span><span class="NLM_article-title">A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic P<sub>3</sub>–P<sub>1</sub> pharmacophore</span>.,  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span>, DOI: <span class="refDoi"> DOI: 10.1021/jm301706j</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm301706j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&author=N.+Ostermann&author=S.+Ruedisser&author=C.+Ehrhardt&author=W.+Breitenstein&author=A.+Marzinzik&author=E.+Jacoby&author=E.+Vangrevelinghe&author=J.+Ottl&author=M.+Klumpp&author=J.+C.+D.+Hartwieg&author=F.+Cumin&author=U.+Hassiepen&author=J.+Trappe&author=R.+Sedrani&author=S.+Geisse&author=B.+Gerhartz&author=P.+Richert&author=E.+Francotte&author=T.+Wagner&author=M.+Kr%C3%B6mer&author=T.+Kosaka&author=R.+L.+Webb&author=D.+F.+Rigel&author=J.+Maibaum&author=D.+K.+Baeschlin&title=A+novel+class+of+oral+direct+renin+inhibitors%3A+highly+potent+3%2C5-disubstituted+piperidines+bearing+a+tricyclic+P3%E2%80%93P1+pharmacophore&doi=10.1021%2Fjm301706j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm301706j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301706j%26sid%3Dliteratum%253Aachs%26aulast%3DOstermann%26aufirst%3DN.%26atitle%3DA%2520novel%2520class%2520of%2520oral%2520direct%2520renin%2520inhibitors%253A%2520highly%2520potent%25203%252C5-disubstituted%2520piperidines%2520bearing%2520a%2520tricyclic%2520P3%25E2%2580%2593P1%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26doi%3D10.1021%2Fjm301706j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Experimental+Section."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">X-ray crystal structure of two ligands trans-3,4-pyrrolidine <b>6a</b> bound to the active site of glycosylated rh-renin, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=X-ray+crystal+structure+of+two+ligands+trans-3%2C4-pyrrolidine+6a+bound+to+the+active+site+of+glycosylated+rh-renin%2C+see+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><div class="note"><p class="first last">Compound <b>5</b>, available from the Novartis Collection, has been described as inhibitor of aspartyl protease by</p></div><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Solid-Phase Synthesis of Aspartic Peptidase Inhibitors: 3-Alkoxy-4-Aryl Piperidines</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2625</span><span class="NLM_x">–</span> <span class="NLM_lpage">2628</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol016280k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=2625-2628&author=M.+G.+Bursavichauthor=D.+H.+Rich&title=Solid-Phase+Synthesis+of+Aspartic+Peptidase+Inhibitors%3A+3-Alkoxy-4-Aryl+Piperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol016280k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol016280k%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DSolid-Phase%2520Synthesis%2520of%2520Aspartic%2520Peptidase%2520Inhibitors%253A%25203-Alkoxy-4-Aryl%2520Piperidines%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D2625%26epage%3D2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span> </span><span class="NLM_article-title">Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS1074-5521%2800%2900134-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=10903938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlKnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=493-504&author=J.+Rahuelauthor=V.+Rasettiauthor=J.+Maibaumauthor=H.+R%C3%BCegerauthor=R.+G%C3%B6schkeauthor=N.-C.+Cohenauthor=S.+Stutzauthor=F.+Cuminauthor=W.+Fuhrerauthor=J.+M.+Woodauthor=M.+G.+Gr%C3%BCtter&title=Structure-based+drug+design%3A+the+discovery+of+novel+nonpeptide+orally+active+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin</span></div><div class="casAuthors">Rahuel, J.; Rasetti, V.; Maibaum, J.; Rueger, H.; Goschke, R.; Cohen, N-C.; Stutz, S.; Cumin, F.; Fuhrer, W.; Wood, J. M.; Grutter, M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493-504</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: The aspartic proteinase renin plays an important physiol. role in the regulation of blood pressure.  It catalyzes the first step in the conversion of angiotensinogen to the hormone angiotensin II.  In the past, potent peptide inhibitors of renin have been developed, but none of these compds. has made it to the end of clin. trials.  Our primary aim was to develop novel nonpeptide inhibitors.  Based on the available structural information concerning renin-substrate interactions, we synthesized inhibitors in which the peptide portion was replaced by lipophilic moieties that interact with the large hydrophobic S1/S3-binding pocket in renin.  Results: Crystal structure anal. of renin-inhibitor complexes combined with computational methods were employed in the medicinal-chem. optimization process.  Structure anal. revealed that the newly designed inhibitors bind as predicted to the S1/S3 pocket.  In addn., however, these compds. interact with a hitherto unrecognized large, distinct, sub-pocket of the enzyme that extends from the S3-binding site towards the hydrophobic core of the enzyme.  Binding to the S3sp sub-pocket was essential for high binding affinity.  This unprecedented binding mode guided the drug-design process in which the mostly hydrophobic interactions within subsite S3sp were optimized.  Conclusions: Our design approach led to compds. with high in vitro affinity and specificity for renin, favorable bioavailability and excellent oral efficacy in lowering blood pressure in primates.  These renin inhibitors are therefore potential therapeutic agents for the treatment of hypertension and related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp__RrHxd--o7Vg90H21EOLACvtfcHk0lg40rRqG0YraQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlKnsbo%253D&md5=69eb034c059696b97faf830727ce924a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900134-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900134-4%26sid%3Dliteratum%253Aachs%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DR%25C3%25BCeger%26aufirst%3DH.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26atitle%3DStructure-based%2520drug%2520design%253A%2520the%2520discovery%2520of%2520novel%2520nonpeptide%2520orally%2520active%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">The P1 <i>N</i>-isopropyl motif bearing hydroxyethylene dipeptide isostere analogs of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4863</span><span class="NLM_x">–</span> <span class="NLM_lpage">4867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4863-4867&author=Y.+Yamaguchiauthor=K.+Menearauthor=N.-C.+Cohenauthor=R.+Mahauthor=F.+Cuminauthor=C.+Schnellauthor=J.+M.+Woodauthor=J.+Maibaum&title=The+P1+N-isopropyl+motif+bearing+hydroxyethylene+dipeptide+isostere+analogs+of+aliskiren+are+in+vitro+potent+inhibitors+of+the+human+aspartyl+protease+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DMah%26aufirst%3DR.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DThe%2520P1%2520N-isopropyl%2520motif%2520bearing%2520hydroxyethylene%2520dipeptide%2520isostere%2520analogs%2520of%2520aliskiren%2520are%2520in%2520vitro%2520potent%2520inhibitors%2520of%2520the%2520human%2520aspartyl%2520protease%2520renin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4863%26epage%3D4867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel 2,7-dialkyl substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamides as in vitro potent peptidomimetic inhibitors of human renin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2735-2740&author=R.+G%C3%B6schkeauthor=N.-C.+Cohenauthor=J.+M.+Woodauthor=J.+Maibaum&title=Design+and+synthesis+of+novel+2%2C7-dialkyl+substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamides+as+in+vitro+potent+peptidomimetic+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%25202%252C7-dialkyl%2520substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamides%2520as%2520in%2520vitro%2520potent%2520peptidomimetic%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2735%26epage%3D2740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Specker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böttcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoop, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebenow, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=106-117&author=E.+Speckerauthor=J.+B%C3%B6ttcherauthor=S.+Brassauthor=A.+Heineauthor=H.+Lilieauthor=A.+Schoopauthor=G.+M%C3%BCllerauthor=N.+Griebenowauthor=G.+Klebe&title=Unexpected+novel+binding+mode+of+pyrrolidine-based+aspartyl+protease+inhibitors%3A+design%2C+synthesis+and+crystal+structure+in+complex+with+HIV+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpecker%26aufirst%3DE.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DJ.%26aulast%3DBrass%26aufirst%3DS.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DLilie%26aufirst%3DH.%26aulast%3DSchoop%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26aulast%3DGriebenow%26aufirst%3DN.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DUnexpected%2520novel%2520binding%2520mode%2520of%2520pyrrolidine-based%2520aspartyl%2520protease%2520inhibitors%253A%2520design%252C%2520synthesis%2520and%2520crystal%2520structure%2520in%2520complex%2520with%2520HIV%2520protease%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D106%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campeau, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauchon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chefson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducharme, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubé, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournier, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagné, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laliberté, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lévesque, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Jacques, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span> </span><span class="NLM_article-title">Renin inhibitors for the treatment of hypertension: Design and optimization of a novel series of pyridone-substituted piperidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3970</span><span class="NLM_x">–</span> <span class="NLM_lpage">3975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3970-3975&author=A.+Chenauthor=L.-C.+Campeauauthor=E.+Cauchonauthor=A.+Chefsonauthor=Y.+Ducharmeauthor=D.+Dub%C3%A9author=J.-P.+Falgueyretauthor=P.-A.+Fournierauthor=S.+Gagn%C3%A9author=E.+Grimmauthor=Y.+Hanauthor=R.+Houleauthor=J.-Q.+Huangauthor=P.+Lacombeauthor=S.+Lalibert%C3%A9author=J.-F.+L%C3%A9vesqueauthor=S.+Liuauthor=D.+MacDonaldauthor=B.+Mackayauthor=D.+McKayauthor=M.+D.+Percivalauthor=C.+Reganauthor=H.+Reganauthor=R.+St-Jacquesauthor=S.+Toulmond&title=Renin+inhibitors+for+the+treatment+of+hypertension%3A+Design+and+optimization+of+a+novel+series+of+pyridone-substituted+piperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DA.%26aulast%3DCampeau%26aufirst%3DL.-C.%26aulast%3DCauchon%26aufirst%3DE.%26aulast%3DChefson%26aufirst%3DA.%26aulast%3DDucharme%26aufirst%3DY.%26aulast%3DDub%25C3%25A9%26aufirst%3DD.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DFournier%26aufirst%3DP.-A.%26aulast%3DGagn%25C3%25A9%26aufirst%3DS.%26aulast%3DGrimm%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DHoule%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DJ.-Q.%26aulast%3DLacombe%26aufirst%3DP.%26aulast%3DLalibert%25C3%25A9%26aufirst%3DS.%26aulast%3DL%25C3%25A9vesque%26aufirst%3DJ.-F.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMacDonald%26aufirst%3DD.%26aulast%3DMackay%26aufirst%3DB.%26aulast%3DMcKay%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DRegan%26aufirst%3DH.%26aulast%3DSt-Jacques%26aufirst%3DR.%26aulast%3DToulmond%26aufirst%3DS.%26atitle%3DRenin%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hypertension%253A%2520Design%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520pyridone-substituted%2520piperidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3970%26epage%3D3975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Scheiper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhagen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böcskei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleuryc, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCort, G.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6268</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2Fj.bmcl.2010.08.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=20850300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KrsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6268-6272&author=A.+Scheiperauthor=H.+Matterauthor=H.+Steinhagenauthor=U.+Stilzauthor=Z.+B%C3%B6cskeiauthor=V.+Fleurycauthor=G.+McCort&title=Discovery+and+optimization+of+a+new+class+of+potent+and+non-chiral+indole-3-carboxamide-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors</span></div><div class="casAuthors">Scheiper, Bodo; Matter, Hans; Steinhagen, Henning; Stilz, Ulrich; Boecskei, Zsolt; Fleury, Valerie; McCort, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6268-6272</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selective inhibition of the aspartyl protease renin has gained attraction as an interesting approach to control hypertension and assocd. cardiovascular risk factors given its unique position in the renin-angiotensin system.  Using a combination of high-throughput screening, parallel synthesis, X-ray crystallog. and structure-based design, we identified and optimized a novel series of potent and non-chiral indole-3-carboxamides with remarkable potency for renin.  The most potent compd. 5k displays an IC50 value of 2 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8587ln8gHC7Vg90H21EOLACvtfcHk0lhTR6DoKPWScA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KrsbnN&md5=7584068acca5baa12d8925c7c43d1e03</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.08.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.08.092%26sid%3Dliteratum%253Aachs%26aulast%3DScheiper%26aufirst%3DA.%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DSteinhagen%26aufirst%3DH.%26aulast%3DStilz%26aufirst%3DU.%26aulast%3DB%25C3%25B6cskei%26aufirst%3DZ.%26aulast%3DFleuryc%26aufirst%3DV.%26aulast%3DMcCort%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520new%2520class%2520of%2520potent%2520and%2520non-chiral%2520indole-3-carboxamide-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6268%26epage%3D6272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Target Family-Directed Masterkeys in Chemogenomics</span>. In  <span class="citation_source-book">Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective</span>; <span class="NLM_contrib-group">Kubinyi, H.; Müller, G.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=7-41&author=G.+M%C3%BCllerauthor=H.+Kubinyi&author=G.+M%C3%BCller&title=Chemogenomics+in+Drug+Discovery%3A+A+Medicinal+Chemistry+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DTarget%2520Family-Directed%2520Masterkeys%2520in%2520Chemogenomics%26btitle%3DChemogenomics%2520in%2520Drug%2520Discovery%253A%2520A%2520Medicinal%2520Chemistry%2520Perspective%26aulast%3DKubinyi%26aufirst%3DH.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D7%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35a"><span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugabook, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugasheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery of pyrrolidine-based-β-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=240-244&author=S.+J.+Stachelauthor=T.+G.+Steeleauthor=A.+Petrocchiauthor=S.+J.+Haugabookauthor=G.+McGaugheyauthor=M.+K.+Hollowayauthor=T.+Allisonauthor=S.+Munshiauthor=P.+Zuckauthor=D.+Colussiauthor=K.+Tugashevaauthor=A.+Wolfeauthor=S.+L.+Grahamauthor=J.+P.+Vacca&title=Discovery+of+pyrrolidine-based-%CE%B2-secretase+inhibitors%3A+lead+advancement+through+conformational+design+for+maintenance+of+ligand+binding+efficiency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DHaugabook%26aufirst%3DS.%2BJ.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DAllison%26aufirst%3DT.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugasheva%26aufirst%3DK.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520pyrrolidine-based-%25CE%25B2-secretase%2520inhibitors%253A%2520lead%2520advancement%2520through%2520conformational%2520design%2520for%2520maintenance%2520of%2520ligand%2520binding%2520efficiency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D240%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">For an account on spiropyrrolidine Bace-1 inhibitors, see:</p></div><div class="NLM_citation" id="cit35b"><span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorff, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oborski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withka, J. M.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9069</span><span class="NLM_x">–</span> <span class="NLM_lpage">9088</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201715d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Efremov%2C+I.+V.%3B+Vajdos%2C+F.+F.%3B+Borzilleri%2C+K.+A.%3B+Capetta%2C+S.%3B+Chen%2C+H.%3B+Dorff%2C+P.+H.%3B+Dutra%2C+J.+K.%3B+Goldstein%2C+S.+W.%3B+Mansour%2C+M.%3B+McColl%2C+A.%3B+Noell%2C+S.%3B+Oborski%2C+C.+E.%3B+O%E2%80%99Connell%2C+T.+N.%3B+O%E2%80%99Sullivan%2C+T.+J.%3B+Pandit%2C+J.%3B+Wang%2C+H.%3B+Wei%2C+B.%3B+Withka%2C+J.+M.J.+Med.+Chem.+2012%2C+55%2C+9069%E2%80%939088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1021%2Fjm201715d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201715d%26sid%3Dliteratum%253Aachs%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DCapetta%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DGoldstein%26aufirst%3DS.%2BW.%26aulast%3DMansour%26aufirst%3DM.%26aulast%3DMcColl%26aufirst%3DA.%26aulast%3DNoell%26aufirst%3DS.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DT.%2BN.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9069%26epage%3D9088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><div class="note"><p class="first last"><i>trans</i>-3,4-Disubstituted proline derivatives have been claimed as renin inhibitors, however, no experimental data on the their binding mode to human renin has been disclosed to date. These compounds may interact with the flap binding pocket of renin in the open conformation in a similar manner as the piperidine-based GRAB peptidomimetic renin inhibitors represented by <b>2</b>, based on the close structural similarities of the extended pharmacophores at the C-4 position of the 5- and 6-membered ring core templates, respectively</p></div>. <span class="NLM_contrib-group">Bezencon, O.; Boss, C.; Bur, D.; Corminboeuf, O.; Grisostomi, C.; Remen, L.; Richard-Bildstein, S.; weller, T.</span>PCT Int. Appl. WO2007034406A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=trans-3%2C4-Disubstituted+proline+derivatives+have+been+claimed+as+renin+inhibitors%2C+however%2C+no+experimental+data+on+the+their+binding+mode+to+human+renin+has+been+disclosed+to+date.+These+compounds+may+interact+with+the+flap+binding+pocket+of+renin+in+the+open+conformation+in+a+similar+manner+as+the+piperidine-based+GRAB+peptidomimetic+renin+inhibitors+represented+by+2%2C+based+on+the+close+structural+similarities+of+the+extended+pharmacophores+at+the+C-4+position+of+the+5-+and+6-membered+ring+core+templates%2C+respectively.+Bezencon%2C+O.%3B+Boss%2C+C.%3B+Bur%2C+D.%3B+Corminboeuf%2C+O.%3B+Grisostomi%2C+C.%3B+Remen%2C+L.%3B+Richard-Bildstein%2C+S.%3B+weller%2C+T.PCT+Int.+Appl.+WO2007034406A1%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBezencon%26aufirst%3DO.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Bohlender, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukamizu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippoldt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganten, D.</span><span> </span><span class="NLM_article-title">High human hypertension in transgenic rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=428-434&author=J.+Bohlenderauthor=A.+Fukamizuauthor=A.+Lippoldtauthor=T.+Nomuraauthor=R.+Dietzauthor=J.+Menardauthor=K.+Murakamiauthor=F.+C.+Luftauthor=D.+Ganten&title=High+human+hypertension+in+transgenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohlender%26aufirst%3DJ.%26aulast%3DFukamizu%26aufirst%3DA.%26aulast%3DLippoldt%26aufirst%3DA.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DDietz%26aufirst%3DR.%26aulast%3DMenard%26aufirst%3DJ.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DGanten%26aufirst%3DD.%26atitle%3DHigh%2520human%2520hypertension%2520in%2520transgenic%2520rats%26jtitle%3DHypertension%26date%3D1997%26volume%3D29%26spage%3D428%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hosomi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, H.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Trimethylsilylmethyl)aminomethyl ethers as azomethine ylide synthons. A new and convenient access to pyrrolidine derivatives</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1984&pages=1117-1120&author=A.+Hosomiauthor=Y.+Sakataauthor=H.+Sakurai&title=N-%28Trimethylsilylmethyl%29aminomethyl+ethers+as+azomethine+ylide+synthons.+A+new+and+convenient+access+to+pyrrolidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHosomi%26aufirst%3DA.%26aulast%3DSakata%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DN-%2528Trimethylsilylmethyl%2529aminomethyl%2520ethers%2520as%2520azomethine%2520ylide%2520synthons.%2520A%2520new%2520and%2520convenient%2520access%2520to%2520pyrrolidine%2520derivatives%26jtitle%3DChem.%2520Lett.%26date%3D1984%26volume%3D7%26spage%3D1117%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Terao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achiwa, K.</span><span> </span><span class="NLM_article-title">Trifluoroacetic acid-catalyzed 1,3-cycloaddition of the simplest iminium ylide leading to 3- or 3,4-substituted pyrrolidines and 2,5-dihydropyrroles</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2762</span><span class="NLM_x">–</span> <span class="NLM_lpage">2766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1985&pages=2762-2766&author=Y.+Teraoauthor=H.+Kotakiauthor=N.+Imaiauthor=K.+Achiwa&title=Trifluoroacetic+acid-catalyzed+1%2C3-cycloaddition+of+the+simplest+iminium+ylide+leading+to+3-+or+3%2C4-substituted+pyrrolidines+and+2%2C5-dihydropyrroles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DY.%26aulast%3DKotaki%26aufirst%3DH.%26aulast%3DImai%26aufirst%3DN.%26aulast%3DAchiwa%26aufirst%3DK.%26atitle%3DTrifluoroacetic%2520acid-catalyzed%25201%252C3-cycloaddition%2520of%2520the%2520simplest%2520iminium%2520ylide%2520leading%2520to%25203-%2520or%25203%252C4-substituted%2520pyrrolidines%2520and%25202%252C5-dihydropyrroles%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1985%26volume%3D33%26spage%3D2762%26epage%3D2766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+amination+of+aldehydes+and+ketones+with+sodium+triacetoxyborohydride.+Studies+on+direct+and+indirect+reductive+amination+procedures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0lii8c0FoOJTsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520amination%2520of%2520aldehydes%2520and%2520ketones%2520with%2520sodium%2520triacetoxyborohydride.%2520Studies%2520on%2520direct%2520and%2520indirect%2520reductive%2520amination%2520procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Breitenstein, W.; Cottens, S.; Ehrhardt, C.; Jacoby, E.; Lorthiois, E.; Maibaum, J.; Ostermann, N.; Sellner, H.; Simic, O.</span><span> </span><span class="NLM_article-title">Preparation of Substituted Pyrrolidines as Renin Inhibitors</span>. PCT Int. Appl. WO2006066896A2,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+Breitenstein&author=S.+Cottens&author=C.+Ehrhardt&author=E.+Jacoby&author=E.+Lorthiois&author=J.+Maibaum&author=N.+Ostermann&author=H.+Sellner&author=O.+Simic&title=Preparation+of+Substituted+Pyrrolidines+as+Renin+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBreitenstein%26aufirst%3DW.%26atitle%3DPreparation%2520of%2520Substituted%2520Pyrrolidines%2520as%2520Renin%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Prashad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repic, O.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed amination of aryl bromides with hindered <i>N</i>-alkyl-substituted anilines using a palladium(I) tri-<i>tert</i>-butylphosphine bromide dimer</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo020609d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=1163-1164&author=M.+Prashadauthor=X.+Y.+Makauthor=Y.+Liuauthor=O.+Repic&title=Palladium-catalyzed+amination+of+aryl+bromides+with+hindered+N-alkyl-substituted+anilines+using+a+palladium%28I%29+tri-tert-butylphosphine+bromide+dimer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo020609d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo020609d%26sid%3Dliteratum%253Aachs%26aulast%3DPrashad%26aufirst%3DM.%26aulast%3DMak%26aufirst%3DX.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRepic%26aufirst%3DO.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520bromides%2520with%2520hindered%2520N-alkyl-substituted%2520anilines%2520using%2520a%2520palladium%2528I%2529%2520tri-tert-butylphosphine%2520bromide%2520dimer%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D1163%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13a','cit13b'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16a'],'ref17':['cit17a','cit17b'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22a','cit22b'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26a','cit26b','cit26c'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35a','cit35b'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38a','cit38b'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Shuhua Ma, Jack A. Henderson, <span class="NLM_string-name hlFld-ContribAuthor">Jana Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring the pH-Dependent Structure–Dynamics–Function Relationship of Human Renin. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (1)
                                     , 400-407. <a href="https://doi.org/10.1021/acs.jcim.0c01201" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01201</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01201%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DExploring%252Bthe%252BpH-Dependent%252BStructure%2525E2%252580%252593Dynamics%2525E2%252580%252593Function%252BRelationship%252Bof%252BHuman%252BRenin%26aulast%3DMa%26aufirst%3DShuhua%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D15102020%26date%3D23122020%26volume%3D61%26issue%3D1%26spage%3D400%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marvin J. Meyers, Jianguang Liu, Jing Xu, Fang Leng, Jiantong Guan, Zhijun Liu, Sarah A. McNitt, Limei Qin, Linglin Dai, Hongwei Ma, Dickson Adah, Siting Zhao, Xiaofen Li, Alex J. Polino, Armiyaw S. Nasamu, Daniel E. Goldberg, Xiaorong Liu, Yongzhi Lu, Zhengchao Tu, Xiaoping Chen, <span class="NLM_string-name hlFld-ContribAuthor">Micky D. Tortorella</span>. </span><span class="cited-content_cbyCitation_article-title">4-Aryl Pyrrolidines as a Novel Class of Orally Efficacious Antimalarial Agents. Part 1: Evaluation of 4-Aryl-N-benzylpyrrolidine-3-carboxamides. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (7)
                                     , 3503-3512. <a href="https://doi.org/10.1021/acs.jmedchem.8b01972" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01972</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01972%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D4-Aryl%252BPyrrolidines%252Bas%252Ba%252BNovel%252BClass%252Bof%252BOrally%252BEfficacious%252BAntimalarial%252BAgents.%252BPart%252B1%25253A%252BEvaluation%252Bof%252B4-Aryl-N-benzylpyrrolidine-3-carboxamides%26aulast%3DMeyers%26aufirst%3DMarvin%2BJ.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D17122018%26date%3D22032019%26date%3D11032019%26volume%3D62%26issue%3D7%26spage%3D3503%26epage%3D3512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takeru  Ehara</span>, <span class="hlFld-ContribAuthor ">Osamu  Irie</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Kosaka</span>, <span class="hlFld-ContribAuthor ">Takanori  Kanazawa</span>, <span class="hlFld-ContribAuthor ">Werner  Breitenstein</span>, <span class="hlFld-ContribAuthor ">Philipp  Grosche</span>, <span class="hlFld-ContribAuthor ">Nils  Ostermann</span>, <span class="hlFld-ContribAuthor ">Masaki  Suzuki</span>, <span class="hlFld-ContribAuthor ">Shimpei  Kawakami</span>, <span class="hlFld-ContribAuthor ">Kazuhide  Konishi</span>, <span class="hlFld-ContribAuthor ">Yuko  Hitomi</span>, <span class="hlFld-ContribAuthor ">Atsushi  Toyao</span>, <span class="hlFld-ContribAuthor ">Hiroki  Gunji</span>, <span class="hlFld-ContribAuthor ">Frederic  Cumin</span>, <span class="hlFld-ContribAuthor ">Nikolaus  Schiering</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Dean F.  Rigel</span>, <span class="hlFld-ContribAuthor ">Randy L.  Webb</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>, and <span class="hlFld-ContribAuthor ">Fumiaki  Yokokawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (7)
                                     , 787-792. <a href="https://doi.org/10.1021/ml500137b" title="DOI URL">https://doi.org/10.1021/ml500137b</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml500137b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml500137b%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-Based%252BDesign%252Bof%252BSubstituted%252BPiperidines%252Bas%252Ba%252BNew%252BClass%252Bof%252BHighly%252BEfficacious%252BOral%252BDirect%252BRenin%252BInhibitors%26aulast%3DEhara%26aufirst%3DTakeru%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05042014%26date%3D21042014%26date%3D08052014%26date%3D10072014%26date%3D21042014%26volume%3D5%26issue%3D7%26spage%3D787%26epage%3D792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nils  Ostermann</span>, <span class="hlFld-ContribAuthor ">Simon  Ruedisser</span>, <span class="hlFld-ContribAuthor ">Claus  Ehrhardt</span>, <span class="hlFld-ContribAuthor ">Werner  Breitenstein</span>, <span class="hlFld-ContribAuthor ">Andreas  Marzinzik</span>, <span class="hlFld-ContribAuthor ">Edgar  Jacoby</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">Johannes  Ottl</span>, <span class="hlFld-ContribAuthor ">Martin  Klumpp</span>, <span class="hlFld-ContribAuthor ">J. Constanze D.  Hartwieg</span>, <span class="hlFld-ContribAuthor ">Frederic  Cumin</span>, <span class="hlFld-ContribAuthor ">Ulrich  Hassiepen</span>, <span class="hlFld-ContribAuthor ">Jörg  Trappe</span>, <span class="hlFld-ContribAuthor ">Richard  Sedrani</span>, <span class="hlFld-ContribAuthor ">Sabine  Geisse</span>, <span class="hlFld-ContribAuthor ">Bernd  Gerhartz</span>, <span class="hlFld-ContribAuthor ">Paul  Richert</span>, <span class="hlFld-ContribAuthor ">Eric  Francotte</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Markus  Krömer</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Kosaka</span>, <span class="hlFld-ContribAuthor ">Randy L.  Webb</span>, <span class="hlFld-ContribAuthor ">Dean F.  Rigel</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>, and <span class="hlFld-ContribAuthor ">Daniel K.  Baeschlin</span>  . </span><span class="cited-content_cbyCitation_article-title">A Novel Class of Oral Direct Renin Inhibitors: Highly Potent 3,5-Disubstituted Piperidines Bearing a Tricyclic P3–P1 Pharmacophore. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (6)
                                     , 2196-2206. <a href="https://doi.org/10.1021/jm301706j" title="DOI URL">https://doi.org/10.1021/jm301706j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm301706j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm301706j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BNovel%252BClass%252Bof%252BOral%252BDirect%252BRenin%252BInhibitors%25253A%252BHighly%252BPotent%252B3%25252C5-Disubstituted%252BPiperidines%252BBearing%252Ba%252BTricyclic%252BP3%2525E2%252580%252593P1%252BPharmacophore%26aulast%3DOstermann%26aufirst%3DNils%26date%3D2013%26date%3D2013%26date%3D2012%26date%3D20112012%26date%3D15032013%26date%3D28032013%26date%3D29012013%26volume%3D56%26issue%3D6%26spage%3D2196%26epage%3D2206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krishnappa  Ramya</span>, <span class="hlFld-ContribAuthor ">Ramalingam  Suresh</span>, <span class="hlFld-ContribAuthor ">Honnavalli Yogish  Kumar</span>, <span class="hlFld-ContribAuthor ">B.R. Prashantha  Kumar</span>, <span class="hlFld-ContribAuthor ">N.B. Sridhara  Murthy</span>. </span><span class="cited-content_cbyCitation_article-title">Decades-old renin inhibitors are still struggling to find a niche in antihypertensive therapy. A fleeting look at the old and the promising new molecules. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (10)
                                     , 115466. <a href="https://doi.org/10.1016/j.bmc.2020.115466" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115466</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115466&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115466%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDecades-old%252Brenin%252Binhibitors%252Bare%252Bstill%252Bstruggling%252Bto%252Bfind%252Ba%252Bniche%252Bin%252Bantihypertensive%252Btherapy.%252BA%252Bfleeting%252Blook%252Bat%252Bthe%252Bold%252Band%252Bthe%252Bpromising%252Bnew%252Bmolecules%26aulast%3DRamya%26aufirst%3DKrishnappa%26date%3D2020%26volume%3D28%26issue%3D10%26spage%3D115466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lakshmanan  Loganathan</span>, <span class="hlFld-ContribAuthor ">Karthikeyan  Muthusamy</span>. </span><span class="cited-content_cbyCitation_article-title">Investigation of Drug Interaction Potentials and Binding Modes on Direct Renin Inhibitors: A Computational Modeling Studies. </span><span class="cited-content_cbyCitation_journal-name">Letters in Drug Design & Discovery</span><span> <strong>2019,</strong> <em>16 </em>
                                    (8)
                                     , 919-938. <a href="https://doi.org/10.2174/1570180815666180827113622" title="DOI URL">https://doi.org/10.2174/1570180815666180827113622</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1570180815666180827113622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1570180815666180827113622%26sid%3Dliteratum%253Aachs%26jtitle%3DLetters%2520in%2520Drug%2520Design%2520%2526%2520Discovery%26atitle%3DInvestigation%252Bof%252BDrug%252BInteraction%252BPotentials%252Band%252BBinding%252BModes%252Bon%252BDirect%252BRenin%252BInhibitors%25253A%252BA%252BComputational%252BModeling%252BStudies%26aulast%3DLoganathan%26aufirst%3DLakshmanan%26date%3D2019%26volume%3D16%26issue%3D8%26spage%3D919%26epage%3D938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Madhurjya  Borah</span>, <span class="hlFld-ContribAuthor ">Anil K.  Saikia</span>. </span><span class="cited-content_cbyCitation_article-title">FeCl
              3
              -Mediated Carbenium Ion-Induced Intramolecular Cyclization of
              N
              -Tethered Alkyne-Benzyl Alkanols. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (7)
                                     , 2162-2166. <a href="https://doi.org/10.1002/slct.201702776" title="DOI URL">https://doi.org/10.1002/slct.201702776</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201702776&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201702776%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DFeCl%252B3%252B-Mediated%252BCarbenium%252BIon-Induced%252BIntramolecular%252BCyclization%252Bof%252BN%252B-Tethered%252BAlkyne-Benzyl%252BAlkanols%26aulast%3DBorah%26aufirst%3DMadhurjya%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D7%26spage%3D2162%26epage%3D2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongxiang  Xie</span>, <span class="hlFld-ContribAuthor ">Bowen  Gong</span>, <span class="hlFld-ContribAuthor ">Xinran  Zhong</span>, <span class="hlFld-ContribAuthor ">Hongming  Cui</span>, <span class="hlFld-ContribAuthor ">Jinbao  Xiang</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular Cycloaddition of Azomethine Ylides Activated by Aromatic Rings: Scope and Limitations. </span><span class="cited-content_cbyCitation_journal-name">Chemistry of Heterocyclic Compounds</span><span> <strong>2016,</strong> <em>52 </em>
                                    (7)
                                     , 484-492. <a href="https://doi.org/10.1007/s10593-016-1912-9" title="DOI URL">https://doi.org/10.1007/s10593-016-1912-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10593-016-1912-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10593-016-1912-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520of%2520Heterocyclic%2520Compounds%26atitle%3DIntramolecular%252BCycloaddition%252Bof%252BAzomethine%252BYlides%252BActivated%252Bby%252BAromatic%252BRings%25253A%252BScope%252Band%252BLimitations%26aulast%3DXie%26aufirst%3DHongxiang%26date%3D2016%26date%3D2016%26volume%3D52%26issue%3D7%26spage%3D484%26epage%3D492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Rüdisser</span>, <span class="hlFld-ContribAuthor ">Eric  Vangrevelinghe</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>. </span><span class="cited-content_cbyCitation_article-title">An Integrated Approach for Fragment-Based Lead Discovery: Virtual, NMR, and High-Throughput Screening Combined with Structure-Guided Design. Application to the Aspartyl Protease Renin.. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 447-486. <a href="https://doi.org/10.1002/9783527683604.ch19" title="DOI URL">https://doi.org/10.1002/9783527683604.ch19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch19%26sid%3Dliteratum%253Aachs%26atitle%3DAn%252BIntegrated%252BApproach%252Bfor%252BFragment-Based%252BLead%252BDiscovery%25253A%252BVirtual%25252C%252BNMR%25252C%252Band%252BHigh-Throughput%252BScreening%252BCombined%252Bwith%252BStructure-Guided%252BDesign.%252BApplication%252Bto%252Bthe%252BAspartyl%252BProtease%252BRenin.%26aulast%3DR%25C3%25BCdisser%26aufirst%3DSimon%26date%3D2016%26date%3D2016%26spage%3D447%26epage%3D486%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samantha K.  Au</span>, <span class="hlFld-ContribAuthor ">Jonathan  Groover</span>, <span class="hlFld-ContribAuthor ">Brent D.  Feske</span>, <span class="hlFld-ContribAuthor ">Andreas S.  Bommarius</span>. </span><span class="cited-content_cbyCitation_article-title">Organic Synthesis with Amino Acid Dehydrogenases, Transaminases, Amine Oxidases, and Amine Dehydrogenases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 187-212. <a href="https://doi.org/10.1016/B978-0-12-411518-7.00007-X" title="DOI URL">https://doi.org/10.1016/B978-0-12-411518-7.00007-X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411518-7.00007-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411518-7.00007-X%26sid%3Dliteratum%253Aachs%26atitle%3DOrganic%252BSynthesis%252Bwith%252BAmino%252BAcid%252BDehydrogenases%25252C%252BTransaminases%25252C%252BAmine%252BOxidases%25252C%252Band%252BAmine%252BDehydrogenases%26aulast%3DAu%26aufirst%3DSamantha%2BK.%26date%3D2016%26spage%3D187%26epage%3D212%26pub%3DElsevier%26atitle%3DOrganic%252BSynthesis%252BUsing%252BBiocatalysis%26date%3D2016%26volume%3D29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaowei  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaoan  Wen</span>, <span class="hlFld-ContribAuthor ">Yan-yan  Chen</span>, <span class="hlFld-ContribAuthor ">Chen  Shi</span>, <span class="hlFld-ContribAuthor ">Chengzhe  Gao</span>, <span class="hlFld-ContribAuthor ">Yong  Wu</span>, <span class="hlFld-ContribAuthor ">Li-jun  Wang</span>, <span class="hlFld-ContribAuthor ">Xiu-hong  Yang</span>, <span class="hlFld-ContribAuthor ">Hongbin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of highly potent renin inhibitors potentially interacting with the S3′ subsite of renin. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>103 </em>, 269-288. <a href="https://doi.org/10.1016/j.ejmech.2015.08.060" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.08.060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.08.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.08.060%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bhighly%252Bpotent%252Brenin%252Binhibitors%252Bpotentially%252Binteracting%252Bwith%252Bthe%252BS3%2525E2%252580%2525B2%252Bsubsite%252Bof%252Brenin%26aulast%3DSun%26aufirst%3DXiaowei%26date%3D2015%26volume%3D103%26spage%3D269%26epage%3D288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marvin J.  Meyers</span>, <span class="hlFld-ContribAuthor ">Elizabeth J.  Anderson</span>, <span class="hlFld-ContribAuthor ">Sarah A.  McNitt</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Krenning</span>, <span class="hlFld-ContribAuthor ">Megh  Singh</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Wentian  Zeng</span>, <span class="hlFld-ContribAuthor ">Limei  Qin</span>, <span class="hlFld-ContribAuthor ">Wanwan  Xu</span>, <span class="hlFld-ContribAuthor ">Siting  Zhao</span>, <span class="hlFld-ContribAuthor ">Li  Qin</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Eickhoff</span>, <span class="hlFld-ContribAuthor ">Jonathan  Oliva</span>, <span class="hlFld-ContribAuthor ">Mary A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Stacy D.  Arnett</span>, <span class="hlFld-ContribAuthor ">Michael J.  Prinsen</span>, <span class="hlFld-ContribAuthor ">David W.  Griggs</span>, <span class="hlFld-ContribAuthor ">Peter G.  Ruminski</span>, <span class="hlFld-ContribAuthor ">Daniel E.  Goldberg</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>, <span class="hlFld-ContribAuthor ">Xiaorong  Liu</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Micky D.  Tortorella</span>, <span class="hlFld-ContribAuthor ">Francis M.  Sverdrup</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of spiropiperidine hydantoins as a novel class of antimalarial agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (16)
                                     , 5144-5150. <a href="https://doi.org/10.1016/j.bmc.2015.02.050" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.02.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.02.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.02.050%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DEvaluation%252Bof%252Bspiropiperidine%252Bhydantoins%252Bas%252Ba%252Bnovel%252Bclass%252Bof%252Bantimalarial%252Bagents%26aulast%3DMeyers%26aufirst%3DMarvin%2BJ.%26date%3D2015%26volume%3D23%26issue%3D16%26spage%3D5144%26epage%3D5150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Edwige  Lorthiois</span>, <span class="hlFld-ContribAuthor ">Frederic  Cumin</span>, <span class="hlFld-ContribAuthor ">Claus  Ehrhardt</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Kosaka</span>, <span class="hlFld-ContribAuthor ">Holger  Sellner</span>, <span class="hlFld-ContribAuthor ">Nils  Ostermann</span>, <span class="hlFld-ContribAuthor ">Eric  Francotte</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>. </span><span class="cited-content_cbyCitation_article-title">trans -(3 S ,4 S )-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part I: Prime site exploration using an amino linker. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (8)
                                     , 1782-1786. <a href="https://doi.org/10.1016/j.bmcl.2015.02.039" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.02.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.02.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3Dtrans%252B-%2525283%252BS%252B%25252C4%252BS%252B%252529-Disubstituted%252Bpyrrolidines%252Bas%252Binhibitors%252Bof%252Bthe%252Bhuman%252Baspartyl%252Bprotease%252Brenin.%252BPart%252BI%25253A%252BPrime%252Bsite%252Bexploration%252Busing%252Ban%252Bamino%252Blinker%26aulast%3DLorthiois%26aufirst%3DEdwige%26date%3D2015%26volume%3D25%26issue%3D8%26spage%3D1782%26epage%3D1786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Holger  Sellner</span>, <span class="hlFld-ContribAuthor ">Sylvain  Cottens</span>, <span class="hlFld-ContribAuthor ">Frédéric  Cumin</span>, <span class="hlFld-ContribAuthor ">Claus  Ehrhardt</span>, <span class="hlFld-ContribAuthor ">Takatoshi  Kosaka</span>, <span class="hlFld-ContribAuthor ">Edwige  Lorthiois</span>, <span class="hlFld-ContribAuthor ">Nils  Ostermann</span>, <span class="hlFld-ContribAuthor ">Randy L.  Webb</span>, <span class="hlFld-ContribAuthor ">Dean F.  Rigel</span>, <span class="hlFld-ContribAuthor ">Trixie  Wagner</span>, <span class="hlFld-ContribAuthor ">Jürgen  Maibaum</span>. </span><span class="cited-content_cbyCitation_article-title">trans -3,4-Disubstituted pyrrolidines as inhibitors of the human aspartyl protease renin. Part II: Prime site exploration using an oxygen linker. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (8)
                                     , 1787-1791. <a href="https://doi.org/10.1016/j.bmcl.2015.02.040" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.02.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.02.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.02.040%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3Dtrans%252B-3%25252C4-Disubstituted%252Bpyrrolidines%252Bas%252Binhibitors%252Bof%252Bthe%252Bhuman%252Baspartyl%252Bprotease%252Brenin.%252BPart%252BII%25253A%252BPrime%252Bsite%252Bexploration%252Busing%252Ban%252Boxygen%252Blinker%26aulast%3DSellner%26aufirst%3DHolger%26date%3D2015%26volume%3D25%26issue%3D8%26spage%3D1787%26epage%3D1791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Y.C.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of Pharmacophore Mapping☆. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.11305-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.11305-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.11305-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.11305-8%26sid%3Dliteratum%253Aachs%26atitle%3DApplications%252Bof%252BPharmacophore%252BMapping%2525E2%252598%252586%26aulast%3DMartin%26aufirst%3DY.C.%26date%3D2014%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fumiaki  Yokokawa</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress on the discovery of non-peptidic direct renin inhibitors for the clinical management of hypertension. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 673-690. <a href="https://doi.org/10.1517/17460441.2013.791279" title="DOI URL">https://doi.org/10.1517/17460441.2013.791279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.791279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.791279%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DRecent%252Bprogress%252Bon%252Bthe%252Bdiscovery%252Bof%252Bnon-peptidic%252Bdirect%252Brenin%252Binhibitors%252Bfor%252Bthe%252Bclinical%252Bmanagement%252Bof%252Bhypertension%26aulast%3DYokokawa%26aufirst%3DFumiaki%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D673%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0009.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Diverse classes of nonpeptide direct inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. <i>trans</i>-3,4-Piperidine (3<i>R</i>,4<i>R</i>)-<b>5</b> used for 3D pharmacophore search and pharmacophore hit <b>6</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. X-ray crystal structure of the <i>trans</i>-3,4-pyrrolidine <b>6a</b> (shown as stick model in green color) bound to the active site of glycosylated rh-renin (refined at 2.6 Å resolution) and superimposed with inhibitor <b>1</b> (left-hand side picture; orange color; PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v0z">2V0Z</a>)<a onclick="showRef(event, 'cit17b ref28'); return false;" href="javascript:void(0);" class="ref cit17b ref28">(17b, 28)</a> and inhibitor <b>5</b> (right-hand side picture; magenta color) in complex with rh-renin. Shown is the solvent accessible surface of renin. Residues of the flap β-hairpin (residues Tyr<sub>75</sub>, Ser<sub>76</sub>, Thr<sub>77</sub>, and Gly<sub>78</sub>) are depicted as thin lines in green, orange, and magenta for the rh-renin/<b>6a</b>, rh-renin/<b>1</b>, and rh-renin/<b>5</b> complexes, respectively, and have been omitted from the protein surface calculation. The oxygen and nitrogen atoms of the ligands are colored in red and blue, respectively. The absolute (3<i>S</i>,4<i>S</i>)-configuration of <b>6a</b> was tentatively assigned based on the observed difference electron density and was subsequently confirmed by synthesis and chemical correlation with an authentic sample (see text for discussion).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. X-ray crystal structure of (3<i>S</i>,4<i>S</i>)-<b>12a</b> (shown as stick model in green color) bound in the rh-renin active site (2.8 Å resolution), see <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. Shown is the solvent accessible surface of the active site of rh-renin. Residues of the flap β-hairpin are depicted in yellow as thin lines and have been omitted for protein surface calculation. The catalytic aspartates are shown as stick models. Oxygen and nitrogen atoms are shown in red and blue color, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0006.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) <i>N</i>-Benzyl-<i>N</i>-(methoxymethyl)trimethylsilyl methylamine, TFA, toluene, 0°C, 88%; (b) H<sub>2</sub>, Pd(OH)<sub>2</sub>, (Boc)<sub>2</sub>O, EtOH, RT, 95%; (c) LiBH<sub>4</sub>, THF, reflux, 60%; (d) Dess–Martin periodinane, wet CH<sub>2</sub>Cl<sub>2</sub>, 89%; (e) R<sup>1</sup>–NH<sub>2</sub>, NaBH(OAc)<sub>3</sub>, 1,2-dichloroethane, RT.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/medium/jm-2012-017078_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0007.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-6/jm3017078/production/images/large/jm-2012-017078_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3017078&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R–CH<sub>2</sub>Br, K<sub>2</sub>CO<sub>3</sub>, DMF, 80°C <i>or</i> 4-methoxy-3-(3-methoxypropoxy)-benzaldehyde, NaBH(OAc)<sub>3</sub>, 1,2-dichloroethane, RT; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub> and formation of HCl salt,<a onclick="showRef(event, 'cit26b'); return false;" href="javascript:void(0);" class="ref cit26b">(26b)</a><i>or</i> 4 M HCl–dioxane; (c) 4-methoxy-3-(3-methoxypropoxy)-benzoylchloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, RT; (d) HCl–<sup><i>i</i></sup>PrOH, RT; (e) [Pd(μ-Br)(<i>t</i>-Bu<sub>3</sub>P)]<sub>2</sub>, tBuOK, PhBr, toluene 110 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i48">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88577" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88577" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Ezzati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vander-Hoorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. J. L.</span><span> </span><span class="NLM_article-title">Selected major risk factors and global and regional burden of disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">360</span><span class="NLM_x"> (</span><span class="NLM_issue">9343</span><span class="NLM_x">) </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2002&pages=1347-1360&issue=9343&author=M.+Ezzatiauthor=A.+D.+Lopezauthor=A.+Rodgersauthor=S.+Vander-Hoornauthor=C.+J.+L.+Murray&title=Selected+major+risk+factors+and+global+and+regional+burden+of+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEzzati%26aufirst%3DM.%26aulast%3DLopez%26aufirst%3DA.%2BD.%26aulast%3DRodgers%26aufirst%3DA.%26aulast%3DVander-Hoorn%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DC.%2BJ.%2BL.%26atitle%3DSelected%2520major%2520risk%2520factors%2520and%2520global%2520and%2520regional%2520burden%2520of%2520disease%26jtitle%3DLancet%26date%3D2002%26volume%3D360%26issue%3D9343%26spage%3D1347%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Scott, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R. R.</span><span> </span><span class="NLM_article-title">Development of inhibitors of the aspartyl protease renin for the treatment of hypertension</span> <span class="citation_source-journal">Curr. Protein Pept. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">241</span><span class="NLM_x">–</span> <span class="NLM_lpage">254</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.2174%2F138920306777452330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=16787263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD28Xmt1emtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=241-254&author=B.+B.+Scottauthor=G.+M.+McGeehanauthor=R.+R.+Harrison&title=Development+of+inhibitors+of+the+aspartyl+protease+renin+for+the+treatment+of+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Development of inhibitors of the aspartyl protease renin for the treatment of hypertension</span></div><div class="casAuthors">Scott, Boyd B.; McGeehan, Gerard M.; Harrison, Richard K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Protein and Peptide Science</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">241-254</span>CODEN:
                <span class="NLM_cas:coden">CPPSCM</span>;
        ISSN:<span class="NLM_cas:issn">1389-2037</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Renin is the rate-limiting enzyme in the renin-angiotensin-aldosterone system (RAS) which controls blood pressure and vol.  The biol. function of renin is to cleave the N-terminus of angiotensinogen releasing the decapeptide, angiotensin I (ANGI).  Subsequently, angiotensin I is further processed by the angiotensin converting enzyme (ACE) to produce angiotensin II (ANGII).  The RAS cascade is a major target for the clin. management of hypertension.  Current clin. treatments include angiotensin converting enzyme inhibitors (ACEi) and ANGII receptor blockers (ARBs).  As the rate-limiting enzyme in ANGII prodn., renin inhibitors have been pursued as an addnl. class of antihypertensives.  Clin. studies conducted with renin inhibitors have shown them to be as effective as ACE inhibitors in lowering blood pressure.  Most importantly, inhibitors of renin may have a no. of potential advantages over ACEi and ARBs.  Renin is specific for angiotensinogen and will not carry the ancillary pharmacol. assocd. with ACEi or ARBs.  To date, no renin inhibitors have made it to market.  The development of these inhibitors has been hindered by poor bioavailability and complex synthesis.  However, despite the pharmacokinetic challenges of designing renin inhibitors, the enzyme remains a promising target for the development of novel treatments for hypertension.  This review consists of an overview of renin biol., the pharmacol. of renin and RAS and focus in on renin as a target for blood pressure regulation.  The authors also cover the evaluation of renin inhibitors in animal models and clin. studies.  Presently a no. of new generation inhibitors of renin are in development with at least one in the clinic and these are discussed.  Finally the authors discuss what might distinguish renin inhibitors from current therapeutic options and discuss other therapeutic indications renin inhibitors might have.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLk69AZtJAJbVg90H21EOLACvtfcHk0lj7DskuMIDDWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xmt1emtb8%253D&md5=8810483befefacec51f88378dfba763a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.2174%2F138920306777452330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138920306777452330%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DB.%2BB.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DHarrison%26aufirst%3DR.%2BR.%26atitle%3DDevelopment%2520of%2520inhibitors%2520of%2520the%2520aspartyl%2520protease%2520renin%2520for%2520the%2520treatment%2520of%2520hypertension%26jtitle%3DCurr.%2520Protein%2520Pept.%2520Sci.%26date%3D2006%26volume%3D7%26spage%3D241%26epage%3D254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Nicholls, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, J. I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inagami, T.</span><span> </span><span class="NLM_article-title">The renin–angiotensin system in the twenty-first century</span> <span class="citation_source-journal">Blood Pressure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">327</span><span class="NLM_x">–</span> <span class="NLM_lpage">343</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=327-343&author=M.+G.+Nichollsauthor=J.+I.+S.+Robertsonauthor=T.+Inagami&title=The+renin%E2%80%93angiotensin+system+in+the+twenty-first+century"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicholls%26aufirst%3DM.%2BG.%26aulast%3DRobertson%26aufirst%3DJ.%2BI.%2BS.%26aulast%3DInagami%26aufirst%3DT.%26atitle%3DThe%2520renin%25E2%2580%2593angiotensin%2520system%2520in%2520the%2520twenty-first%2520century%26jtitle%3DBlood%2520Pressure%26date%3D2001%26volume%3D10%26spage%3D327%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Castrop, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Höcherl, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurtz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweda, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todorov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, C.</span><span> </span><span class="NLM_article-title">Physiology of kidney renin</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">90</span><span class="NLM_x">, </span> <span class="NLM_fpage">607</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2010&pages=607-673&author=H.+Castropauthor=K.+H%C3%B6cherlauthor=A.+Kurtzauthor=F.+Schwedaauthor=V.+Todorovauthor=C.+Wagner&title=Physiology+of+kidney+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCastrop%26aufirst%3DH.%26aulast%3DH%25C3%25B6cherl%26aufirst%3DK.%26aulast%3DKurtz%26aufirst%3DA.%26aulast%3DSchweda%26aufirst%3DF.%26aulast%3DTodorov%26aufirst%3DV.%26aulast%3DWagner%26aufirst%3DC.%26atitle%3DPhysiology%2520of%2520kidney%2520renin%26jtitle%3DPhysiol.%2520Rev.%26date%3D2010%26volume%3D90%26spage%3D607%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Skeggs, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lentz, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumway, N. P.</span><span> </span><span class="NLM_article-title">Preparation, purification and amino acid sequence of a polypeptide renin substrate</span> <span class="citation_source-journal">J. Exp. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1957</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">439</span><span class="NLM_x">–</span> <span class="NLM_lpage">453</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=1957&pages=439-453&author=L.+Skeggsauthor=J.+R.+Kahnauthor=K.+E.+Lentzauthor=N.+P.+Shumway&title=Preparation%2C+purification+and+amino+acid+sequence+of+a+polypeptide+renin+substrate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkeggs%26aufirst%3DL.%26aulast%3DKahn%26aufirst%3DJ.%2BR.%26aulast%3DLentz%26aufirst%3DK.%2BE.%26aulast%3DShumway%26aufirst%3DN.%2BP.%26atitle%3DPreparation%252C%2520purification%2520and%2520amino%2520acid%2520sequence%2520of%2520a%2520polypeptide%2520renin%2520substrate%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D1957%26volume%3D106%26spage%3D439%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Jackson, E. K.</span><span> </span><span class="NLM_article-title">Renin and Angiotensin</span>. In  <span class="citation_source-book">Goodman and Gilman’s: The Pharmacological Basis of Therapeutics</span>, <span class="NLM_edition">11th</span> ed.; <span class="NLM_contrib-group">Brunton, L.; Lazo, J.; Parker, K.; Buxton, I.; Blumenthal, D.</span>, Eds.; <span class="NLM_publisher-name">McGraw-Hill</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">789</span><span class="NLM_x">–</span> <span class="NLM_lpage">821</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=789-821&author=E.+K.+Jacksonauthor=L.+Brunton&author=J.+Lazo&author=K.+Parker&author=I.+Buxton&author=D.+Blumenthal&title=Goodman+and+Gilman%E2%80%99s%3A+The+Pharmacological+Basis+of+Therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DE.%2BK.%26atitle%3DRenin%2520and%2520Angiotensin%26btitle%3DGoodman%2520and%2520Gilman%25E2%2580%2599s%253A%2520The%2520Pharmacological%2520Basis%2520of%2520Therapeutics%26aulast%3DBrunton%26aufirst%3DL.%26pub%3DMcGraw-Hill%26date%3D2006%26spage%3D789%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Mehta, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griendling, K. K.</span><span> </span><span class="NLM_article-title">Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system</span> <span class="citation_source-journal">Am. J. Physiol. Cell Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">292</span><span class="NLM_x">, </span> <span class="NLM_fpage">C82</span><span class="NLM_x">–</span> <span class="NLM_lpage">C97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2007&pages=C82-C97&author=P.+K.+Mehtaauthor=K.+K.+Griendling&title=Angiotensin+II+cell+signaling%3A+physiological+and+pathological+effects+in+the+cardiovascular+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMehta%26aufirst%3DP.%2BK.%26aulast%3DGriendling%26aufirst%3DK.%2BK.%26atitle%3DAngiotensin%2520II%2520cell%2520signaling%253A%2520physiological%2520and%2520pathological%2520effects%2520in%2520the%2520cardiovascular%2520system%26jtitle%3DAm.%2520J.%2520Physiol.%2520Cell%2520Physiol.%26date%3D2007%26volume%3D292%26spage%3DC82%26epage%3DC97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hofbauer, K. G.</span><span> </span><span class="NLM_article-title">Inhibitors of renin as potential therapeutic agents</span> <span class="citation_source-journal">J. Enzyme Inhib.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.3109%2F14756368709020115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=3334243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADyaL2sXhs1yht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1987&pages=169-185&author=J.+M.+Woodauthor=J.+L.+Stantonauthor=K.+G.+Hofbauer&title=Inhibitors+of+renin+as+potential+therapeutic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of renin as potential therapeutic agents</span></div><div class="casAuthors">Wood, Jeanette M.; Stanton, James L.; Hofbauer, Karl G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">169-85</span>CODEN:
                <span class="NLM_cas:coden">ENINEG</span>;
        ISSN:<span class="NLM_cas:issn">8755-5093</span>.
    </div><div class="casAbstract">A review, with 98 refs., of the biochem. of human renin  [9015-94-5]; the structures and biol. activity of various renin inhibitors; and the therapeutic potential of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAfx87wdULsbVg90H21EOLACvtfcHk0lh_a3Ar9keWQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhs1yht70%253D&md5=0ffad109e3123855070aeef23fb27035</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.3109%2F14756368709020115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756368709020115%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DStanton%26aufirst%3DJ.%2BL.%26aulast%3DHofbauer%26aufirst%3DK.%2BG.%26atitle%3DInhibitors%2520of%2520renin%2520as%2520potential%2520therapeutic%2520agents%26jtitle%3DJ.%2520Enzyme%2520Inhib.%26date%3D1987%26volume%3D1%26spage%3D169%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Fisher, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Is there a future for renin inhibitors?</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">426</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2001&pages=417-426&author=N.+D.+Fisherauthor=N.+K.+Hollenberg&title=Is+there+a+future+for+renin+inhibitors%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DN.%2BD.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DIs%2520there%2520a%2520future%2520for%2520renin%2520inhibitors%253F%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2001%26volume%3D10%26spage%3D417%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Ferro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krum, H.</span><span> </span><span class="NLM_article-title">Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition</span> <span class="citation_source-journal">Int. J. Clin. Pract.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">577</span><span class="NLM_x">–</span> <span class="NLM_lpage">581</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1111%2Fj.1368-5031.2006.00920.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=16700858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlGntrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2006&pages=577-581&author=A.+Ferroauthor=R.+Gilbertauthor=H.+Krum&title=Importance+of+renin+in+blood+pressure+regulation+and+therapeutic+potential+of+renin+inhibition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Importance of renin in blood pressure regulation and therapeutic potential of renin inhibition</span></div><div class="casAuthors">Ferro, A.; Gilbert, R.; Krum, H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Clinical Practice</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">577-581</span>CODEN:
                <span class="NLM_cas:coden">IJCPF9</span>;
        ISSN:<span class="NLM_cas:issn">1368-5031</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Despite improvements in its detection and treatment, hypertension remains a significant public health problem worldwide.  In recent years, many international hypertension societies and organizations have set increasingly rigorous blood pressure (BP) targets, with the aim of reducing cardiovascular complications, and this has in turn necessitated the use of more antihypertensive medications to reach these targets in individual patients.  There is therefore an ongoing need to develop antihypertensive drugs with new mechanisms of action.  Renin inhibitors represent a novel class of compds. which offer considerable promise as BP-lowering agents.  Here, we review the rationale for renin inhibition as a therapeutic target and examine the preclin. and clin. evidence for the antihypertensive effectiveness of the renin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-BT84LqqRZrVg90H21EOLACvtfcHk0lh_a3Ar9keWQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlGntrY%253D&md5=006b2b8d40a0dcc5ed3b33b6f8f4cc38</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fj.1368-5031.2006.00920.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1368-5031.2006.00920.x%26sid%3Dliteratum%253Aachs%26aulast%3DFerro%26aufirst%3DA.%26aulast%3DGilbert%26aufirst%3DR.%26aulast%3DKrum%26aufirst%3DH.%26atitle%3DImportance%2520of%2520renin%2520in%2520blood%2520pressure%2520regulation%2520and%2520therapeutic%2520potential%2520of%2520renin%2520inhibition%26jtitle%3DInt.%2520J.%2520Clin.%2520Pract.%26date%3D2006%26volume%3D60%26spage%3D577%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Cheng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, R. C.</span><span> </span><span class="NLM_article-title">Potential side effects of renin inhibitors—mechanisms based on comparison with other renin–angiotensin blockers</span> <span class="citation_source-journal">Expert Opin. Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1517%2F14740338.5.5.631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=16907653" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD28XotFKhtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=631-641&author=H.+Chengauthor=R.+C.+Harris&title=Potential+side+effects+of+renin+inhibitors%E2%80%94mechanisms+based+on+comparison+with+other+renin%E2%80%93angiotensin+blockers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Potential side effects of renin inhibitors - mechanisms based on comparison with other renin-angiotensin blockers</span></div><div class="casAuthors">Cheng, Huifang; Harris, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Safety</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">631-641</span>CODEN:
                <span class="NLM_cas:coden">EODSA9</span>;
        ISSN:<span class="NLM_cas:issn">1474-0338</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Angiotensin (Ang) II plays important roles in the development of hypertension and cardiovascular and renal injury.  Pharmaceutical approaches to block its activity led to the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.  Numerous trials have documented their efficacy in controlling blood pressure, minimizing left ventricular remodelling, preventing progression to heart failure, ameliorating proteinuria and retarding renal disease progression.  Although they are considered safe in general, there remain concerns about the potential for adverse events in certain target populations.  Recently, several novel, low mol. wt. renin inhibitors without the extended peptide-like backbone of previous renin inhibitors were developed with favorable pharmacokinetic properties.  They have been shown to successfully reduce Ang II levels in normal volunteers and to lower blood pressure in patients with mild-to-moderate hypertension.  In this review, the authors summarize current knowledge about these renin inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmu6jtwrNjn7Vg90H21EOLACvtfcHk0ljYS8OszYOIaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XotFKhtL0%253D&md5=dfdbd57c1e456dfbaace6fb9ad5bb52a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1517%2F14740338.5.5.631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14740338.5.5.631%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DH.%26aulast%3DHarris%26aufirst%3DR.%2BC.%26atitle%3DPotential%2520side%2520effects%2520of%2520renin%2520inhibitors%25E2%2580%2594mechanisms%2520based%2520on%2520comparison%2520with%2520other%2520renin%25E2%2580%2593angiotensin%2520blockers%26jtitle%3DExpert%2520Opin.%2520Drug%2520Safety%26date%3D2006%26volume%3D5%26spage%3D631%26epage%3D641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Azizi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span> </span><span class="NLM_article-title">Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">2492</span><span class="NLM_x">–</span> <span class="NLM_lpage">2499</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2004&pages=2492-2499&author=M.+Aziziauthor=J.+Menard&title=Combined+blockade+of+the+renin-angiotensin+system+with+angiotensin-converting+enzyme+inhibitors+and+angiotensin+II+type+1+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAzizi%26aufirst%3DM.%26aulast%3DMenard%26aufirst%3DJ.%26atitle%3DCombined%2520blockade%2520of%2520the%2520renin-angiotensin%2520system%2520with%2520angiotensin-converting%2520enzyme%2520inhibitors%2520and%2520angiotensin%2520II%2520type%25201%2520receptor%2520antagonists%26jtitle%3DCirculation%26date%3D2004%26volume%3D109%26spage%3D2492%26epage%3D2499" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karlberg, B. E.</span><span> </span><span class="NLM_article-title">Cough and inhibition of the renin–angiotensin system</span> <span class="citation_source-journal">J. Hypertens.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl</span><span class="NLM_x">) </span> <span class="NLM_fpage">S49</span><span class="NLM_x">–</span> <span class="NLM_lpage">S52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1993&pages=S49-S52&issue=Suppl&author=B.+E.+Karlberg&title=Cough+and+inhibition+of+the+renin%E2%80%93angiotensin+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarlberg%26aufirst%3DB.%2BE.%26atitle%3DCough%2520and%2520inhibition%2520of%2520the%2520renin%25E2%2580%2593angiotensin%2520system%26jtitle%3DJ.%2520Hypertens.%26date%3D1993%26volume%3D11%26issue%3DSuppl%26spage%3DS49%26epage%3DS52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cugno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nussberger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cicardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agostoni, A.</span><span> </span><span class="NLM_article-title">Bradykinin and the pathophysiology of angioedema</span> <span class="citation_source-journal">Int. Immunopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS1567-5769%2802%2900162-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=12639808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvFGktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=311-317&author=M.+Cugnoauthor=J.+Nussbergerauthor=M.+Cicardiauthor=A.+Agostoni&title=Bradykinin+and+the+pathophysiology+of+angioedema"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Bradykinin and the pathophysiology of angioedema</span></div><div class="casAuthors">Cugno, Massimo; Nussberger, Jurg; Cicardi, Marco; Agostoni, Angelo</div><div class="citationInfo"><span class="NLM_cas:title">International Immunopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">311-317</span>CODEN:
                <span class="NLM_cas:coden">IINMBA</span>;
        ISSN:<span class="NLM_cas:issn">1567-5769</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">Angioedema has different causes and different clin. presentations.  Some types of angioedema may be mediated by bradykinin.  We measured plasma levels of bradykinin-(1-9) nonapeptide by RIA after high-performance liq. chromatog. in patients with different types of angioedema during acute attacks and/or in remission, i.e. hereditary C1-inhibitor deficiency, angiotensin converting enzyme (ACE) inhibitor treatment, idiopathic non histaminergic and responders to antihistamines.  Eleven patients with the deficiency of C1-inhibitor had very high levels of bradykinin during acute attacks of angioedema (18.0-90.0 pM) (normal range 0.2-7.1 pM).  In three patients with history of ACE inhibitor-related angioedema, plasma bradykinin was high during ACE inhibitor treatment (62.0, 8.9 and 27.0 pM) and in a fourth patient was 47.0 pM during an acute attack and decreased by 93% to 3.2 pM after withdrawal of the ACE inhibitor.  The patient with idiopathic angioedema, during an acute attack involving the right arm, had high levels of bradykinin in the venous blood refluent from the angioedematous arm (20.0 pM) while in the contralateral arm bradykinin levels were normal (6.6 pM), similarly to what we previously obsd. in cases of brachial angioedema due to C1-inhibitor deficiency.  The four patients with angioedema responsive to antihistamines had normal levels of bradykinin even during acute attacks (5.7, 3.4, 4.7 and 1.2 pM).  In one of these patients who had a brachial angioedema, bradykinin levels were normal in the venous blood refluent from both arms.  Bradykinin is involved in hereditary C1-inhibitor deficiency angioedema, in ACE inhibitor-related angioedema, and in idiopathic non-histaminergic angioedema, while bradykinin is not related to allergen-dependent or idiopathic angioedema that are responsive to antihistamines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMq4a94xBobLVg90H21EOLACvtfcHk0ljYS8OszYOIaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvFGktLY%253D&md5=8a549aaf69ac0108ad33be591729f615</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2FS1567-5769%2802%2900162-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1567-5769%252802%252900162-5%26sid%3Dliteratum%253Aachs%26aulast%3DCugno%26aufirst%3DM.%26aulast%3DNussberger%26aufirst%3DJ.%26aulast%3DCicardi%26aufirst%3DM.%26aulast%3DAgostoni%26aufirst%3DA.%26atitle%3DBradykinin%2520and%2520the%2520pathophysiology%2520of%2520angioedema%26jtitle%3DInt.%2520Immunopharmacol.%26date%3D2003%26volume%3D3%26spage%3D311%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Parving, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenberg, N. K.</span><span> </span><span class="NLM_article-title">Aliskiren combined with losartan in type 2 diabetes and nephropathy</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">2433</span><span class="NLM_x">–</span> <span class="NLM_lpage">2445</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1056%2FNEJMoa0708379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=18525041" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvFKmtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2008&pages=2433-2445&author=H.+H.+Parvingauthor=F.+Perssonauthor=J.+B.+Lewisauthor=E.+J.+Lewisauthor=N.+K.+Hollenberg&title=Aliskiren+combined+with+losartan+in+type+2+diabetes+and+nephropathy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Aliskiren combined with losartan in type 2 diabetes and nephropathy</span></div><div class="casAuthors">Parving, Hans-Henrik; Persson, Frederik; Lewis, Julia B.; Lewis, Edmund J.; Hollenberg, Norman K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2433-2446</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries.  We evaluated the renoprotective effects of dual blockade of the renin-angiotensin-aldosterone system by adding treatment with aliskiren, an oral direct renin inhibitor, to treatment with the maximal recommended dose of losartan (100 mg daily) and optimal antihypertensive therapy in patients who had hypertension and type 2 diabetes with nephropathy.  We enrolled 599 patients in this multinational, randomized, double-blind study.  After a 3-mo, open-label, run-in period during which patients received 100 mg of losartan daily, patients were randomly assigned to receive 6 mo of treatment with aliskiren (150 mg daily for 3 mo, followed by an increase in dosage to 300 mg daily for another 3 mo) or placebo, in addn. to losartan.  The primary outcome was a redn. in the ratio of albumin to creatinine, as measured in an early-morning urine sample, at 6 mo.  The baseline characteristics of the two groups were similar.  Treatment with 300 mg of aliskiren daily, as compared with placebo, reduced the mean urinary albumin-to-creatinine ratio by 20% (95% confidence interval, 9 to 30; P<0.001), with a redn. of 50% or more in 24.7% of the patients who received aliskiren as compared with 12.5% of those who received placebo (P<0.001).  A small difference in blood pressure was seen between the treatment groups by the end of the study period (systolic, 2 mm Hg lower [P = 0.07] and diastolic, 1 mm Hg lower [P = 0.08] in the aliskiren group).  The total nos. of adverse and serious adverse events were similar in the groups.  Aliskiren may have renoprotective effects that are independent of its blood pressure-lowering effect in patients with hypertension, type 2 diabetes, and nephropathy who are receiving the recommended renoprotective treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrVSPga0hzXrVg90H21EOLACvtfcHk0li6oAZU_6GOsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvFKmtLY%253D&md5=e53fcda0023dbc3c567f412179cd3328</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0708379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0708379%26sid%3Dliteratum%253Aachs%26aulast%3DParving%26aufirst%3DH.%2BH.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DLewis%26aufirst%3DJ.%2BB.%26aulast%3DLewis%26aufirst%3DE.%2BJ.%26aulast%3DHollenberg%26aufirst%3DN.%2BK.%26atitle%3DAliskiren%2520combined%2520with%2520losartan%2520in%2520type%25202%2520diabetes%2520and%2520nephropathy%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2008%26volume%3D358%26spage%3D2433%26epage%3D2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiering, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedrani, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Direct Renin Inhibitors as A New Therapy for Hypertension</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7490</span><span class="NLM_x">–</span> <span class="NLM_lpage">7520</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901885s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7490-7520&author=R.+L.+Webbauthor=N.+Schieringauthor=R.+Sedraniauthor=J.+Maibaum&title=Direct+Renin+Inhibitors+as+A+New+Therapy+for+Hypertension"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm901885s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901885s%26sid%3Dliteratum%253Aachs%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DSchiering%26aufirst%3DN.%26aulast%3DSedrani%26aufirst%3DR.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDirect%2520Renin%2520Inhibitors%2520as%2520A%2520New%2520Therapy%2520for%2520Hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7490%26epage%3D7520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16a"><span><span class="NLM_contrib-group">Tice, C. M.; Singh, S. B.</span><span> </span><span class="NLM_article-title">Evolution of Diverse Classes of Renin Inhibitors through the Years</span>. In  <span class="citation_source-journal">Aspartic Acid Proteases as Therapeutic Targets</span>, <span class="NLM_contrib-group">Ghosh, A. K.</span>, Ed.; <span class="NLM_series">Methods and Principles in Medicinal Chemistry</span>, <span class="NLM_contrib-group">Mannhold, R.; Kubinyi, H.; Folkers, G.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span>Vol.  <span class="NLM_volume">45</span>, pp  <span class="NLM_fpage">297</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=297-324&author=C.+M.+Tice&author=S.+B.+Singhauthor=A.+K.+Ghoshauthor=R.+Mannhold&author=H.+Kubinyi&author=G.+Folkers&title=Evolution+of+Diverse+Classes+of+Renin+Inhibitors+through+the+Years"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTice%26aufirst%3DC.%2BM.%26atitle%3DEvolution%2520of%2520Diverse%2520Classes%2520of%2520Renin%2520Inhibitors%2520through%2520the%2520Years%26jtitle%3DAspartic%2520Acid%2520Proteases%2520as%2520Therapeutic%2520Targets%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DMannhold%26aufirst%3DR.%26pub%3DWiley-VCH%26date%3D2010%26volume%3D45%26spage%3D297%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herold, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jensen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bedigian, M. P.</span><span> </span><span class="NLM_article-title">Structure-based design of aliskiren, a novel orally effective renin inhibitor</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">308</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">705</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS0006-291X%2803%2901451-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=12927775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17a&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVGkt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2003&pages=698-705&author=J.+M.+Woodauthor=J.+Maibaumauthor=J.+Rahuelauthor=M.+G.+Gr%C3%BCtterauthor=N.-C.+Cohenauthor=V.+Rasettiauthor=H.+R%C3%BCegerauthor=R.+G%C3%B6schkeauthor=S.+Stutzauthor=W.+Fuhrerauthor=W.+Schillingauthor=P.+Rigollierauthor=Y.+Yamaguchiauthor=F.+Cuminauthor=H.-P.+Baumauthor=C.+R.+Schnellauthor=P.+Heroldauthor=R.+Mahauthor=C.+Jensenauthor=E.+O%E2%80%99Brienauthor=A.+Stantonauthor=M.+P.+Bedigian&title=Structure-based+design+of+aliskiren%2C+a+novel+orally+effective+renin+inhibitor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17aR"><div class="casContent"><span class="casTitleNuber">17a</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of aliskiren, a novel orally effective renin inhibitor</span></div><div class="casAuthors">Wood, Jeanette M.; Maibaum, Juergen; Rahuel, Joseph; Gruetter, Markus G.; Cohen, Nissim-Claude; Rasetti, Vittorio; Rueger, Heinrich; Goeschke, Richard; Stutz, Stefan; Fuhrer, Walter; Schilling, Walter; Rigollier, Pascal; Yamaguchi, Yasuchika; Cumin, Frederic; Baum, Hans-Peter; Schnell, Christian R.; Herold, Peter; Mah, Robert; Jensen, Chris; O'Brien, Eoin; Stanton, Alice; Bedigian, Martin P.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">308</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">698-705</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Hypertension is a major risk factor for cardiovascular diseases such as stroke, myocardial infarction, and heart failure, the leading causes of death in the Western world.  Inhibitors of the renin-angiotensin system (RAS) have proven to be successful treatments for hypertension.  As renin specifically catalyzes the rate-limiting step of the RAS, it represents the optimal target for RAS inhibition.  Several peptide-like renin inhibitors have been synthesized previously, but poor pharmacokinetic properties meant that these compds. were not clin. useful.  We employed a combination of mol. modeling and crystallog. structure anal. to design renin inhibitors lacking the extended peptide-like backbone of earlier inhibitors, for improved pharmacokinetic properties.  This led to the discovery of aliskiren, a highly potent and selective inhibitor of human renin in vitro, and in vivo; once-daily oral doses of aliskiren inhibit renin and lower blood pressure in sodium-depleted marmosets and hypertensive human patients.  Aliskiren represents the first in a novel class of renin inhibitors with the potential for treatment of hypertension and related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV5YmV3cdr0LVg90H21EOLACvtfcHk0li6oAZU_6GOsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVGkt7k%253D&md5=20b71ca3ccfe2324752cb2bb541d9ba2</span></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2803%2901451-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252803%252901451-7%26sid%3Dliteratum%253Aachs%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DR%25C3%25BCeger%26aufirst%3DH.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DBaum%26aufirst%3DH.-P.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DHerold%26aufirst%3DP.%26aulast%3DMah%26aufirst%3DR.%26aulast%3DJensen%26aufirst%3DC.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DE.%26aulast%3DStanton%26aufirst%3DA.%26aulast%3DBedigian%26aufirst%3DM.%2BP.%26atitle%3DStructure-based%2520design%2520of%2520aliskiren%252C%2520a%2520novel%2520orally%2520effective%2520renin%2520inhibitor%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2003%26volume%3D308%26spage%3D698%26epage%3D705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigollier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baum, H.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schilling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4832</span><span class="NLM_x">–</span> <span class="NLM_lpage">4844</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070316i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17b&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVSgs7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Maibaum%2C+J.%3B+Stutz%2C+S.%3B+G%C3%B6schke%2C+R.%3B+Rigollier%2C+P.%3B+Yamaguchi%2C+Y.%3B+Cumin%2C+F.%3B+Rahuel%2C+J.%3B+Baum%2C+H.-P.%3B+Cohen%2C+N.-C.%3B+Schnell%2C+C.+R.%3B+Fuhrer%2C+W.%3B+Gr%C3%BCtter%2C+M.+G.%3B+Schilling%2C+W.%3B+Wood%2C+J.+M.J.+Med.+Chem.+2007%2C+50%2C+4832%E2%80%934844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17bR"><div class="casContent"><span class="casTitleNuber">17b</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Modification of the P2' Position of 2,7-Dialkyl-Substituted 5(S)-Amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: The Discovery of Aliskiren, a Potent Nonpeptide Human Renin Inhibitor Active after Once Daily Dosing in Marmosets</span></div><div class="casAuthors">Maibaum, Juergen; Stutz, Stefan; Goeschke, Richard; Rigollier, Pascal; Yamaguchi, Yasuchika; Cumin, Frederic; Rahuel, Joseph; Baum, Hans-Peter; Cohen, Nissim-Claude; Schnell, Christian R.; Fuhrer, Walter; Gruetter, Markus G.; Schilling, Walter; Wood, Jeanette M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4832-4844</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Due to its function in the rate limiting initial step of the renin-angiotensin system, renin is a particularly promising target for drugs designed to control hypertension, a growing risk to health worldwide.  Despite vast efforts over more than two decades, no orally efficacious renin inhibitor had reached the market.  As a result of a structure-based topol. design approach, we have identified a novel class of small-mol. inhibitors with good oral blood-pressure lowering effects in primates.  Further lead optimization aimed for improvement of in vivo potency and duration of action, mainly by P2' modifications at the hydroxyethylene transition-state isostere.  These efforts resulted in the discovery of aliskiren (46, CGP060536B, SPP100), a highly potent, selective inhibitor of renin, demonstrating excellent efficacy in sodium-depleted marmosets after oral administration, with sustained duration of action in reducing dose-dependently mean arterial blood pressure.  Aliskiren has recently received regulatory approval by the U.S. Food and Drug Administration for the treatment of hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfKfNx9HchP7Vg90H21EOLACvtfcHk0liT0E3vVT3omQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVSgs7zJ&md5=bce469eed92c55b133b4be98ffdc2794</span></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=10.1021%2Fjm070316i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070316i%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DRigollier%26aufirst%3DP.%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DBaum%26aufirst%3DH.-P.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DSchnell%26aufirst%3DC.%2BR.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26aulast%3DSchilling%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4832%26epage%3D4844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, D. L.</span><span> </span><span class="NLM_article-title">Case history on Tekturna/Rasilez (aliskiren), a highly efficacious direct oral renin inhibitor as a new therapy for hypertension</span> <span class="citation_source-journal">Annu. Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">127</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS0065-7743%2809%2904405-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsrnM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2009&pages=105-127&author=J.+Maibaumauthor=D.+L.+Feldman&title=Case+history+on+Tekturna%2FRasilez+%28aliskiren%29%2C+a+highly+efficacious+direct+oral+renin+inhibitor+as+a+new+therapy+for+hypertension"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Case history on Tekturna Rasilez (Aliskiren), a highly efficacious direct oral renin inhibitor as a new therapy for hypertension</span></div><div class="casAuthors">Maibaum, Jurgen; Feldman, David L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Reports in Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-127</span>CODEN:
                <span class="NLM_cas:coden">ARMCBI</span>;
        ISSN:<span class="NLM_cas:issn">0065-7743</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The rationale for the use of direct renin inhibitors, pre-clin. models to study direct renin inhibitors, and the early renin inhibitor program at Ciba-Geigy are shown.  The first convergent and scalable synthesis development, pre-clin. properties of aliskiren, effects of aliskiren in disease models, and clin. studies with aliskiren are also described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOCbXc9SNs7LVg90H21EOLACvtfcHk0liT0E3vVT3omQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaqsrnM&md5=7fb4459d367392233e0569a8809a3f41</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0065-7743%2809%2904405-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0065-7743%252809%252904405-4%26sid%3Dliteratum%253Aachs%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DFeldman%26aufirst%3DD.%2BL.%26atitle%3DCase%2520history%2520on%2520Tekturna%252FRasilez%2520%2528aliskiren%2529%252C%2520a%2520highly%2520efficacious%2520direct%2520oral%2520renin%2520inhibitor%2520as%2520a%2520new%2520therapy%2520for%2520hypertension%26jtitle%3DAnnu.%2520Rev.%2520Med.%2520Chem.%26date%3D2009%26volume%3D44%26spage%3D105%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Designing non-peptide peptidomimetics in the 21st century: inhibitors targeting conformational ensembles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">541</span><span class="NLM_x">–</span> <span class="NLM_lpage">558</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm010425b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD38XmsVantw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=541-558&author=M.+G.+Bursavichauthor=D.+H.+Rich&title=Designing+non-peptide+peptidomimetics+in+the+21st+century%3A+inhibitors+targeting+conformational+ensembles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Designing Non-Peptide Peptidomimetics in the 21st Century: Inhibitors Targeting Conformational Ensembles</span></div><div class="casAuthors">Bursavich, Matthew G.; Rich, Daniel H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">541-558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The goal of this Perspective is to outline for medicinal chemists the potential impact of receptor conformational mobility on rational drug design.  While others have postulated receptor-based conformational selection of ligands and successfully designed inhibitors to emulate the -strand binding motif of native ligands , we show that novel protein conformations (not obsd. in either native or enzyme-inhibitor complexes) can be exploited to create nonpeptide enzyme inhibitors.  We begin with a review of the development of peptidomimetic aspartic peptidase inhibitors and conclude with a new proposal for discovering fundamentally novel nonpeptide peptidomimetics by targeting conformational ensembles.  Although we focus on the aspartic peptidases, the lessons derived therein are applicable to other peptidase and receptor-ligand systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1URmBiLvD97Vg90H21EOLACvtfcHk0lgNefutv09phg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmsVantw%253D%253D&md5=8f00dc08b4d51c3021dd22a247bd56c0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm010425b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010425b%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DDesigning%2520non-peptide%2520peptidomimetics%2520in%2520the%252021st%2520century%253A%2520inhibitors%2520targeting%2520conformational%2520ensembles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D541%26epage%3D558" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Oefner, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorn, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ridley, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, F. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">127</span><span class="NLM_x">–</span> <span class="NLM_lpage">131</span><div class="note"><p class="first last">The X-ray structure for the disclosed GRAB peptidomimetic inhibitor 2-chloro-benzoic acid 4-[(3<i>S</i>,4<i>R</i>,5<i>R</i>)-3-methoxymethyl-5-(naphthalen-2-ylmethoxy)-piperidin-4-yl]-benzyl ester in complex with recombinant human renin (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PR8">1PR8</a>) had been made publicly available by the Protein Data Bank during a restricted time period. This data has been retracted in the meantime for unknown reasons</p></div></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS1074-5521%2899%2989004-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=10074464" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADyaK1MXhs1yqsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Oefner%2C+C.%3B+Binggeli%2C+A.%3B+Breu%2C+V.%3B+Bur%2C+D.%3B+Clozel%2C+J.-P.%3B+D%E2%80%99Arcy%2C+A.%3B+Dorn%2C+A.%3B+Fischli%2C+W.%3B+Gr%C3%BCninger%2C+F.%3B+G%C3%BCller%2C+R.%3B+M%C3%A4rki%2C+H.+P.%3B+Mathews%2C+S.%3B+M%C3%BCller%2C+M.%3B+Ridley%2C+R.+G.%3B+Stadler%2C+H.%3B+Vieira%2C+E.%3B+Wilhelm%2C+M.%3B+Winkler%2C+F.+K.%3B+Wostl%2C+W.Chem.+Biol.+1999%2C+6%2C+127%E2%80%93131The+X-ray+structure+for+the+disclosed+GRAB+peptidomimetic+inhibitor+2-chloro-benzoic+acid+4-%5B%283S%2C4R%2C5R%29-3-methoxymethyl-5-%28naphthalen-2-ylmethoxy%29-piperidin-4-yl%5D-benzyl+ester+in+complex+with+recombinant+human+renin+%28PDB+code+1PR8%29+had+been+made+publicly+available+by+the+Protein+Data+Bank+during+a+restricted+time+period.+This+data+has+been+retracted+in+the+meantime+for+unknown+reasons"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?</span></div><div class="casAuthors">Oefner, C.; Binggeli, A.; Breu, V.; Bur, D.; Clozel, J.-P.; D'Arcy, A.; Dorn, A.; Fischli, W.; Gruninger, F.; Guller, R.; Hirth, G.; Marki, H. P.; Mathews, S.; Muller, M.; Ridley, R. G.; Stadler, H.; Vieira, E.; Wilhelm, M.; Winkler, F. K.; Wostl, W.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">127-131</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology Publications</span>)
        </div><div class="casAbstract">The aspartic proteinase renin catalyzes the first and rate-limiting step in the conversion of angiotensinogen to the hormone angiotensin II, and therefore plays an important physiol. role in the regulation of blood pressure.  Numerous potent peptidomimetic inhibitors of this important drug target have been developed, but none of these compds. have progressed past clin. phase II trials.  Limited oral bioavailability or excessive prodn. costs have prevented these inhibitors from becoming new antihypertensive drugs.  We were interested in developing new nonpeptidomimetic renin inhibitors.  High-throughput screening of the Roche compd. library identified a simple 3,4-disubstituted piperidine lead compd.  We detd. the crystal structures of recombinant human renin complexed with two representatives of this new class.  Binding of these substituted piperidine derivs. is accompanied by major induced-fit adaptations around the enzyme's active site.  The efficient optimization of the piperidine inhibitors was facilitated by structural anal. of the renin active site in two renin-inhibitor complexes (some of the piperidine derivs. have picomolar affinities for renin).  These structural changes provide the basis for a novel paradigm for inhibition of monomeric aspartic proteinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvIEMz9YB6oLVg90H21EOLACvtfcHk0lgNefutv09phg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhs1yqsrY%253D&md5=071dd0984f8880eb09ee26c878d47e61</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2899%2989004-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252899%252989004-8%26sid%3Dliteratum%253Aachs%26aulast%3DOefner%26aufirst%3DC.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DClozel%26aufirst%3DJ.-P.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DDorn%26aufirst%3DA.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DMathews%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DRidley%26aufirst%3DR.%2BG.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWinkler%26aufirst%3DF.%2BK.%26aulast%3DWostl%26aufirst%3DW.%26jtitle%3DChem.%2520Biol.%26date%3D1999%26volume%3D6%26spage%3D127%26epage%3D131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Märki, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binggeli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohner-Lang, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coassolo, Ph.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clozel, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Arcy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doebeli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funk, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foricher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grüninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guenzi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Güller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartung, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirth, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenny, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klinkhammer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lave, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mervaala, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, D. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montavon, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oefner, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanwald-Ducray, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalone, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schleimer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stadler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valdenaire, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vieira, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiegand-Chou, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilhelm, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zell, R.</span><span> </span><span class="NLM_article-title">Piperidine renin inhibitors: from leads to drug candidates</span> <span class="citation_source-journal">Farmaco</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS0014-827X%2801%2901004-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=11347960" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD3MXltFKqsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2001&pages=21-27&author=H.+P.+M%C3%A4rkiauthor=A.+Binggeliauthor=B.+Bittnerauthor=V.+Bohner-Langauthor=V.+Breuauthor=D.+Burauthor=Ph.+Coassoloauthor=J.+P.+Clozelauthor=A.+D%E2%80%99Arcyauthor=H.+Doebeliauthor=W.+Fischliauthor=Ch.+Funkauthor=J.+Foricherauthor=T.+Gillerauthor=F.+Gr%C3%BCningerauthor=A.+Guenziauthor=R.+G%C3%BCllerauthor=T.+Hartungauthor=G.+Hirthauthor=Ch.+Jennyauthor=M.+Kansyauthor=U.+Klinkhammerauthor=T.+Laveauthor=B.+Lohriauthor=F.+C.+Luftauthor=E.+M.+Mervaalaauthor=D.+N.+M%C3%BCllerauthor=M.+M%C3%BCllerauthor=F.+Montavonauthor=Ch.+Oefnerauthor=C.+Qiuauthor=A.+Reichelauthor=P.+Sanwald-Ducrayauthor=M.+Scaloneauthor=M.+Schleimerauthor=R.+Schmidauthor=H.+Stadlerauthor=A.+Treiberauthor=O.+Valdenaireauthor=E.+Vieiraauthor=P.+Waldmeierauthor=R.+Wiegand-Chouauthor=M.+Wilhelmauthor=W.+Wostlauthor=M.+Zellauthor=R.+Zell&title=Piperidine+renin+inhibitors%3A+from+leads+to+drug+candidates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Piperidine renin inhibitors: from leads to drug candidates</span></div><div class="casAuthors">Marki, H. P.; Binggeli, A.; Bittner, B.; Bohner-Lang, V.; Breu, V.; Bur, D.; Coassolo, Ph.; Clozel, J. P.; D'Arcy, A.; Doebeli, H.; Fischli, W.; Funk, Ch.; Foricher, J.; Giller, T.; Gruninger, F.; Guenzi, A.; Guller, R.; Hartung, T.; Hirth, G.; Jenny, Ch.; Kansy, M.; Klinkhammer, U.; Lave, T.; Lohri, B.; Luft, F. C.; Mervaala, E. M.; Muller, D. N.; Muller, M.; Montavon, F.; Oefner, Ch.; Qiu, C.; Reichel, A.; Sanwald-Ducray, P.; Scalone, M.; Schleimer, M.; Schmid, R.; Stadler, H.; Treiber, A.; Valdenaire, O.; Vieira, E.; Waldmeier, P.; Wiegand-Chou, R.; Wilhelm, M.; Wostl, W.; Zell, M.; Zell, R.</div><div class="citationInfo"><span class="NLM_cas:title">Farmaco</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">21-27</span>CODEN:
                <span class="NLM_cas:coden">FRMCE8</span>;
        ISSN:<span class="NLM_cas:issn">0014-827X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science S.A.</span>)
        </div><div class="casAbstract">Non-peptidomimetic renin inhibitors of the piperidine type represent a novel structural class of compds. potentially free of the drawbacks seen with peptidomimetic compds. so far.  Synthetic optimization in two structural series focusing on improvement of potency, as well as on physicochem. properties and metabolic stability, has led to the identification of two candidate compds.  Both display potent and long-lasting blood pressure lowering effects in conscious sodium-depleted marmoset monkeys and double transgenic rats harboring both the human angiotensinogen and the human renin genes.  In addn., one of compds. normalizes albuminuria and kidney tissue damage in these rats when given over a period of 4 wk.  These data suggest that treatment of chronic renal failure patients with a renin inhibitor might result in a significant improvement of the disease status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBZ7-kozTn8LVg90H21EOLACvtfcHk0ljBb8kjJh6XFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXltFKqsLg%253D&md5=e1d96ac5db152e148a3deca5289a3b11</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2FS0014-827X%2801%2901004-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-827X%252801%252901004-7%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4rki%26aufirst%3DH.%2BP.%26aulast%3DBinggeli%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DB.%26aulast%3DBohner-Lang%26aufirst%3DV.%26aulast%3DBreu%26aufirst%3DV.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DCoassolo%26aufirst%3DPh.%26aulast%3DClozel%26aufirst%3DJ.%2BP.%26aulast%3DD%25E2%2580%2599Arcy%26aufirst%3DA.%26aulast%3DDoebeli%26aufirst%3DH.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DFunk%26aufirst%3DCh.%26aulast%3DForicher%26aufirst%3DJ.%26aulast%3DGiller%26aufirst%3DT.%26aulast%3DGr%25C3%25BCninger%26aufirst%3DF.%26aulast%3DGuenzi%26aufirst%3DA.%26aulast%3DG%25C3%25BCller%26aufirst%3DR.%26aulast%3DHartung%26aufirst%3DT.%26aulast%3DHirth%26aufirst%3DG.%26aulast%3DJenny%26aufirst%3DCh.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DKlinkhammer%26aufirst%3DU.%26aulast%3DLave%26aufirst%3DT.%26aulast%3DLohri%26aufirst%3DB.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DMervaala%26aufirst%3DE.%2BM.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BN.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DMontavon%26aufirst%3DF.%26aulast%3DOefner%26aufirst%3DCh.%26aulast%3DQiu%26aufirst%3DC.%26aulast%3DReichel%26aufirst%3DA.%26aulast%3DSanwald-Ducray%26aufirst%3DP.%26aulast%3DScalone%26aufirst%3DM.%26aulast%3DSchleimer%26aufirst%3DM.%26aulast%3DSchmid%26aufirst%3DR.%26aulast%3DStadler%26aufirst%3DH.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DValdenaire%26aufirst%3DO.%26aulast%3DVieira%26aufirst%3DE.%26aulast%3DWaldmeier%26aufirst%3DP.%26aulast%3DWiegand-Chou%26aufirst%3DR.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DZell%26aufirst%3DM.%26aulast%3DZell%26aufirst%3DR.%26atitle%3DPiperidine%2520renin%2520inhibitors%253A%2520from%2520leads%2520to%2520drug%2520candidates%26jtitle%3DFarmaco%26date%3D2001%26volume%3D56%26spage%3D21%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Bezencon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weller, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Bildstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remeň, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sifferlen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corminboeuf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisostomi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delahye, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binkert, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span> </span><span class="NLM_article-title">Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">3689</span><span class="NLM_x">–</span> <span class="NLM_lpage">3702</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900022f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=3689-3702&author=O.+Bezenconauthor=D.+Burauthor=T.+Wellerauthor=S.+Richard-Bildsteinauthor=L.+Reme%C5%88author=T.+Sifferlenauthor=O.+Corminboeufauthor=C.+Grisostomiauthor=C.+Bossauthor=L.+Pradeauthor=S.+Delahyeauthor=A.+Treiberauthor=P.+Stricknerauthor=C.+Binkertauthor=P.+Hessauthor=B.+Steinerauthor=W.+Fischli&title=Design+and+preparation+of+potent%2C+nonpeptidic%2C+bioavailable+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1021%2Fjm900022f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900022f%26sid%3Dliteratum%253Aachs%26aulast%3DBezencon%26aufirst%3DO.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DWeller%26aufirst%3DT.%26aulast%3DRichard-Bildstein%26aufirst%3DS.%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DSifferlen%26aufirst%3DT.%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DBoss%26aufirst%3DC.%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DDelahye%26aufirst%3DS.%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DStrickner%26aufirst%3DP.%26aulast%3DBinkert%26aufirst%3DC.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DFischli%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520potent%252C%2520nonpeptidic%252C%2520bioavailable%2520renin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D3689%26epage%3D3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">For the discovery of ACT-178882/MK-1597, see also</p></div><span class="NLM_contrib-group">Corminboeuf, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bezençon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remeň, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grisostomi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richard-Bildstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bur, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prade, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischli, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treiber, A.</span><span> </span><span class="NLM_article-title">Piperidine-based renin inhibitors: upper chain optimization</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6291</span><span class="NLM_x">–</span> <span class="NLM_lpage">6296</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6291-6296&author=O.+Corminboeufauthor=O.+Bezen%C3%A7onauthor=L.+Reme%C5%88author=C.+Grisostomiauthor=S.+Richard-Bildsteinauthor=D.+Burauthor=L.+Pradeauthor=P.+Stricknerauthor=P.+Hessauthor=W.+Fischliauthor=B.+Steinerauthor=A.+Treiber&title=Piperidine-based+renin+inhibitors%3A+upper+chain+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DBezen%25C3%25A7on%26aufirst%3DO.%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DGrisostomi%26aufirst%3DC.%26aulast%3DRichard-Bildstein%26aufirst%3DS.%26aulast%3DBur%26aufirst%3DD.%26aulast%3DPrade%26aufirst%3DL.%26aulast%3DStrickner%26aufirst%3DP.%26aulast%3DHess%26aufirst%3DP.%26aulast%3DFischli%26aufirst%3DW.%26aulast%3DSteiner%26aufirst%3DB.%26aulast%3DTreiber%26aufirst%3DA.%26atitle%3DPiperidine-based%2520renin%2520inhibitors%253A%2520upper%2520chain%2520optimization%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6291%26epage%3D6296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kasai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subedi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holsworth, D. D.</span><span> </span><span class="NLM_article-title">Cardiovascular agents: renin inhibitors and factor Xa inhibitors</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">47</span><span class="NLM_x">–</span> <span class="NLM_lpage">85</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2007&pages=47-85&author=A.+Kasaiauthor=R.+Subediauthor=M.+Stierauthor=D.+D.+Holsworth&title=Cardiovascular+agents%3A+renin+inhibitors+and+factor+Xa+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DA.%26aulast%3DSubedi%26aufirst%3DR.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DHolsworth%26aufirst%3DD.%2BD.%26atitle%3DCardiovascular%2520agents%253A%2520renin%2520inhibitors%2520and%2520factor%2520Xa%2520inhibitors%26jtitle%3DHeterocycles%26date%3D2007%26volume%3D73%26spage%3D47%26epage%3D85" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Jia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacatian, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tice, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishchenko, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singh, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKeever, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bukhtiyarov, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judith, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doe, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGeehan, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dillard, L. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baldwin, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claremon, D. A.</span><span> </span><span class="NLM_article-title">Discovery of VTP-27999, an Alkyl Amine Renin Inhibitor with Potential for Clinical Utility</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">747</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200137x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=747-751&author=L.+Jiaauthor=R.+D.+Simpsonauthor=J.+Yuanauthor=Z.+Xuauthor=W.+Zhaoauthor=S.+Cacatianauthor=C.+M.+Ticeauthor=J.+Guoauthor=A.+Ishchenkoauthor=S.+B.+Singhauthor=Z.+Wuauthor=B.+M.+McKeeverauthor=Y.+Bukhtiyarovauthor=+Johnsonauthor=A.+Judithauthor=C.+P.+Doeauthor=R.+K.+Harrisonauthor=G.+M.+McGeehanauthor=L.+W.+Dillardauthor=J.+J.+Baldwinauthor=D.+A.+Claremon&title=Discovery+of+VTP-27999%2C+an+Alkyl+Amine+Renin+Inhibitor+with+Potential+for+Clinical+Utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fml200137x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200137x%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DSimpson%26aufirst%3DR.%2BD.%26aulast%3DYuan%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DW.%26aulast%3DCacatian%26aufirst%3DS.%26aulast%3DTice%26aufirst%3DC.%2BM.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DIshchenko%26aufirst%3DA.%26aulast%3DSingh%26aufirst%3DS.%2BB.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DMcKeever%26aufirst%3DB.%2BM.%26aulast%3DBukhtiyarov%26aufirst%3DY.%26aulast%3DJohnson%26aulast%3DJudith%26aufirst%3DA.%26aulast%3DDoe%26aufirst%3DC.%2BP.%26aulast%3DHarrison%26aufirst%3DR.%2BK.%26aulast%3DMcGeehan%26aufirst%3DG.%2BM.%26aulast%3DDillard%26aufirst%3DL.%2BW.%26aulast%3DBaldwin%26aufirst%3DJ.%2BJ.%26aulast%3DClaremon%26aufirst%3DD.%2BA.%26atitle%3DDiscovery%2520of%2520VTP-27999%252C%2520an%2520Alkyl%2520Amine%2520Renin%2520Inhibitor%2520with%2520Potential%2520for%2520Clinical%2520Utility%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D2%26spage%3D747%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ostermann, N.; Ruedisser, S.; Ehrhardt, C.; Breitenstein, W.; Marzinzik, A.; Jacoby, E.; Vangrevelinghe, E.; Ottl, J.; Klumpp, M.; Hartwieg, J. C. D.; Cumin, F.; Hassiepen, U.; Trappe, J.; Sedrani, R.; Geisse, S.; Gerhartz, B.; Richert, P.; Francotte, E.; Wagner, T.; Krömer, M.; Kosaka, T.; Webb, R. L.; Rigel, D. F.; Maibaum, J.; Baeschlin, D. K.</span><span> </span><span class="NLM_article-title">A novel class of oral direct renin inhibitors: highly potent 3,5-disubstituted piperidines bearing a tricyclic P<sub>3</sub>–P<sub>1</sub> pharmacophore</span>.,  <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span>, DOI: <span class="refDoi"> DOI: 10.1021/jm301706j</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/jm301706j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&author=N.+Ostermann&author=S.+Ruedisser&author=C.+Ehrhardt&author=W.+Breitenstein&author=A.+Marzinzik&author=E.+Jacoby&author=E.+Vangrevelinghe&author=J.+Ottl&author=M.+Klumpp&author=J.+C.+D.+Hartwieg&author=F.+Cumin&author=U.+Hassiepen&author=J.+Trappe&author=R.+Sedrani&author=S.+Geisse&author=B.+Gerhartz&author=P.+Richert&author=E.+Francotte&author=T.+Wagner&author=M.+Kr%C3%B6mer&author=T.+Kosaka&author=R.+L.+Webb&author=D.+F.+Rigel&author=J.+Maibaum&author=D.+K.+Baeschlin&title=A+novel+class+of+oral+direct+renin+inhibitors%3A+highly+potent+3%2C5-disubstituted+piperidines+bearing+a+tricyclic+P3%E2%80%93P1+pharmacophore&doi=10.1021%2Fjm301706j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm301706j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301706j%26sid%3Dliteratum%253Aachs%26aulast%3DOstermann%26aufirst%3DN.%26atitle%3DA%2520novel%2520class%2520of%2520oral%2520direct%2520renin%2520inhibitors%253A%2520highly%2520potent%25203%252C5-disubstituted%2520piperidines%2520bearing%2520a%2520tricyclic%2520P3%25E2%2580%2593P1%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26doi%3D10.1021%2Fjm301706j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">See <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">See <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=See+Experimental+Section."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26c"><span><span class="NLM_label">(c) </span><div class="note"><p class="first last">X-ray crystal structure of two ligands trans-3,4-pyrrolidine <b>6a</b> bound to the active site of glycosylated rh-renin, see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=X-ray+crystal+structure+of+two+ligands+trans-3%2C4-pyrrolidine+6a+bound+to+the+active+site+of+glycosylated+rh-renin%2C+see+Supporting+Information."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><div class="note"><p class="first last">Compound <b>5</b>, available from the Novartis Collection, has been described as inhibitor of aspartyl protease by</p></div><span class="NLM_contrib-group">Bursavich, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, D. H.</span><span> </span><span class="NLM_article-title">Solid-Phase Synthesis of Aspartic Peptidase Inhibitors: 3-Alkoxy-4-Aryl Piperidines</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">2625</span><span class="NLM_x">–</span> <span class="NLM_lpage">2628</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol016280k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2001&pages=2625-2628&author=M.+G.+Bursavichauthor=D.+H.+Rich&title=Solid-Phase+Synthesis+of+Aspartic+Peptidase+Inhibitors%3A+3-Alkoxy-4-Aryl+Piperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol016280k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol016280k%26sid%3Dliteratum%253Aachs%26aulast%3DBursavich%26aufirst%3DM.%2BG.%26aulast%3DRich%26aufirst%3DD.%2BH.%26atitle%3DSolid-Phase%2520Synthesis%2520of%2520Aspartic%2520Peptidase%2520Inhibitors%253A%25203-Alkoxy-4-Aryl%2520Piperidines%26jtitle%3DOrg.%2520Lett.%26date%3D2001%26volume%3D3%26spage%3D2625%26epage%3D2628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Rahuel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasetti, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rüeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stutz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuhrer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grütter, M. G.</span><span> </span><span class="NLM_article-title">Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">493</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2FS1074-5521%2800%2900134-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=10903938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltlKnsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=493-504&author=J.+Rahuelauthor=V.+Rasettiauthor=J.+Maibaumauthor=H.+R%C3%BCegerauthor=R.+G%C3%B6schkeauthor=N.-C.+Cohenauthor=S.+Stutzauthor=F.+Cuminauthor=W.+Fuhrerauthor=J.+M.+Woodauthor=M.+G.+Gr%C3%BCtter&title=Structure-based+drug+design%3A+the+discovery+of+novel+nonpeptide+orally+active+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design: the discovery of novel nonpeptide orally active inhibitors of human renin</span></div><div class="casAuthors">Rahuel, J.; Rasetti, V.; Maibaum, J.; Rueger, H.; Goschke, R.; Cohen, N-C.; Stutz, S.; Cumin, F.; Fuhrer, W.; Wood, J. M.; Grutter, M. G.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">493-504</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: The aspartic proteinase renin plays an important physiol. role in the regulation of blood pressure.  It catalyzes the first step in the conversion of angiotensinogen to the hormone angiotensin II.  In the past, potent peptide inhibitors of renin have been developed, but none of these compds. has made it to the end of clin. trials.  Our primary aim was to develop novel nonpeptide inhibitors.  Based on the available structural information concerning renin-substrate interactions, we synthesized inhibitors in which the peptide portion was replaced by lipophilic moieties that interact with the large hydrophobic S1/S3-binding pocket in renin.  Results: Crystal structure anal. of renin-inhibitor complexes combined with computational methods were employed in the medicinal-chem. optimization process.  Structure anal. revealed that the newly designed inhibitors bind as predicted to the S1/S3 pocket.  In addn., however, these compds. interact with a hitherto unrecognized large, distinct, sub-pocket of the enzyme that extends from the S3-binding site towards the hydrophobic core of the enzyme.  Binding to the S3sp sub-pocket was essential for high binding affinity.  This unprecedented binding mode guided the drug-design process in which the mostly hydrophobic interactions within subsite S3sp were optimized.  Conclusions: Our design approach led to compds. with high in vitro affinity and specificity for renin, favorable bioavailability and excellent oral efficacy in lowering blood pressure in primates.  These renin inhibitors are therefore potential therapeutic agents for the treatment of hypertension and related cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp__RrHxd--o7Vg90H21EOLACvtfcHk0lg7NOq70tjjrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltlKnsbo%253D&md5=69eb034c059696b97faf830727ce924a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900134-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900134-4%26sid%3Dliteratum%253Aachs%26aulast%3DRahuel%26aufirst%3DJ.%26aulast%3DRasetti%26aufirst%3DV.%26aulast%3DMaibaum%26aufirst%3DJ.%26aulast%3DR%25C3%25BCeger%26aufirst%3DH.%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DStutz%26aufirst%3DS.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DFuhrer%26aufirst%3DW.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DGr%25C3%25BCtter%26aufirst%3DM.%2BG.%26atitle%3DStructure-based%2520drug%2520design%253A%2520the%2520discovery%2520of%2520novel%2520nonpeptide%2520orally%2520active%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26spage%3D493%26epage%3D504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Yamaguchi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menear, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnell, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">The P1 <i>N</i>-isopropyl motif bearing hydroxyethylene dipeptide isostere analogs of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4863</span><span class="NLM_x">–</span> <span class="NLM_lpage">4867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4863-4867&author=Y.+Yamaguchiauthor=K.+Menearauthor=N.-C.+Cohenauthor=R.+Mahauthor=F.+Cuminauthor=C.+Schnellauthor=J.+M.+Woodauthor=J.+Maibaum&title=The+P1+N-isopropyl+motif+bearing+hydroxyethylene+dipeptide+isostere+analogs+of+aliskiren+are+in+vitro+potent+inhibitors+of+the+human+aspartyl+protease+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamaguchi%26aufirst%3DY.%26aulast%3DMenear%26aufirst%3DK.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DMah%26aufirst%3DR.%26aulast%3DCumin%26aufirst%3DF.%26aulast%3DSchnell%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DThe%2520P1%2520N-isopropyl%2520motif%2520bearing%2520hydroxyethylene%2520dipeptide%2520isostere%2520analogs%2520of%2520aliskiren%2520are%2520in%2520vitro%2520potent%2520inhibitors%2520of%2520the%2520human%2520aspartyl%2520protease%2520renin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4863%26epage%3D4867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Göschke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, N.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maibaum, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of novel 2,7-dialkyl substituted 5(<i>S</i>)-amino-4(<i>S</i>)-hydroxy-8-phenyl-octanecarboxamides as in vitro potent peptidomimetic inhibitors of human renin</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=2735-2740&author=R.+G%C3%B6schkeauthor=N.-C.+Cohenauthor=J.+M.+Woodauthor=J.+Maibaum&title=Design+and+synthesis+of+novel+2%2C7-dialkyl+substituted+5%28S%29-amino-4%28S%29-hydroxy-8-phenyl-octanecarboxamides+as+in+vitro+potent+peptidomimetic+inhibitors+of+human+renin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6schke%26aufirst%3DR.%26aulast%3DCohen%26aufirst%3DN.-C.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DMaibaum%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520novel%25202%252C7-dialkyl%2520substituted%25205%2528S%2529-amino-4%2528S%2529-hydroxy-8-phenyl-octanecarboxamides%2520as%2520in%2520vitro%2520potent%2520peptidomimetic%2520inhibitors%2520of%2520human%2520renin%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1997%26volume%3D7%26spage%3D2735%26epage%3D2740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Specker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böttcher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brass, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lilie, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoop, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Müller, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griebenow, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">117</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2006&pages=106-117&author=E.+Speckerauthor=J.+B%C3%B6ttcherauthor=S.+Brassauthor=A.+Heineauthor=H.+Lilieauthor=A.+Schoopauthor=G.+M%C3%BCllerauthor=N.+Griebenowauthor=G.+Klebe&title=Unexpected+novel+binding+mode+of+pyrrolidine-based+aspartyl+protease+inhibitors%3A+design%2C+synthesis+and+crystal+structure+in+complex+with+HIV+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSpecker%26aufirst%3DE.%26aulast%3DB%25C3%25B6ttcher%26aufirst%3DJ.%26aulast%3DBrass%26aufirst%3DS.%26aulast%3DHeine%26aufirst%3DA.%26aulast%3DLilie%26aufirst%3DH.%26aulast%3DSchoop%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26aulast%3DGriebenow%26aufirst%3DN.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DUnexpected%2520novel%2520binding%2520mode%2520of%2520pyrrolidine-based%2520aspartyl%2520protease%2520inhibitors%253A%2520design%252C%2520synthesis%2520and%2520crystal%2520structure%2520in%2520complex%2520with%2520HIV%2520protease%26jtitle%3DChemMedChem%26date%3D2006%26volume%3D1%26spage%3D106%26epage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Chen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campeau, L.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cauchon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chefson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ducharme, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubé, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falgueyret, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fournier, P.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gagné, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, J.-Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lacombe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laliberté, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lévesque, J.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKay, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Percival, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St-Jacques, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toulmond, S.</span><span> </span><span class="NLM_article-title">Renin inhibitors for the treatment of hypertension: Design and optimization of a novel series of pyridone-substituted piperidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3970</span><span class="NLM_x">–</span> <span class="NLM_lpage">3975</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3970-3975&author=A.+Chenauthor=L.-C.+Campeauauthor=E.+Cauchonauthor=A.+Chefsonauthor=Y.+Ducharmeauthor=D.+Dub%C3%A9author=J.-P.+Falgueyretauthor=P.-A.+Fournierauthor=S.+Gagn%C3%A9author=E.+Grimmauthor=Y.+Hanauthor=R.+Houleauthor=J.-Q.+Huangauthor=P.+Lacombeauthor=S.+Lalibert%C3%A9author=J.-F.+L%C3%A9vesqueauthor=S.+Liuauthor=D.+MacDonaldauthor=B.+Mackayauthor=D.+McKayauthor=M.+D.+Percivalauthor=C.+Reganauthor=H.+Reganauthor=R.+St-Jacquesauthor=S.+Toulmond&title=Renin+inhibitors+for+the+treatment+of+hypertension%3A+Design+and+optimization+of+a+novel+series+of+pyridone-substituted+piperidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DA.%26aulast%3DCampeau%26aufirst%3DL.-C.%26aulast%3DCauchon%26aufirst%3DE.%26aulast%3DChefson%26aufirst%3DA.%26aulast%3DDucharme%26aufirst%3DY.%26aulast%3DDub%25C3%25A9%26aufirst%3DD.%26aulast%3DFalgueyret%26aufirst%3DJ.-P.%26aulast%3DFournier%26aufirst%3DP.-A.%26aulast%3DGagn%25C3%25A9%26aufirst%3DS.%26aulast%3DGrimm%26aufirst%3DE.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DHoule%26aufirst%3DR.%26aulast%3DHuang%26aufirst%3DJ.-Q.%26aulast%3DLacombe%26aufirst%3DP.%26aulast%3DLalibert%25C3%25A9%26aufirst%3DS.%26aulast%3DL%25C3%25A9vesque%26aufirst%3DJ.-F.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMacDonald%26aufirst%3DD.%26aulast%3DMackay%26aufirst%3DB.%26aulast%3DMcKay%26aufirst%3DD.%26aulast%3DPercival%26aufirst%3DM.%2BD.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DRegan%26aufirst%3DH.%26aulast%3DSt-Jacques%26aufirst%3DR.%26aulast%3DToulmond%26aufirst%3DS.%26atitle%3DRenin%2520inhibitors%2520for%2520the%2520treatment%2520of%2520hypertension%253A%2520Design%2520and%2520optimization%2520of%2520a%2520novel%2520series%2520of%2520pyridone-substituted%2520piperidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D3970%26epage%3D3975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Scheiper, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matter, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinhagen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stilz, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böcskei, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fleuryc, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCort, G.</span><span> </span><span class="NLM_article-title">Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6268</span><span class="NLM_x">–</span> <span class="NLM_lpage">6272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm3017078&amp;key=10.1016%2Fj.bmcl.2010.08.092" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm3017078&amp;key=20850300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1KrsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6268-6272&author=A.+Scheiperauthor=H.+Matterauthor=H.+Steinhagenauthor=U.+Stilzauthor=Z.+B%C3%B6cskeiauthor=V.+Fleurycauthor=G.+McCort&title=Discovery+and+optimization+of+a+new+class+of+potent+and+non-chiral+indole-3-carboxamide-based+renin+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and optimization of a new class of potent and non-chiral indole-3-carboxamide-based renin inhibitors</span></div><div class="casAuthors">Scheiper, Bodo; Matter, Hans; Steinhagen, Henning; Stilz, Ulrich; Boecskei, Zsolt; Fleury, Valerie; McCort, Gary</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6268-6272</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Selective inhibition of the aspartyl protease renin has gained attraction as an interesting approach to control hypertension and assocd. cardiovascular risk factors given its unique position in the renin-angiotensin system.  Using a combination of high-throughput screening, parallel synthesis, X-ray crystallog. and structure-based design, we identified and optimized a novel series of potent and non-chiral indole-3-carboxamides with remarkable potency for renin.  The most potent compd. 5k displays an IC50 value of 2 nM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8587ln8gHC7Vg90H21EOLACvtfcHk0lhMBNpNP8ZNCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1KrsbnN&md5=7584068acca5baa12d8925c7c43d1e03</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.08.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.08.092%26sid%3Dliteratum%253Aachs%26aulast%3DScheiper%26aufirst%3DA.%26aulast%3DMatter%26aufirst%3DH.%26aulast%3DSteinhagen%26aufirst%3DH.%26aulast%3DStilz%26aufirst%3DU.%26aulast%3DB%25C3%25B6cskei%26aufirst%3DZ.%26aulast%3DFleuryc%26aufirst%3DV.%26aulast%3DMcCort%26aufirst%3DG.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520a%2520new%2520class%2520of%2520potent%2520and%2520non-chiral%2520indole-3-carboxamide-based%2520renin%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6268%26epage%3D6272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Müller, G.</span><span> </span><span class="NLM_article-title">Target Family-Directed Masterkeys in Chemogenomics</span>. In  <span class="citation_source-book">Chemogenomics in Drug Discovery: A Medicinal Chemistry Perspective</span>; <span class="NLM_contrib-group">Kubinyi, H.; Müller, G.</span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">7</span><span class="NLM_x">–</span> <span class="NLM_lpage">41</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&pages=7-41&author=G.+M%C3%BCllerauthor=H.+Kubinyi&author=G.+M%C3%BCller&title=Chemogenomics+in+Drug+Discovery%3A+A+Medicinal+Chemistry+Perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DG.%26atitle%3DTarget%2520Family-Directed%2520Masterkeys%2520in%2520Chemogenomics%26btitle%3DChemogenomics%2520in%2520Drug%2520Discovery%253A%2520A%2520Medicinal%2520Chemistry%2520Perspective%26aulast%3DKubinyi%26aufirst%3DH.%26pub%3DWiley-VCH%26date%3D2004%26spage%3D7%26epage%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35a"><span><span class="NLM_contrib-group">Stachel, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steele, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrocchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haugabook, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugasheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery of pyrrolidine-based-β-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=240-244&author=S.+J.+Stachelauthor=T.+G.+Steeleauthor=A.+Petrocchiauthor=S.+J.+Haugabookauthor=G.+McGaugheyauthor=M.+K.+Hollowayauthor=T.+Allisonauthor=S.+Munshiauthor=P.+Zuckauthor=D.+Colussiauthor=K.+Tugashevaauthor=A.+Wolfeauthor=S.+L.+Grahamauthor=J.+P.+Vacca&title=Discovery+of+pyrrolidine-based-%CE%B2-secretase+inhibitors%3A+lead+advancement+through+conformational+design+for+maintenance+of+ligand+binding+efficiency"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26aulast%3DSteele%26aufirst%3DT.%2BG.%26aulast%3DPetrocchi%26aufirst%3DA.%26aulast%3DHaugabook%26aufirst%3DS.%2BJ.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DAllison%26aufirst%3DT.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugasheva%26aufirst%3DK.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520of%2520pyrrolidine-based-%25CE%25B2-secretase%2520inhibitors%253A%2520lead%2520advancement%2520through%2520conformational%2520design%2520for%2520maintenance%2520of%2520ligand%2520binding%2520efficiency%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D240%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">For an account on spiropyrrolidine Bace-1 inhibitors, see:</p></div><div class="NLM_citation" id="rightTab-cit35b"><span><span class="NLM_contrib-group">Efremov, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borzilleri, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capetta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorff, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldstein, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansour, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McColl, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oborski, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connell, T. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Sullivan, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Withka, J. M.</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9069</span><span class="NLM_x">–</span> <span class="NLM_lpage">9088</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201715d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Efremov%2C+I.+V.%3B+Vajdos%2C+F.+F.%3B+Borzilleri%2C+K.+A.%3B+Capetta%2C+S.%3B+Chen%2C+H.%3B+Dorff%2C+P.+H.%3B+Dutra%2C+J.+K.%3B+Goldstein%2C+S.+W.%3B+Mansour%2C+M.%3B+McColl%2C+A.%3B+Noell%2C+S.%3B+Oborski%2C+C.+E.%3B+O%E2%80%99Connell%2C+T.+N.%3B+O%E2%80%99Sullivan%2C+T.+J.%3B+Pandit%2C+J.%3B+Wang%2C+H.%3B+Wei%2C+B.%3B+Withka%2C+J.+M.J.+Med.+Chem.+2012%2C+55%2C+9069%E2%80%939088"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35b&amp;dbid=16384&amp;doi=10.1021%2Fjm201715d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201715d%26sid%3Dliteratum%253Aachs%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DCapetta%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DGoldstein%26aufirst%3DS.%2BW.%26aulast%3DMansour%26aufirst%3DM.%26aulast%3DMcColl%26aufirst%3DA.%26aulast%3DNoell%26aufirst%3DS.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DO%25E2%2580%2599Connell%26aufirst%3DT.%2BN.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9069%26epage%3D9088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><div class="note"><p class="first last"><i>trans</i>-3,4-Disubstituted proline derivatives have been claimed as renin inhibitors, however, no experimental data on the their binding mode to human renin has been disclosed to date. These compounds may interact with the flap binding pocket of renin in the open conformation in a similar manner as the piperidine-based GRAB peptidomimetic renin inhibitors represented by <b>2</b>, based on the close structural similarities of the extended pharmacophores at the C-4 position of the 5- and 6-membered ring core templates, respectively</p></div>. <span class="NLM_contrib-group">Bezencon, O.; Boss, C.; Bur, D.; Corminboeuf, O.; Grisostomi, C.; Remen, L.; Richard-Bildstein, S.; weller, T.</span>PCT Int. Appl. WO2007034406A1,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=trans-3%2C4-Disubstituted+proline+derivatives+have+been+claimed+as+renin+inhibitors%2C+however%2C+no+experimental+data+on+the+their+binding+mode+to+human+renin+has+been+disclosed+to+date.+These+compounds+may+interact+with+the+flap+binding+pocket+of+renin+in+the+open+conformation+in+a+similar+manner+as+the+piperidine-based+GRAB+peptidomimetic+renin+inhibitors+represented+by+2%2C+based+on+the+close+structural+similarities+of+the+extended+pharmacophores+at+the+C-4+position+of+the+5-+and+6-membered+ring+core+templates%2C+respectively.+Bezencon%2C+O.%3B+Boss%2C+C.%3B+Bur%2C+D.%3B+Corminboeuf%2C+O.%3B+Grisostomi%2C+C.%3B+Remen%2C+L.%3B+Richard-Bildstein%2C+S.%3B+weller%2C+T.PCT+Int.+Appl.+WO2007034406A1%2C+2007."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBezencon%26aufirst%3DO.%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Bohlender, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukamizu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippoldt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dietz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luft, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganten, D.</span><span> </span><span class="NLM_article-title">High human hypertension in transgenic rats</span> <span class="citation_source-journal">Hypertension</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">428</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1997&pages=428-434&author=J.+Bohlenderauthor=A.+Fukamizuauthor=A.+Lippoldtauthor=T.+Nomuraauthor=R.+Dietzauthor=J.+Menardauthor=K.+Murakamiauthor=F.+C.+Luftauthor=D.+Ganten&title=High+human+hypertension+in+transgenic+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBohlender%26aufirst%3DJ.%26aulast%3DFukamizu%26aufirst%3DA.%26aulast%3DLippoldt%26aufirst%3DA.%26aulast%3DNomura%26aufirst%3DT.%26aulast%3DDietz%26aufirst%3DR.%26aulast%3DMenard%26aufirst%3DJ.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DLuft%26aufirst%3DF.%2BC.%26aulast%3DGanten%26aufirst%3DD.%26atitle%3DHigh%2520human%2520hypertension%2520in%2520transgenic%2520rats%26jtitle%3DHypertension%26date%3D1997%26volume%3D29%26spage%3D428%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hosomi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakurai, H.</span><span> </span><span class="NLM_article-title"><i>N</i>-(Trimethylsilylmethyl)aminomethyl ethers as azomethine ylide synthons. A new and convenient access to pyrrolidine derivatives</span> <span class="citation_source-journal">Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1984</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">–</span> <span class="NLM_lpage">1120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1984&pages=1117-1120&author=A.+Hosomiauthor=Y.+Sakataauthor=H.+Sakurai&title=N-%28Trimethylsilylmethyl%29aminomethyl+ethers+as+azomethine+ylide+synthons.+A+new+and+convenient+access+to+pyrrolidine+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHosomi%26aufirst%3DA.%26aulast%3DSakata%26aufirst%3DY.%26aulast%3DSakurai%26aufirst%3DH.%26atitle%3DN-%2528Trimethylsilylmethyl%2529aminomethyl%2520ethers%2520as%2520azomethine%2520ylide%2520synthons.%2520A%2520new%2520and%2520convenient%2520access%2520to%2520pyrrolidine%2520derivatives%26jtitle%3DChem.%2520Lett.%26date%3D1984%26volume%3D7%26spage%3D1117%26epage%3D1120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit38b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Terao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Achiwa, K.</span><span> </span><span class="NLM_article-title">Trifluoroacetic acid-catalyzed 1,3-cycloaddition of the simplest iminium ylide leading to 3- or 3,4-substituted pyrrolidines and 2,5-dihydropyrroles</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">2762</span><span class="NLM_x">–</span> <span class="NLM_lpage">2766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1985&pages=2762-2766&author=Y.+Teraoauthor=H.+Kotakiauthor=N.+Imaiauthor=K.+Achiwa&title=Trifluoroacetic+acid-catalyzed+1%2C3-cycloaddition+of+the+simplest+iminium+ylide+leading+to+3-+or+3%2C4-substituted+pyrrolidines+and+2%2C5-dihydropyrroles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTerao%26aufirst%3DY.%26aulast%3DKotaki%26aufirst%3DH.%26aulast%3DImai%26aufirst%3DN.%26aulast%3DAchiwa%26aufirst%3DK.%26atitle%3DTrifluoroacetic%2520acid-catalyzed%25201%252C3-cycloaddition%2520of%2520the%2520simplest%2520iminium%2520ylide%2520leading%2520to%25203-%2520or%25203%252C4-substituted%2520pyrrolidines%2520and%25202%252C5-dihydropyrroles%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1985%26volume%3D33%26spage%3D2762%26epage%3D2766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Abdel-Magid, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maryanoff, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, R. D.</span><span> </span><span class="NLM_article-title">Reductive amination of aldehydes and ketones with sodium triacetoxyborohydride. Studies on direct and indirect reductive amination procedures</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">3849</span><span class="NLM_x">–</span> <span class="NLM_lpage">3862</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo960057x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm3017078&amp;key=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1996&pages=3849-3862&author=A.+F.+Abdel-Magidauthor=K.+G.+Carsonauthor=B.+D.+Harrisauthor=C.+A.+Maryanoffauthor=R.+D.+Shah&title=Reductive+amination+of+aldehydes+and+ketones+with+sodium+triacetoxyborohydride.+Studies+on+direct+and+indirect+reductive+amination+procedures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Reductive Amination of Aldehydes and Ketones with Sodium Triacetoxyborohydride. Studies on Direct and Indirect Reductive Amination Procedures</span></div><div class="casAuthors">Abdel-Magid, Ahmed F.; Carson, Kenneth G.; Harris, Bruce D.; Maryanoff, Cynthia A.; Shah, Rekha D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3849-3862</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sodium triacetoxyborohydride is presented as a general reducing agent for the reductive amination of aldehydes and ketones.  Procedures for using this mild and selective reagent have been developed for a wide variety of substrates.  The scope of the reaction includes aliph. acyclic and cyclic ketones, aliph. and arom. aldehydes, and primary and secondary amines including a variety of weakly basic and nonbasic amines.  Limitations include reactions with arom. and unsatd. ketones and some sterically hindered ketones and amines.  1,2-Dichloroethane (DCE) is the preferred reaction solvent, but reactions can also be carried out in THF and occasionally in acetonitrile.  Acetic acid may be used as catalyst with ketone reactions, but it is generally not needed with aldehydes.  The procedure is carried out effectively in the presence of acid sensitive functional groups such as acetals and ketals; it can also be carried out in the presence of reducible functional groups such as C-C multiple bonds and cyano and nitro groups.  Reactions are generally faster in DCE than in THF, and in both solvents, reactions are faster in the presence of AcOH.  In comparison with other reductive amination procedures such as NaBH3CN/MeOH, borane-pyridine, and catalytic hydrogenation, NaBH(OAc)3 gave consistently higher yields and fewer side products.  In the reductive amination of some aldehydes with primary amines where dialkylation is a problem we adopted a stepwise procedure involving imine formation in MeOH followed by redn. with NaBH4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1pj6c2VgVU7Vg90H21EOLACvtfcHk0lipUfVoEXjkUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XivFShu7o%253D&md5=9cc14c9adbbb916bd3326cb3e83a9b40</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo960057x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo960057x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdel-Magid%26aufirst%3DA.%2BF.%26aulast%3DCarson%26aufirst%3DK.%2BG.%26aulast%3DHarris%26aufirst%3DB.%2BD.%26aulast%3DMaryanoff%26aufirst%3DC.%2BA.%26aulast%3DShah%26aufirst%3DR.%2BD.%26atitle%3DReductive%2520amination%2520of%2520aldehydes%2520and%2520ketones%2520with%2520sodium%2520triacetoxyborohydride.%2520Studies%2520on%2520direct%2520and%2520indirect%2520reductive%2520amination%2520procedures%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1996%26volume%3D61%26spage%3D3849%26epage%3D3862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Breitenstein, W.; Cottens, S.; Ehrhardt, C.; Jacoby, E.; Lorthiois, E.; Maibaum, J.; Ostermann, N.; Sellner, H.; Simic, O.</span><span> </span><span class="NLM_article-title">Preparation of Substituted Pyrrolidines as Renin Inhibitors</span>. PCT Int. Appl. WO2006066896A2,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=W.+Breitenstein&author=S.+Cottens&author=C.+Ehrhardt&author=E.+Jacoby&author=E.+Lorthiois&author=J.+Maibaum&author=N.+Ostermann&author=H.+Sellner&author=O.+Simic&title=Preparation+of+Substituted+Pyrrolidines+as+Renin+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBreitenstein%26aufirst%3DW.%26atitle%3DPreparation%2520of%2520Substituted%2520Pyrrolidines%2520as%2520Renin%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Prashad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repic, O.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed amination of aryl bromides with hindered <i>N</i>-alkyl-substituted anilines using a palladium(I) tri-<i>tert</i>-butylphosphine bromide dimer</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">1163</span><span class="NLM_x">–</span> <span class="NLM_lpage">1164</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo020609d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2003&pages=1163-1164&author=M.+Prashadauthor=X.+Y.+Makauthor=Y.+Liuauthor=O.+Repic&title=Palladium-catalyzed+amination+of+aryl+bromides+with+hindered+N-alkyl-substituted+anilines+using+a+palladium%28I%29+tri-tert-butylphosphine+bromide+dimer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjo020609d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo020609d%26sid%3Dliteratum%253Aachs%26aulast%3DPrashad%26aufirst%3DM.%26aulast%3DMak%26aufirst%3DX.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DRepic%26aufirst%3DO.%26atitle%3DPalladium-catalyzed%2520amination%2520of%2520aryl%2520bromides%2520with%2520hindered%2520N-alkyl-substituted%2520anilines%2520using%2520a%2520palladium%2528I%2529%2520tri-tert-butylphosphine%2520bromide%2520dimer%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2003%26volume%3D68%26spage%3D1163%26epage%3D1164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v0z" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2v0z','PDB','2v0z'); return false;">PDB: 2V0Z</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PR8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1PR8','PDB','1PR8'); return false;">PDB: 1PR8</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ5','PDB','4GJ5'); return false;">PDB: 4GJ5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ6','PDB','4GJ6'); return false;">PDB: 4GJ6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ7','PDB','4GJ7'); return false;">PDB: 4GJ7</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i42"><a href="/doi/suppl/10.1021/jm3017078">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_82750"></div></div></div></div></div><hr /></hr><p class="last">Description of the 3D pharmacophore searching protocol, experimental procedures for biological assays, in vivo pharmacokinetics, in vivo pharmacology, X-ray crystallographic information for the rh-renin–inhibitor complexes with <b>5</b>, <b>6a</b>, and <b>12a</b>, X-ray crystal structure of two ligands <i>trans</i>-3,4-pyrrolidine <b>6a</b> bound to the active site of glycosylated rh-renin. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3017078/suppl_file/jm3017078_si_001.pdf">jm3017078_si_001.pdf (652.61 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The crystal structures of rh-renin in complex with <b>5</b>, <b>6a</b>, and <b>12a</b> have been deposited at the Protein Data Bank RSCB PDB with the PDB IDs <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ5">4GJ5</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ6">4GJ6</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4GJ7">4GJ7</a>, respectively.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3017078&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm3017078%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-6%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3017078" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799958d3e593cc4","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
